[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 340
1. Coenegrachts K, Orlent H, ter Beek L, Haspeslagh M, Bipat S, Stoker J, Rigauts H: Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI. J Magn Reson Imaging; 2008 Jan;27(1):117-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI.
  • PURPOSE: To prospectively compare single-shot spin-echo echo-planar imaging (SSSE-EPI) using b = 0, 10, 150, and 400 seconds/mm(2) with standard MRI techniques after intravenous super paramagnetic iron oxide (SPIO) in the detection and characterization of focal liver lesions with focus on small (<10 mm) focal liver lesions.
  • MATERIALS AND METHODS: A total of 25 patients suspected for colorectal liver metastases were included.
  • RESULTS: Reference standard demonstrated 25 hemangiomas and 70 metastases.
  • CONCLUSION: This preliminary study shows the potential of SSSE-EPI as a stand-alone sequence for the detection of liver hemangiomas and metastases when compared with SPIO-enhanced imaging.
  • [MeSH-major] Colorectal Neoplasms / pathology. Contrast Media / administration & dosage. Echo-Planar Imaging / methods. Iron / administration & dosage. Liver Neoplasms / secondary. Magnetic Resonance Imaging / methods. Oxides / administration & dosage

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Iron.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Ferumoxides .
  • Hazardous Substances Data Bank. IRON, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18050350.001).
  • [ISSN] 1053-1807
  • [Journal-full-title] Journal of magnetic resonance imaging : JMRI
  • [ISO-abbreviation] J Magn Reson Imaging
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Magnetite Nanoparticles; 0 / Oxides; E1UOL152H7 / Iron; G6N3J05W84 / ferumoxides; K3R6ZDH4DU / Dextrans; XM0M87F357 / Ferrosoferric Oxide
  •  go-up   go-down


2. Laverdiere M, Aggarawal R, Blei F: Hemangiomatosis in two sets of premature twins. Am J Perinatol; 2008 May;25(5):295-300
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We attempted to identify the association of multifocal hemangiomas, specifically hepatic hemangiomatosis, in twins.
  • We retrospectively reviewed our database of infants with hemangiomas, identifying those twins who both had hemangiomas, and we report two cases of twins with hemangiomatosis, including hepatic hemangiomas.
  • Of 39 sets of twins in our Hemangioma Program, both twins had hemangiomas in seven twin sets.
  • There were also five sets of triplets, with one set having two siblings affected by hemangiomas.
  • We concluded that although hemangiomas in multiple gestation infants is well known, hemangiomatosis including hepatic hemangiomatosis is unusual.
  • [MeSH-major] Diseases in Twins. Hemangioma / diagnosis. Infant, Premature, Diseases / diagnosis. Liver Neoplasms / diagnosis. Skin Neoplasms / diagnosis


3. Alomari AI: Comments on imaging and management of hepatic hemangiomas. Pediatr Radiol; 2009 Jun;39(6):637-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comments on imaging and management of hepatic hemangiomas.
  • [MeSH-major] Diagnostic Imaging / methods. Hemangioma / diagnosis. Liver Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Diagnostic Imaging.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Pediatr Radiol. 2009 Mar;39(3):277-81 [19083217.001]
  • [Cites] Eur J Pediatr. 2008 Aug;167(8):961-2; author reply 963 [17952463.001]
  • [Cites] Plast Reconstr Surg. 1999 Nov;104(6):1616-23 [10541160.001]
  • [Cites] J Pediatr Surg. 2007 Jan;42(1):62-7; discussion 67-8 [17208542.001]
  • [Cites] Eur J Radiol. 2006 Sep;59(3):460-4 [16644166.001]
  • [Cites] Pediatr Radiol. 2009 Mar;39(3):277-81 [19083217.001]
  • [Cites] N Engl J Med. 2000 Jul 20;343(3):185-9 [10900278.001]
  • [Cites] Plast Reconstr Surg. 1982 Mar;69(3):412-22 [7063565.001]
  • (PMID = 19387632.001).
  • [ISSN] 1432-1998
  • [Journal-full-title] Pediatric radiology
  • [ISO-abbreviation] Pediatr Radiol
  • [Language] eng
  • [Publication-type] Comment; Letter
  • [Publication-country] Germany
  •  go-up   go-down


Advertisement
4. Colli A, Fraquelli M, Massironi S, Colucci A, Paggi S, Conte D: Elective surgery for benign liver tumours. Cochrane Database Syst Rev; 2007;(1):CD005164
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Elective surgery for benign liver tumours.
  • BACKGROUND: Benign liver tumours (haemangioma, focal nodular hyperplasia, and hepatic adenoma) have different prevalence and prognosis.
  • Spontaneous rupture and malignant transformation can complicate hepatic adenoma.
  • Elective surgery is controversial, and indications are represented by uncertain diagnosis, presence of symptoms, and prevention of major complications.
  • OBJECTIVES: To assess the beneficial and harmful effects of elective surgery of benign liver tumours.
  • A further search included the proceedings of major hepatological and surgical congresses (Annual Meetings of the American Association for the Study of the Liver (AASLD) and European Association for the Study of the Liver (EASL)), and examination of the references of relevant papers and reference lists of the identified studies.
  • SELECTION CRITERIA: Randomised clinical trials in adult patients with benign liver tumours without indications for emergency surgery in which elective surgery (resection) versus no intervention or sham operation are compared.
  • AUTHORS' CONCLUSIONS: We were unable to find evidence supporting or refuting elective surgery for patients with benign liver tumours.
  • [MeSH-major] Adenoma, Liver Cell / surgery. Elective Surgical Procedures. Focal Nodular Hyperplasia / surgery. Hemangioma / surgery. Liver Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17253542.001).
  • [ISSN] 1469-493X
  • [Journal-full-title] The Cochrane database of systematic reviews
  • [ISO-abbreviation] Cochrane Database Syst Rev
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 55
  •  go-up   go-down


5. Oto A, Kulkarni K, Nishikawa R, Baron RL: Contrast enhancement of hepatic hemangiomas on multiphase MDCT: Can we diagnose hepatic hemangiomas by comparing enhancement with blood pool? AJR Am J Roentgenol; 2010 Aug;195(2):381-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Contrast enhancement of hepatic hemangiomas on multiphase MDCT: Can we diagnose hepatic hemangiomas by comparing enhancement with blood pool?
  • OBJECTIVE: The purpose of this article is to determine whether enhancement of nodular foci within hemangiomas is homogeneous and matches blood vessels at different phases on contrast-enhanced MDCT.
  • MATERIALS AND METHODS: Multiphase (unenhanced, arterial, portal venous, and delayed phases) MDCT images of 58 hemangiomas were reviewed by two radiologists.
  • Nodular-enhancing foci within hemangiomas were evaluated for enhancement pattern and were subjectively compared with enhancement of the aorta, inferior vena cava, hepatic vein, and portal vein for each contrast-enhanced phase.
  • RESULTS: Qualitative analysis showed heterogeneously enhancing nodules in 79.3% and 65.5% of hemangiomas in the arterial phase and in 74.1% and 53.4% of hemangiomas in the portal venous phase, according to readers 1 and 2, respectively.
  • In the portal venous phase, 15.4% and 21.7%, 16.8% and 18.2%, 14.1% and 23.8%, and 19.5% and 25.9% of nodules were scored with enhancement similar to that in the aorta, inferior vena cava, hepatic vein, and portal vein by readers 1 and 2, respectively.
  • CONCLUSION: Attenuation of enhancing foci within hemangiomas does not match vessel density qualitatively or quantitatively.
  • Although persistent enhancement without washout is a useful CT criterion, specific criteria to match the blood pool cannot be used to confirm a diagnosis of hemangioma.
  • [MeSH-major] Hemangioma / radiography. Liver Neoplasms / radiography. Tomography, X-Ray Computed / methods

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20651193.001).
  • [ISSN] 1546-3141
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


6. Shimada K, Nakamoto Y, Isoda H, Saito H, Arizono S, Shibata T, Togashi K: FDG PET for giant cavernous hemangioma: important clue to differentiate from a malignant vascular tumor in the liver. Clin Nucl Med; 2010 Dec;35(12):924-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] FDG PET for giant cavernous hemangioma: important clue to differentiate from a malignant vascular tumor in the liver.
  • Giant cavernous hemangioma of the liver sometimes has a very inhomogeneous appearance with intratumoral degeneration on computed tomography or magnetic resonance imaging, and may mimic a malignant hepatic tumor, including angiosarcoma.
  • There are many reports about F-18 fluorodeoxyglucose (FDG) uptake of angiosarcoma; however, knowledge regarding positron emission tomography findings with FDG for giant hepatic cavernous hemangioma is still limited.
  • We herein present 2 cases of giant hepatic cavernous hemangioma in which low FDG uptake was considered helpful to differentiate from malignant hepatic tumor.
  • [MeSH-major] Fluorodeoxyglucose F18. Hemangioma, Cavernous / radionuclide imaging. Liver Neoplasms / radionuclide imaging. Positron-Emission Tomography
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Middle Aged

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21206221.001).
  • [ISSN] 1536-0229
  • [Journal-full-title] Clinical nuclear medicine
  • [ISO-abbreviation] Clin Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


7. Vilgrain V: Focal nodular hyperplasia. Eur J Radiol; 2006 May;58(2):236-45
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Focal nodular hyperplasia is the second most common benign liver tumor after hemangioma and occurs predominantly in young women.
  • Imaging techniques are crucial in the diagnosis of this lesion.
  • [MeSH-major] Focal Nodular Hyperplasia. Liver / radiography. Liver / ultrasonography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16414229.001).
  • [ISSN] 0720-048X
  • [Journal-full-title] European journal of radiology
  • [ISO-abbreviation] Eur J Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Organometallic Compounds; 15G12L5X8K / gadobenic acid; 6HG8UB2MUY / Meglumine
  • [Number-of-references] 48
  •  go-up   go-down


8. Masui T, Katayama M, Nakagawara M, Shimizu S, Kojima K: Exophytic giant cavernous hemangioma of the liver with growing tendency. Radiat Med; 2005 Mar;23(2):121-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Exophytic giant cavernous hemangioma of the liver with growing tendency.
  • Hepatic hemangioma is a common benign tumor, but its exophytic and expansile forms may be atypical.
  • We report a case of exophytic hemangioma of the liver with a growing tendency, demonstrated using magnetic resonance imaging (MRI) and computed tomography (CT) combined with angiography.
  • [MeSH-major] Hemangioma, Cavernous / diagnosis. Liver Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15827530.001).
  • [ISSN] 0288-2043
  • [Journal-full-title] Radiation medicine
  • [ISO-abbreviation] Radiat Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


9. Sylvestre VT, Dunton CJ: Treatment of recurrent endometrial stromal sarcoma with letrozole: a case report and literature review. Horm Cancer; 2010 Apr;1(2):112-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • She had a computed tomography that showed a pelvic mass, an enlarged right internal iliac lymph node, an atypical liver hemangioma, and a severe left hydronephrosis.

  • Genetic Alliance. consumer health - Endometrial Stromal Sarcoma.
  • Hazardous Substances Data Bank. LETROZOLE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Reprod Update. 1995 Jan;1(1):19-34 [9080204.001]
  • [Cites] Gynecol Oncol. 1987 Jan;26(1):87-97 [3792939.001]
  • [Cites] Curr Opin Oncol. 2007 Jul;19(4):347-52 [17545798.001]
  • [Cites] Cancer. 2009 May 1;115(9):1867-74 [19241422.001]
  • [Cites] Drugs. 1998 Dec;56(6):1125-40 [9878997.001]
  • [Cites] Anticancer Res. 2007 Sep-Oct;27(5B):3477-80 [17972504.001]
  • [Cites] Surg Gynecol Obstet. 1965 Sep;121:531-7 [14332889.001]
  • [Cites] Clin Oncol (R Coll Radiol). 2008 Aug;20(6):433-47 [18499412.001]
  • [Cites] Clin Cancer Res. 1995 Dec;1(12):1511-5 [9815951.001]
  • [Cites] Gynecol Oncol. 2003 Jul;90(1):170-6 [12821359.001]
  • [Cites] N Engl J Med. 1993 Aug 5;329(6):404-12 [8326975.001]
  • [Cites] Mod Pathol. 2004 Jan;17(1):104-8 [14631363.001]
  • [Cites] Gynecol Oncol. 2004 Dec;95(3):769-71 [15582003.001]
  • [Cites] Gynecol Oncol. 2006 Jun;101(3):464-9 [16368128.001]
  • [Cites] Obstet Gynecol. 1962 Jul;20:23-35 [13871981.001]
  • [Cites] Gynecol Oncol. 2001 Aug;82(2):384-8 [11531300.001]
  • [Cites] Am J Clin Oncol. 2008 Dec;31(6):595-605 [19060594.001]
  • [Cites] Curr Opin Investig Drugs. 2004 Oct;5(10):1031-44 [15535424.001]
  • [Cites] Gynecol Oncol. 2005 Jul;98(1):173-4; author reply 174-5 [15963815.001]
  • [Cites] J Natl Cancer Inst. 1986 Mar;76(3):399-402 [3456457.001]
  • [Cites] Pathology. 2007 Feb;39(1):55-71 [17365823.001]
  • [Cites] N Engl J Med. 2003 Jun 12;348(24):2431-42 [12802030.001]
  • [Cites] Med Oncol. 2003;20(1):87-93 [12665689.001]
  • (PMID = 21761354.001).
  • [ISSN] 1868-8500
  • [Journal-full-title] Hormones & cancer
  • [ISO-abbreviation] Horm Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal; 0 / Aromatase Inhibitors; 0 / Nitriles; 0 / Triazoles; 7LKK855W8I / letrozole
  •  go-up   go-down


10. Mzali R, Affess N, Gharbi A, Boujelbene S, Beyrouti MI: [Enucleation of an hepatic hemangioma: case report]. Tunis Med; 2008 Jan;86(1):89-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Enucleation of an hepatic hemangioma: case report].
  • [Transliterated title] Enucléation d'un angiome du foie: a propos d'un cas.
  • [MeSH-major] Hemangioma / surgery. Liver Neoplasms / surgery

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19472713.001).
  • [ISSN] 0041-4131
  • [Journal-full-title] La Tunisie médicale
  • [ISO-abbreviation] Tunis Med
  • [Language] fre
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Tunisia
  •  go-up   go-down


11. Griffa B, Basilico V, Bellotti R, Griffa A, Senatore S, Capriata G: [Spontaneous rupture of giant subcapsular hemangioma of the liver with hemoperitoneum and hemorrhagic shock: a case report]. Chir Ital; 2005 May-Jun;57(3):389-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Spontaneous rupture of giant subcapsular hemangioma of the liver with hemoperitoneum and hemorrhagic shock: a case report].
  • [Transliterated title] Rottura spontanea di emangioma gigante sottocapsulare del fegato con emoperitoneo e shock emorragico: presentazione di un caso clinico.
  • Cavernous hemangioma is the most common benign tumour of the liver and is found quite commonly during abdominal ultrasonography performed for other diseases.
  • Spontaneous rupture of a giant hepatic hemangioma (diameter > 4 cm) with hemoperitoneum occurs very rarely.
  • We describe a new case of a giant subcapsular hemangioma localised in hepatic segments II and III in an 84-year-old woman, which ruptured spontaneously into the abdominal cavity and presented with hemoperitoneum and hypovolaemic shock.
  • The hemangioma was diagnosed preoperatively by spiral CAT and treated successfully with emergency hepatic bisegmentectomy.
  • [MeSH-major] Hemangioma, Cavernous / complications. Hemoperitoneum / etiology. Liver Neoplasms / complications. Shock, Hemorrhagic / etiology

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16231832.001).
  • [ISSN] 0009-4773
  • [Journal-full-title] Chirurgia italiana
  • [ISO-abbreviation] Chir Ital
  • [Language] ita
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


12. Corsale I, Buccianelli E, Rigutini M, Mori P, Bartolomei M, Aloise F, Sorce S, Veltroni A: [Liver haemangioma: current surgical indications. Our experience]. G Chir; 2005 Apr;26(4):153-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Liver haemangioma: current surgical indications. Our experience].
  • Hemangiomas are the more frequent benign liver tumours.
  • Therapeutic approach at these neoplasms is changed in the last years because has resulted that massive haemoperitoneum from a spontaneous rupture of the hemangiomas is a rare occurrence.
  • From a personal review of 124 liver resection performed for traumatic and organic, benign and malignant, pathologies, the Authors present two cases of symptomatic liver haemangioma surgically treated Excluding emergency induced by tumour hemorrhage, actually indications to surgical treatment are controversial.
  • In all patients the right approach is choice by the integrated evaluation of general conditions of the patient, liver functionality and from anatomical location of the neoplasm.
  • [MeSH-major] Hemangioma / surgery. Hepatectomy / standards. Liver Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16035251.001).
  • [ISSN] 0391-9005
  • [Journal-full-title] Il Giornale di chirurgia
  • [ISO-abbreviation] G Chir
  • [Language] ita
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


13. Winterer JT, Kotter E, Ghanem N, Langer M: Detection and characterization of benign focal liver lesions with multislice CT. Eur Radiol; 2006 Nov;16(11):2427-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detection and characterization of benign focal liver lesions with multislice CT.
  • MDCT is a rapidly evolving technique that significantly improves CT imaging for several indications including depiction of focal benign lesions.
  • This review provides an overview of the current status of MDCT with respect to liver imaging and the implications for characterizing benign focal liver lesions.
  • MDCT currently allows the acquisition of thin slices in daily routine diagnostics providing an improved detection rate of small liver lesions.
  • Whereas large benign focal liver lesions exhibit typical patterns of morphology, attenuation and perfusion, which also may be assessed with single-slice scanners, small lesions remain challenging even with MDCT, since the specific criteria for confident diagnosis become more ambiguous.
  • Here, MR imaging provides more detailed information about tissue components and the availability of liver-specific contrast agents, adding further impact to this technique.
  • [MeSH-major] Focal Nodular Hyperplasia / diagnostic imaging. Focal Nodular Hyperplasia / pathology. Liver Neoplasms / diagnostic imaging. Liver Neoplasms / pathology. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Adenoma, Liver Cell / diagnostic imaging. Adenoma, Liver Cell / pathology. Contrast Media. Hemangioma / diagnostic imaging. Hemangioma / pathology. Humans. Image Processing, Computer-Assisted. Liver Circulation. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Magn Reson Imaging Clin N Am. 1997 May;5(2):255-88 [9113675.001]
  • [Cites] Br J Radiol. 2003 Dec;76(912):866-74 [14711773.001]
  • [Cites] Eur Radiol. 2001;11(8):1396-400 [11519548.001]
  • [Cites] Radiology. 2001 Mar;218(3):763-7 [11230652.001]
  • [Cites] Rofo. 2004 Nov;176(11):1676-82 [15497087.001]
  • [Cites] Radiology. 1985 May;155(2):417-20 [3983393.001]
  • [Cites] Eur Radiol. 2005 Sep;15(9):1881-7 [15868125.001]
  • [Cites] Neuroimaging Clin N Am. 1998 Aug;8(3):497-513 [9673309.001]
  • [Cites] Radiology. 1994 Aug;192(2):367-71 [8029399.001]
  • [Cites] Radiology. 1997 Dec;205(3):709-15 [9393525.001]
  • [Cites] Radiology. 1989 Jul;172(1):27-34 [2662254.001]
  • [Cites] Radiology. 2001 Jun;219(3):699-706 [11376257.001]
  • [Cites] Eur Radiol. 2003 Sep;13(9):2155-60 [12736754.001]
  • [Cites] Radiology. 2005 Jul;236(1):166-77 [15955857.001]
  • [Cites] Radiology. 2002 Sep;224(3):757-63 [12202710.001]
  • [Cites] AJR Am J Roentgenol. 2003 Apr;180(4):929-34 [12646431.001]
  • [Cites] Nihon Igaku Hoshasen Gakkai Zasshi. 2003 Sep;63(8):409-11 [14587411.001]
  • [Cites] Rofo. 2004 Apr;176(4):556-63 [15088181.001]
  • [Cites] Eur Radiol. 2003 May;13(5):1072-9 [12695830.001]
  • [Cites] Radiographics. 2000 Mar-Apr;20(2):379-97 [10715338.001]
  • [Cites] Radiology. 2004 Jan;230(1):142-50 [14695390.001]
  • [Cites] Gastroenterology. 1989 Jul;97(1):154-7 [2542117.001]
  • [Cites] Radiology. 2005 Jun;235(3):872-8 [15833992.001]
  • [Cites] Eur Radiol. 2004 Jun;14 (6):1082-91 [15108017.001]
  • [Cites] Eur Radiol. 2003 Aug;13(8):1979-91 [12687286.001]
  • [Cites] Radiology. 1988 Jan;166(1 Pt 1):135-8 [3275965.001]
  • [Cites] Radiology. 2002 Oct;225(1):137-42 [12354997.001]
  • [Cites] Abdom Imaging. 2003 May-Jun;28(3):333-46 [12719903.001]
  • [Cites] Radiology. 1999 Jan;210(1):71-4 [9885589.001]
  • [Cites] Eur Radiol. 2003 Dec;13 Suppl 5:M31-41 [14989610.001]
  • [Cites] Eur Radiol. 2002 Apr;12 (4):745-52 [11960221.001]
  • [Cites] AJR Am J Roentgenol. 1987 Jul;149(1):83-5 [3495995.001]
  • [Cites] Rontgenpraxis. 1990 Feb;43(2):65-73 [2406955.001]
  • [Cites] Eur Radiol. 2005 Aug;15(8):1643-9 [15712000.001]
  • [Cites] J Comput Assist Tomogr. 1995 Mar-Apr;19(2):216-20 [7890844.001]
  • [Cites] J Clin Pathol. 1986 Feb;39(2):183-8 [3950039.001]
  • [Cites] Radiology. 2005 Jun;235(3):756-73 [15833981.001]
  • [Cites] Med Clin North Am. 1975 Jul;59(4):995-1013 [167242.001]
  • [Cites] AJR Am J Roentgenol. 1985 Dec;145(6):1195-9 [3904370.001]
  • [Cites] AJR Am J Roentgenol. 2000 Sep;175(3):679-85 [10954450.001]
  • [Cites] Hum Pathol. 1977 May;8(3):255-68 [192659.001]
  • [Cites] Radiology. 1998 Jun;207 (3):647-55 [9609886.001]
  • [Cites] Radiology. 2004 Aug;232(2):354-60 [15215556.001]
  • [Cites] Radiology. 1998 Nov;209(2):417-26 [9807568.001]
  • [Cites] Ann Pathol. 1995;15(5):380-7 [8540924.001]
  • [Cites] Rofo. 2002 Jul;174(7):839-45 [12101473.001]
  • [Cites] Radiology. 2003 Jun;227(3):883-9 [12773687.001]
  • [Cites] AJR Am J Roentgenol. 1987 Apr;148(4):717-22 [3548283.001]
  • [Cites] AJR Am J Roentgenol. 2005 May;184(5):1535-40 [15855112.001]
  • [Cites] Radiology. 1986 Sep;160(3):613-8 [3016794.001]
  • [Cites] AJR Am J Roentgenol. 2001 Jun;176(6):1493-8 [11373219.001]
  • [Cites] Eur Radiol. 2003 May;13(5):1085-94 [12695832.001]
  • [Cites] Radiology. 1995 May;195(2):353-7 [7724752.001]
  • [Cites] Radiology. 2004 May;231(2):413-20 [15044747.001]
  • [Cites] Radiology. 1987 Dec;165(3):785-90 [3685361.001]
  • [Cites] AJR Am J Roentgenol. 2003 May;180(5):1217-24 [12704026.001]
  • [Cites] Radiology. 1985 Sep;156(3):593-5 [3895291.001]
  • [Cites] Eur Radiol. 2003 Dec;13 Suppl 5:M26-30 [14989609.001]
  • [Cites] AJR Am J Roentgenol. 1989 Jun;152(6):1221-6 [2718858.001]
  • [Cites] Radiology. 1995 Oct;197(1):83-8 [7568859.001]
  • [Cites] Radiology. 1995 Aug;196 (2):465-9 [7617862.001]
  • [Cites] Eur Radiol. 2003 May;13(5):1148-53 [12695839.001]
  • [Cites] Eur Radiol. 2004 Sep;14 (9):1665-73 [15067427.001]
  • [Cites] Radiology. 2004 Dec;233(3):682-8 [15486215.001]
  • [Cites] Eur J Radiol. 2003 Mar;45 Suppl 1:S53-8 [12598028.001]
  • (PMID = 16724204.001).
  • [ISSN] 0938-7994
  • [Journal-full-title] European radiology
  • [ISO-abbreviation] Eur Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Contrast Media
  • [Number-of-references] 79
  •  go-up   go-down


14. Ontachi Y, Asakura H, Omote M, Yoshida T, Matsui O, Nakao S: Kasabach-Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid. Haematologica; 2005 Nov;90 Suppl:ECR29
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Kasabach-Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid.
  • A 39-year-old woman with an enlarging giant liver hemangioma was diagnosed as having KMS with DIC.
  • Rapid improvement of the bleeding tendency and coagulopathy occurred in response to this treatment - that is, DIC was controlled without removing the giant hemangioma.
  • [MeSH-major] Antifibrinolytic Agents / therapeutic use. Chondroitin Sulfates / therapeutic use. Dermatan Sulfate / therapeutic use. Disseminated Intravascular Coagulation / etiology. Hemangioma / complications. Hemorrhagic Disorders / etiology. Heparitin Sulfate / therapeutic use. Liver Neoplasms / complications. Tranexamic Acid / therapeutic use
  • [MeSH-minor] Adult. Blood Proteins / analysis. Drug Therapy, Combination. Female. Hepatic Artery / surgery. Humans. Ligation. Syndrome

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16266920.001).
  • [ISSN] 1592-8721
  • [Journal-full-title] Haematologica
  • [ISO-abbreviation] Haematologica
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Antifibrinolytic Agents; 0 / Blood Proteins; 24967-94-0 / Dermatan Sulfate; 6T84R30KC1 / Tranexamic Acid; 83513-48-8 / danaproid; 9007-28-7 / Chondroitin Sulfates; 9050-30-0 / Heparitin Sulfate
  •  go-up   go-down


15. Magnies M, Giezek F, Jouandeau V, Custoza E: [Multiple calvarial cavernous hemangiomas]. J Neuroradiol; 2009 Dec;36(5):294-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Multiple calvarial cavernous hemangiomas].
  • [Transliterated title] Multiples hémangiomes caverneux de la voûte du crâne.
  • Intraosseous cavernous hemangioma is rarely located in the calvarium.
  • This benign tumor, arising from the intrinsic vasculature of bone, grows slowly over a period of years before it causes symptoms such as headaches or localized compression.
  • We report here the case of a 27-year-old man, who presented with multiple calvarial cavernous hemangiomas associated with several hepatic hemangiomas.
  • The patient had a family history of the disease, and is only the second case of multiple calvarial cavernous hemangiomas reported in the literature.
  • [MeSH-major] Hemangioma, Cavernous / pathology. Neoplasms, Multiple Primary / pathology. Skull Neoplasms / pathology
  • [MeSH-minor] Adult. Contrast Media. Gadolinium. Humans. Liver Neoplasms / pathology. Magnetic Resonance Imaging. Male

  • Hazardous Substances Data Bank. GADOLINIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19403170.001).
  • [ISSN] 0150-9861
  • [Journal-full-title] Journal of neuroradiology. Journal de neuroradiologie
  • [ISO-abbreviation] J Neuroradiol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Contrast Media; AU0V1LM3JT / Gadolinium
  •  go-up   go-down


16. Borzellino G, Ruzzenente A, Minicozzi AM, Giovinazzo F, Pedrazzani C, Guglielmi A: Laparoscopic hepatic resection. Surg Endosc; 2006 May;20(5):787-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic hepatic resection.
  • BACKGROUND: Although laparoscopy in general surgery is increasingly being performed, only recently has liver surgery been performed with laparoscopy.
  • We critically review our experience with laparoscopic liver resections.
  • METHODS: From January 2000 to April 2004, we performed laparoscopic hepatic resection in 16 patients with 18 hepatic lesions.
  • Nine lesions were benign in seven patients (five hydatid cysts, three hemangiomas, and one simple cyst), five were malignant in five patients (five hepatocarcinoma), and four patients had an uncertain preoperative diagnosis (one suspected hemangioma and three suspected adenomas).
  • CONCLUSIONS: Hepatic resection with laparoscopy is feasible in malignant and benign hepatic lesions located in the left lobe and anterior inferior right lobe segments (IV, V, and VI).
  • [MeSH-major] Laparoscopy. Liver / surgery. Liver Diseases / surgery

  • MedlinePlus Health Information. consumer health - Liver Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hepatogastroenterology. 1998 Jan-Feb;45(19):29-33 [9496482.001]
  • [Cites] Ann Chir. 2002 Mar;127(3):164-70 [11933628.001]
  • [Cites] Surg Endosc. 1995 Dec;9(12):1289-91 [8629211.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2000;7(1):1-8 [10982584.001]
  • [Cites] Semin Laparosc Surg. 1998 Sep;5(3):204-10 [9787208.001]
  • [Cites] Hepatogastroenterology. 2002 May-Jun;49(45):803-5 [12063994.001]
  • [Cites] Surg Clin North Am. 2000 Aug;80(4):1203-11 [10987031.001]
  • [Cites] Ann Surg. 2002 Jul;236(1):90-7 [12131090.001]
  • [Cites] Surg Endosc. 2001 Aug;15(8):794-8 [11443467.001]
  • [Cites] Hepatogastroenterology. 1998 Nov-Dec;45(24):2333-8 [9951918.001]
  • [Cites] Surg Endosc. 2003 Jan;17(1):23-30 [12364994.001]
  • [Cites] Br J Surg. 1999 Nov;86(11):1397-400 [10583285.001]
  • [Cites] Surg Endosc. 2002 Mar;16(3):521-4 [11928040.001]
  • [Cites] Endosc Surg Allied Technol. 1994 Jun-Aug;2(3-4):186-8 [8000883.001]
  • [Cites] Hepatogastroenterology. 2001 Jan-Feb;48(37):235-43 [11268973.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2002;9(2):242-8 [12140614.001]
  • [Cites] Dig Surg. 1998;15(4):333-6 [9845609.001]
  • [Cites] Ann Surg. 2000 Dec;232(6):753-62 [11088070.001]
  • [Cites] Surg Endosc. 2001 Jun;15(6):541-4 [11591936.001]
  • [Cites] Ann Chir. 2002 Mar;127(3):171-4 [11933629.001]
  • [Cites] Surg Endosc. 2002 Jul;16(7):1059-63 [12165823.001]
  • [Cites] J Chir (Paris). 1996;133(9-10):432-6 [9296017.001]
  • [Cites] Hepatogastroenterology. 2000 Sep-Oct;47(35):1260-3 [11100327.001]
  • [Cites] Surgery. 2000 Jul;128(1):36-40 [10876183.001]
  • [Cites] Ann Chir. 2000 Dec;125(10):941-7 [11195923.001]
  • [Cites] Arch Surg. 2001 Jul;136(7):789-95 [11448392.001]
  • (PMID = 16544083.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


17. Au WY, Liu CL: Growth of giant hepatic hemangioma after triplet pregnancy. J Hepatol; 2005 May;42(5):781
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Growth of giant hepatic hemangioma after triplet pregnancy.
  • [MeSH-major] Hemangioma / etiology. Hemangioma / pathology. Liver / blood supply. Pregnancy Complications, Cardiovascular / pathology. Triplets

  • Genetic Alliance. consumer health - Hemangioma.
  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15826730.001).
  • [ISSN] 0168-8278
  • [Journal-full-title] Journal of hepatology
  • [ISO-abbreviation] J. Hepatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


18. Strobel D, Seitz K, Blank W, Schuler A, Dietrich CF, von Herbay A, Friedrich-Rust M, Bernatik T: Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Ultraschall Med; 2009 Aug;30(4):376-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
  • AIM: To evaluate the incidence and diagnostic accuracy of tumor-specific vascularization pattern in contrast-enhanced ultrasound (CEUS) in the differential diagnosis of liver tumors in clinical practice.
  • MATERIALS AND METHODS: From May 2004 to December 2006 1349 patients (male 677, female 672) with a hepatic tumor lacking a definite diagnosis based on B-mode ultrasound and power Doppler ultrasound were examined at 14 hospitals by CEUS using a standardized protocol (pulse/phase inversion imaging, mechanical index < 0.4).
  • The tumor-specific diagnosis established after CEUS was compared to histology (> 75 % cases) or in some cases to CT or MRI.
  • RESULTS: The final diagnosis of 573 benign hepatic tumors included hemangiomas (n = 242) and focal nodular hyperplasia (n = 170), other benign lesions (n = 161).
  • Tumor-specific vascularization pattern such as a wheel-spoke pattern and arterial hyperenhancement followed by isoenhancement in the late phase in FNH or a nodular peripheral enhancement and partial or complete fill-in pattern in hemangiomas could be assessed in the majority, but not all lesions.
  • The diagnostic accuracy of CEUS was 83.1 % for all benign lesions and 82.2 % for hemangioma and 87.1 % for FNH.
  • The final diagnosis of 755 malignant hepatic tumors included metastases n = 383, hepatocellular carcinoma n = 279 and other malignant lesions n = 93.
  • Late phase hypoenhancement was seen in almost all liver metastases (94.7 %) The diagnostic accuracy of CEUS was 95.8 % for all malignant lesions and 91.4 % for liver metastases and 84.9 % for hepatocellular carcinomas.
  • CONCLUSION: Tumor-specific vascularization pattern in CEUS have a high diagnostic impact on the overall high diagnostic accuracy of CEUS for the differential diagnosis of hepatic tumors in clinical practice.
  • [MeSH-major] Carcinoma, Hepatocellular / blood supply. Carcinoma, Hepatocellular / ultrasonography. Contrast Media / administration & dosage. Focal Nodular Hyperplasia / ultrasonography. Hematoma / ultrasonography. Liver Neoplasms / blood supply. Liver Neoplasms / secondary. Liver Neoplasms / ultrasonography. Neovascularization, Pathologic / ultrasonography
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Diagnosis, Differential. Female. Hepatic Artery / ultrasonography. Humans. Image Enhancement. Incidental Findings. Liver Cirrhosis / ultrasonography. Male. Middle Aged. Portal Vein / ultrasonography. Prospective Studies. Sensitivity and Specificity. Young Adult

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) Georg Thieme Verlag KG Stuttgart, New York.
  • (PMID = 19688669.001).
  • [ISSN] 1438-8782
  • [Journal-full-title] Ultraschall in der Medizin (Stuttgart, Germany : 1980)
  • [ISO-abbreviation] Ultraschall Med
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


19. Chang X, Han J, Pang L, Zhao Y, Yang Y, Shen Z: Increased PADI4 expression in blood and tissues of patients with malignant tumors. BMC Cancer; 2009;9:40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, PADI4 expression was not observed in benign leiomyomas of stomach, uterine myomas, endometrial hyperplasias, cervical polyps, teratomas, hydatidiform moles, trophoblastic cell hyperplasias, hyroid adenomas, hemangiomas, lymph hyperplasias, schwannomas, neurofibromas, lipomas, and cavernous hemangiomas of the liver.
  • ELISA detected increased PADI4 and cAT levels in the blood of patients with various malignant tumors compared to those in patients with chronic inflammation and benign tumors.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Tumori. 1998 May-Jun;84(3):364-7 [9678618.001]
  • [Cites] Pathologe. 1996 Nov;17(6):425-32 [9082363.001]
  • [Cites] J Cell Mol Med. 2004 Oct-Dec;8(4):498-508 [15601578.001]
  • [Cites] Folia Histochem Cytobiol. 2004;42(4):235-40 [15704650.001]
  • [Cites] Rheumatology (Oxford). 2005 Mar;44(3):293-8 [15561738.001]
  • [Cites] Semin Cancer Biol. 2005 Aug;15(4):309-18 [15907383.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2936-42 [16365013.001]
  • [Cites] Mol Carcinog. 2006 Mar;45(3):183-96 [16355400.001]
  • [Cites] Mod Pathol. 2006 Sep;19(9):1261-9 [16799479.001]
  • [Cites] Mol Endocrinol. 2007 Jul;21(7):1617-29 [17456793.001]
  • [Cites] J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):76-80 [17826626.001]
  • [Cites] World J Gastroenterol. 2008 Mar 21;14(11):1682-9 [18350599.001]
  • [Cites] Histochem Cell Biol. 2008 Jun;129(6):705-33 [18461349.001]
  • [Cites] Endocr Relat Cancer. 2008 Jun;15(2):475-83 [18509000.001]
  • [Cites] J Biol Chem. 2008 Jul 18;283(29):20060-8 [18499678.001]
  • [Cites] Mol Cell Biol. 2008 Aug;28(15):4745-58 [18505818.001]
  • [Cites] Adv Exp Med Biol. 2008;630:112-32 [18637488.001]
  • [Cites] Histopathology. 2001 Jan;38(1):62-7 [11135048.001]
  • [Cites] Cell Death Differ. 2002 May;9(5):486-92 [11973607.001]
  • [Cites] Biochem Soc Trans. 2002 Apr;30(2):173-7 [12023846.001]
  • [Cites] Biochem Soc Trans. 2002 Apr;30(2):201-7 [12023851.001]
  • [Cites] Nat Genet. 2003 Aug;34(4):395-402 [12833157.001]
  • [Cites] Best Pract Res Clin Anaesthesiol. 2004 Sep;18(3):385-405 [15212335.001]
  • [Cites] Cell. 2004 Sep 3;118(5):545-53 [15339660.001]
  • [Cites] Anticancer Res. 1990 May-Jun;10(3):579-82 [2114816.001]
  • [Cites] APMIS. 1991 Nov;99(11):981-8 [1720319.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1992;421(3):209-15 [1384221.001]
  • [Cites] Int J Cancer. 1993 Jul 9;54(5):793-806 [7686887.001]
  • [Cites] Thromb Haemost. 1998 Nov;80(5):767-72 [9843169.001]
  • (PMID = 19183436.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antithrombins; 0 / Neoplasm Proteins; 29VT07BGDA / Citrulline; EC 3.- / Hydrolases; EC 3.5.3.15 / peptidylarginine deiminase type IV
  • [Other-IDs] NLM/ PMC2637889
  •  go-up   go-down


20. Kim EH, Park SY, Ihn YK, Hwang SS: Diffuse hepatic hemangiomatosis without extrahepatic involvement in an adult patient. Korean J Radiol; 2008 Nov-Dec;9(6):559-62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diffuse hepatic hemangiomatosis without extrahepatic involvement in an adult patient.
  • We report an extremely rare case of a diffuse hepatic hemangiomatosis without extrahepatic involvement in an adult.
  • The imaging findings of this tumor were similar to those of a hepatic hemangioma and included contrast enhancement with a centripetal filling pattern of the entire hepatic tumor on the delayed phase of a dynamic CT and inhomogeneous diffuse uptake of the entire tumor on blood-pool images obtained five hours later on a 99mTc-labeled red blood cell scan.
  • Despite its rarity, diffuse hepatic hemangiomatosis can be suggested in adult patients with diffusely involved hepatic tumors showing the radiological findings of a hepatic hemangioma.
  • [MeSH-major] Hemangioma / diagnosis. Liver Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pathologe. 2001 Nov;22(6):424-8 [11766642.001]
  • [Cites] Angiology. 2002 Mar-Apr;53(2):235-7 [11952117.001]
  • [Cites] Ann Surg. 1988 Feb;207(2):115-9 [2829759.001]
  • [Cites] Gastroenterology. 1990 Jul;99(1):258-62 [2344931.001]
  • [Cites] J Comput Assist Tomogr. 1992 Nov-Dec;16(6):971-3 [1430450.001]
  • [Cites] J Korean Med Sci. 2000 Aug;15(4):471-4 [10983701.001]
  • [Cites] Br J Clin Pract. 1995 Jul-Aug;49(4):215-6 [7547166.001]
  • [Cites] Acta Paediatr. 1999 Jan;88(1):93-7 [10090556.001]
  • [Cites] J Hepatol. 1999 May;30(5):951-4 [10365825.001]
  • [Cites] Arch Pediatr Adolesc Med. 2000 Jul;154(7):743-4 [10891029.001]
  • [Cites] Radiographics. 1994 Jan;14(1):153-66; quiz 167-8 [8128048.001]
  • (PMID = 19039274.001).
  • [ISSN] 1229-6929
  • [Journal-full-title] Korean journal of radiology
  • [ISO-abbreviation] Korean J Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2627242
  •  go-up   go-down


21. Kim GE, Thung SN, Tsui WM, Ferrell LD: Hepatic cavernous hemangioma: underrecognized associated histologic features. Liver Int; 2006 Apr;26(3):334-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hepatic cavernous hemangioma: underrecognized associated histologic features.
  • BACKGROUND/AIMS: Cavernous hemangiomas (CH) are typically described as solitary, well-circumscribed lesions and are reported to have a distinct fibrous interface.
  • This study describes underrecognized histological changes of large hepatic hemangiomas that contradict this long-standing view.
  • METHODS: Nineteen cases of hepatic resections for CH were reviewed.
  • Stains for estrogen and progesterone receptors (ER/PR), MIB-1, alpha-smooth muscle actin, collagen IV, and elastic Van Gieson stains were applied to the lesions.
  • Sixteen (84%) CHs had an irregular interface with the liver parenchyma while only three had the well-defined fibrous capsule typically described for CH.
  • Fifteen (79%) CHs had dilated vascular spaces filled with blood 0.1-2.0 cm beyond the confines of the main CH, which we have designated hemangioma-like vessels (HLVs).
  • CONCLUSION: Irregular edges of CH and HLVs in the liver parenchyma adjacent to CH have been underrecognized.
  • [MeSH-major] Hemangioma, Cavernous / pathology. Liver Neoplasms / pathology

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16584396.001).
  • [ISSN] 1478-3223
  • [Journal-full-title] Liver international : official journal of the International Association for the Study of the Liver
  • [ISO-abbreviation] Liver Int.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


22. Banton KL, D'Cunha J, Laudi N, Flynn C, Hammerschmidt D, Humar A, Sielaff T: Postoperative severe microangiopathic hemolytic anemia associated with a giant hepatic cavernous hemangioma. J Gastrointest Surg; 2005 May-Jun;9(5):679-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Postoperative severe microangiopathic hemolytic anemia associated with a giant hepatic cavernous hemangioma.
  • Complications related to liver hemangioma are rare.
  • We herein describe the case of a patient with three giant cavernous hemangiomas of the liver, of which two were resected for symptoms.
  • Surgeons should be aware of the potential for hemolytic complications after major surgery when giant hepatic hemangiomas are present.
  • [MeSH-major] Anemia, Hemolytic / etiology. Hemangioma, Cavernous / pathology. Hemangioma, Cavernous / surgery. Liver Neoplasms / pathology. Liver Neoplasms / surgery. Postoperative Complications / diagnosis

  • Genetic Alliance. consumer health - Hemangioma.
  • Genetic Alliance. consumer health - Anemia.
  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Med Okayama. 1978 Apr;32(1):61-8 [148835.001]
  • [Cites] Am J Surg. 1974 May;127(5):588-92 [4545017.001]
  • [Cites] Clin Lab Haematol. 2002 Aug;24(4):243-51 [12181029.001]
  • [Cites] Gut. 1991 Jun;32(6):677-80 [2060877.001]
  • [Cites] Am J Med. 1969 Jun;46(6):997-1002 [5816223.001]
  • [Cites] Eur J Pediatr. 1990 Aug;149(11):804-5 [2226558.001]
  • [Cites] Aust N Z J Surg. 1992 Jul;62(7):521-4 [1610320.001]
  • [Cites] Annu Rev Med. 1970;21:133-44 [4913945.001]
  • [Cites] Radiology. 1988 Oct;169(1):145-8 [3420251.001]
  • [Cites] J Pediatr. 1975 Nov;87(5):766-8 [1185346.001]
  • [Cites] J Clin Pathol. 1986 Feb;39(2):183-8 [3950039.001]
  • [Cites] Med Clin North Am. 1975 Jul;59(4):995-1013 [167242.001]
  • [Cites] J Pediatr Hematol Oncol. 2002 Aug-Sep;24(6):459-62 [12218593.001]
  • [Cites] Am J Med. 1970 May;48(5):624-8 [5425239.001]
  • [Cites] J Clin Gastroenterol. 1991 Jun;13(3):255-8 [2066541.001]
  • [Cites] Ann Surg. 1970 Aug;172(2):239-45 [5433290.001]
  • [Cites] Postgrad Med J. 1972 Feb;48(556):111-3 [5015115.001]
  • [Cites] World J Surg. 1995 Jan-Feb;19(1):19-24 [7740805.001]
  • [Cites] Am J Gastroenterol. 1990 Oct;85(10):1411-3 [2220739.001]
  • [Cites] Arch Intern Med. 2002 Jan 28;162(2):221-2 [11802757.001]
  • [Cites] Ann Surg. 1980 Jul;192(1):25-7 [7406559.001]
  • [Cites] Acta Pathol Jpn. 1981 Jan;31(1):135-42 [7234417.001]
  • [Cites] Bone Marrow Transplant. 1998 Jun;21(12):1263-6 [9674861.001]
  • [Cites] Eur J Pediatr. 1976 Dec 9;124(1):23-9 [1001325.001]
  • [Cites] J Pediatr. 2001 May;138(5):756-8 [11343057.001]
  • (PMID = 15862263.001).
  • [ISSN] 1091-255X
  • [Journal-full-title] Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
  • [ISO-abbreviation] J. Gastrointest. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 25
  •  go-up   go-down


23. Arkadopoulos N, Stafyla V, Karapanos K, Yiallourou AI, Koureas A, Kondi-Pafiti A, Smyrniotis V: Recurrent pulmonary embolism due to giant hepatic hamangioma treated with hepatectomy under vascular exclusion. Ann Vasc Surg; 2010 Aug;24(6):827.e1-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent pulmonary embolism due to giant hepatic hamangioma treated with hepatectomy under vascular exclusion.
  • Giant hepatic hemangiomas are benign tumors that measure more than 4 cm and are usually asymptomatic.
  • Pulmonary embolism (PE) is an extremely rare manifestation of giant hepatic hemangiomas.
  • We report a case of a 44-year-old woman who suffered of recurrent pulmonary emboli that, after thorough work up, were attributed to thrombi formation inside a giant hepatic hemangioma.
  • A right hepatectomy under vascular exclusion was performed and the hemangioma, measuring 17 cm, was resected.
  • The report highlights the value of investigating giant liver hemangiomas in case of PE.
  • In such cases, the hemangioma should be resected preferably under occlusion of the venous outflow of the liver to avoid PE intraoperatively.
  • [MeSH-major] Hemangioma / surgery. Hepatectomy. Hepatic Veins / surgery. Liver Neoplasms / surgery. Portal System / surgery. Pulmonary Embolism / prevention & control

  • Genetic Alliance. consumer health - Embolism.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Pulmonary Embolism.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20471202.001).
  • [ISSN] 1615-5947
  • [Journal-full-title] Annals of vascular surgery
  • [ISO-abbreviation] Ann Vasc Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


24. Du X, Bao G, He X, Zhao H, Yu F, Qiao Q, Lu J, Ma Q: Expression and biological significance of c-FLIP in human hepatocellular carcinomas. J Exp Clin Cancer Res; 2009;28:24
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Positive immunostaining was detected for c-FLIP in 83.72% (72/86) human HCC tissues, 14.81% (4/27) hepatic cirrhosis, 11.11% (2/18) hepatic hemangioma tissues, and absent in normal hepatic tissues.
  • [MeSH-major] CASP8 and FADD-Like Apoptosis Regulating Protein / biosynthesis. Carcinoma, Hepatocellular / metabolism. Liver Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Curr Biol. 2000 Jun 1;10(11):640-8 [10837247.001]
  • [Cites] Histopathology. 2007 Aug;51(2):150-6 [17559541.001]
  • [Cites] Mol Cell Biol. 2001 Dec;21(24):8247-54 [11713262.001]
  • [Cites] Exp Cell Res. 2002 Feb 15;273(2):256-64 [11822881.001]
  • [Cites] Am J Pathol. 2002 Apr;160(4):1521-8 [11943736.001]
  • [Cites] Science. 2002 Apr 19;296(5567):550-3 [11910072.001]
  • [Cites] Nat Rev Cancer. 2002 Apr;2(4):277-88 [12001989.001]
  • [Cites] Cancer Biol Ther. 2002 Jul-Aug;1(4):401-6 [12432255.001]
  • [Cites] Mol Med. 2002 Oct;8(10):612-23 [12477972.001]
  • [Cites] Mol Med. 2002 Nov;8(11):725-32 [12520089.001]
  • [Cites] APMIS. 2003 Feb;111(2):309-14 [12716387.001]
  • [Cites] Anticancer Res. 2003 Mar-Apr;23(2B):1213-8 [12820373.001]
  • [Cites] Lab Invest. 2003 Jul;83(7):1033-43 [12861043.001]
  • [Cites] Mol Interv. 2003 May;3(3):124-7 [14993418.001]
  • [Cites] Urology. 2004 Jun;63(6):1198-204 [15183989.001]
  • [Cites] Clin Cancer Res. 2004 Aug 1;10(15):5202-14 [15297424.001]
  • [Cites] J Pathol. 1989 May;158(1):23-9 [2547043.001]
  • [Cites] Cell. 1997 Jun 27;89(7):1067-76 [9215629.001]
  • [Cites] Nature. 1997 Jul 10;388(6638):190-5 [9217161.001]
  • [Cites] HNO. 1998 Jun;46(6):614-25 [9677498.001]
  • [Cites] Mol Cancer Ther. 2005 Dec;4(12):2026-36 [16373718.001]
  • [Cites] Oncogene. 2006 Feb 9;25(6):838-48 [16247474.001]
  • [Cites] Apoptosis. 2006 Feb;11(2):255-63 [16502263.001]
  • [Cites] Mol Cancer Ther. 2007 May;6(5):1544-51 [17513603.001]
  • [Cites] Cancer Res. 2007 Jun 15;67(12):5754-62 [17575142.001]
  • [Cites] Genes Cells. 2007 Jun;12(6):735-44 [17573774.001]
  • [Cites] Mol Cell Biol. 2001 Jun;21(12):3964-73 [11359904.001]
  • (PMID = 19232089.001).
  • [ISSN] 1756-9966
  • [Journal-full-title] Journal of experimental & clinical cancer research : CR
  • [ISO-abbreviation] J. Exp. Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / CASP8 and FADD-Like Apoptosis Regulating Protein; 0 / CFLAR protein, human; 0 / RNA, Messenger; 0 / RNA, Small Interfering; 80168379AG / Doxorubicin
  • [Other-IDs] NLM/ PMC2654864
  •  go-up   go-down


26. Fernández-Pineda I, Bernabeu-Wittel J: [Hepatic hemangiomas]. Gastroenterol Hepatol; 2010 Jun-Jul;33(6):473-4; author reply 474-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Hepatic hemangiomas].
  • [Transliterated title] Hemangiomas hepáticos.
  • [MeSH-major] Hemangioma / classification. Hepatic Veins / abnormalities. Liver Neoplasms / classification. Terminology as Topic. Vascular Malformations / classification
  • [MeSH-minor] Adolescent. Adult. Age of Onset. Child. Embolization, Therapeutic. Female. Hemangioma, Capillary / classification. Hemangioma, Capillary / therapy. Humans. Infant. Infant, Newborn. Portacaval Shunt, Surgical. Pregnancy. Pregnancy Complications, Neoplastic. Vasoconstrictor Agents / therapeutic use

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Gastroenterol Hepatol. 2010 May;33(5):391-7 [20096966.001]
  • (PMID = 20537429.001).
  • [ISSN] 0210-5705
  • [Journal-full-title] Gastroenterología y hepatología
  • [ISO-abbreviation] Gastroenterol Hepatol
  • [Language] spa
  • [Publication-type] Comment; Letter
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Vasoconstrictor Agents
  •  go-up   go-down


27. Wang QS, Liu L, Dong L, Shen ZL, Zhou DH, Hu CX: Laparoscopic Heller-Dor operation for patients with achalasia. Chin Med J (Engl); 2006 Mar 20;119(6):443-7; discussion 447-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • All the patients received upper gastrointestinal series (barium swallow), esophagogastroscopy, esophageal manometry to exclude esophageal carcinoma and to confirm the diagnosis, and 21 patients also had 24-hour ambulatory pH studies.
  • In addition, 2 of them had combined laparoscopic cholecystectomy + excision of hepatic hemangioma and laparoscopic cholecystectomy, respectively.

  • Genetic Alliance. consumer health - Achalasia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16584640.001).
  • [ISSN] 0366-6999
  • [Journal-full-title] Chinese medical journal
  • [ISO-abbreviation] Chin. Med. J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  •  go-up   go-down


28. Zakavi R: How should we image liver hemangioma? Hell J Nucl Med; 2006 Sep-Dec;9(3):187
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] How should we image liver hemangioma?
  • [MeSH-major] Erythrocytes / radionuclide imaging. Hemangioma / radionuclide imaging. Liver Neoplasms / radionuclide imaging. Technetium. Technetium Tc 99m Sulfur Colloid. Tomography, Emission-Computed, Single-Photon / methods

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. TECHNETIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Hell J Nucl Med. 2006 May-Aug;9(2):109-10 [16894416.001]
  • (PMID = 17160164.001).
  • [ISSN] 1790-5427
  • [Journal-full-title] Hellenic journal of nuclear medicine
  • [ISO-abbreviation] Hell J Nucl Med
  • [Language] eng
  • [Publication-type] Comment; Letter
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 556Q0P6PB1 / Technetium Tc 99m Sulfur Colloid; 7440-26-8 / Technetium
  •  go-up   go-down


29. Colović N, Cemerikić-Martinović V, Micev M, Radak V, Colović R: [Hemangioma of the spleen]. Srp Arh Celok Lek; 2006 Jul-Aug;134(7-8):325-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Hemangioma of the spleen].
  • Although the most frequent benign tumors of the spleen, hemangiomas are very rare, much rarer than hemangiomas of the liver.
  • They manifest as localized (either single or multiple) or diffuse lesions, vary from solid to cystic, histologically from capillary to cavernous.
  • The spleen weighing 2600 grams was removed, in which the number of lesions histologically corresponded to hemangioma of the spleen.
  • [MeSH-major] Hemangioma
  • [MeSH-minor] Aged. Female. Humans. Splenic Neoplasms / diagnosis. Splenic Neoplasms / pathology. Splenic Neoplasms / surgery

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17009613.001).
  • [ISSN] 0370-8179
  • [Journal-full-title] Srpski arhiv za celokupno lekarstvo
  • [ISO-abbreviation] Srp Arh Celok Lek
  • [Language] srp
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Serbia and Montenegro
  •  go-up   go-down


30. Brody JM, Schafer L, Tung GA, Breuer J, Shamsi K: Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid. J Magn Reson Imaging; 2005 Apr;21(4):391-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.
  • PURPOSE: To compare conspicuity of liver hemangiomas on STIR, T1-weighted, and T2-weighted magnetic resonance (MR) images before and after administration of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA) (hepatocellular contrast agent), using contrast-to-noise ratios (CNRs).
  • MATERIALS AND METHODS: Thirteen hemangiomas were imaged using breath-hold gradient echo (GRE) T1, fat-saturated turbo spin echo (TSE)-T2, and short tau inversion recovery (STIR) sequences.
  • Background noise and signal-to-noise ratios (SNRs) for liver and hemangioma, along with CNR for normal liver and hemangioma, were measured on each sequence before and after administration of Gd-EOB-DTPA.
  • Hemangioma conspicuity was also evaluated qualitatively.
  • RESULTS: After Gd-EOB-DTPA administration, the quantitative liver SNR decreased 54% on STIR, increased 45% on T1-weighted images, and increased 14.5% on TSE-T2-weighted images.
  • The CNR for liver and hemangioma increased 50% on STIR images (P < 0.0001), increased 46% on T1-weighted imaging (P = 0.0033), and increased 22% on TSE-T2-weighted MR imaging (MRI) (P = 0.0083).
  • Qualitatively, signal change was visually apparent in the liver on T1 and STIR, but not on T2 images or in the hemangiomas on any sequence.
  • CONCLUSION: Despite the statistically significant T1 and STIR increase in CNR, liver hemangiomas were most conspicuous on TSE-T2 images after Gd-EOB-DTPA.
  • This pilot study with hemangiomas highlights the newly recognized potential benefit of TSE-T2 imaging with hepatocellular contrast.
  • [MeSH-major] Contrast Media. Gadolinium DTPA. Hemangioma / diagnosis. Liver Neoplasms / diagnosis. Magnetic Resonance Imaging / methods

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 Wiley-Liss, Inc.
  • (PMID = 15778951.001).
  • [ISSN] 1053-1807
  • [Journal-full-title] Journal of magnetic resonance imaging : JMRI
  • [ISO-abbreviation] J Magn Reson Imaging
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; 0 / gadolinium ethoxybenzyl DTPA; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


31. Turowski C, Feist H, Alzen G, Glüer S, Petersen C: Conversion of a neonatal hepatic hemangioma to focal nodular hyperplasia. Pathol Int; 2009 Apr;59(4):251-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Conversion of a neonatal hepatic hemangioma to focal nodular hyperplasia.
  • Hepatic hemangioma and focal nodular hyperplasia are both frequently observed benign lesions of the liver.
  • Whereas hepatic hemangioma is the most frequent benign liver tumor in children, focal nodular hyperplasia occurs predominantly in adult patients.
  • We report on a 6-month-old child with a continuously shrinking hepatic hemangioma after interventional therapy and a growing hepatic mass 5 years later, which emerged as focal nodular hyperplasia at the site of the former hemangioma.
  • [MeSH-major] Focal Nodular Hyperplasia / pathology. Hemangioma / pathology. Liver Neoplasms / pathology

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19351369.001).
  • [ISSN] 1440-1827
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


32. Yeh WC, Yang PM, Huang GT, Sheu JC, Chen DS: Long-term follow-up of hepatic hemangiomas by ultrasonography: with emphasis on the growth rate of the tumor. Hepatogastroenterology; 2007 Mar;54(74):475-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term follow-up of hepatic hemangiomas by ultrasonography: with emphasis on the growth rate of the tumor.
  • BACKGROUND/AIMS: It is not rare to find hepatic hemangiomas in people in Taiwan where hepatitis B is endemic during ultrasonographic examinations for the screening of hepatocellular carcinoma, and we can therefore monitor these hemangiomas longitudinally since detected.
  • METHODOLOGY: Totally 180 hepatic hemangiomas in 130 adult patients were followed up for more than 5 years with at least twice ultrasound examinations in our hospital.
  • The diagnosis of hemangiomas was made by typical ultrasonographic findings as well as compatible findings in other imaging modalities.
  • The doubling time of tumor volume was calculated for the enlarging hepatic hemangiomas.
  • RESULTS: The diameters of the 180 hemangiomas ranged from <8 cm - >4 cm in 11 (6.1%), < or =4 cm - >2 cm in 55 (30.6%), and < or =2 cm in 114 (63.3%).
  • Among them, the diameter of 14 (7.7%) hemangiomas in 13 patients increased.
  • The tumor volume doubling time of these hemangiomas ranged from 17.3 to 178.1 months.
  • CONCLUSIONS: Although hepatic hemangiomas are benign, some of them indeed grow slowly.
  • The growth rates of these hemangiomas varied and were definitely slower as compared with those of malignant hepatic tumors.
  • [MeSH-major] Carcinoma, Hepatocellular / ultrasonography. Hemangioma / ultrasonography. Liver Neoplasms / ultrasonography. Neoplasms, Multiple Primary / ultrasonography

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17523302.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


33. Willenbrock K, Kriener S, Oeschger S, Hansmann ML: Nodular lymphoid lesion of the liver with simultaneous focal nodular hyperplasia and hemangioma: discrimination from primary hepatic MALT-type non-Hodgkin's lymphoma. Virchows Arch; 2006 Feb;448(2):223-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nodular lymphoid lesion of the liver with simultaneous focal nodular hyperplasia and hemangioma: discrimination from primary hepatic MALT-type non-Hodgkin's lymphoma.
  • Nodular lymphoid lesion (NLL) of the liver is a rare but unique entity and has also been termed reactive lymphoid hyperplasia of the liver.
  • We describe the histological, immunohistochemical and molecular biologic findings of a case with NLL and two other tumors of the liver.
  • The nodular lymphoid mass found in the liver was composed of heterogeneous small lymphocytes forming reactive follicles.
  • The lymphoid infiltrate displaced the adjacent hepatic parenchyma.
  • The diagnosis of NLL was made.
  • In addition to NLL, focal nodular hyperplasia and hemangioma were detected.
  • The discrimination of NLL from primary hepatic malignant non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue-type may pose diagnostic difficulties and may require the use of immunohistochemical and molecular techniques.
  • The simultaneous occurrence of NLL with focal nodular hyperplasia and hemangioma in the liver has not been described before.
  • [MeSH-major] Focal Nodular Hyperplasia / pathology. Hemangioma / pathology. Liver Neoplasms / pathology
  • [MeSH-minor] Adult. Antigens, CD20 / analysis. Antigens, CD3 / analysis. B-Lymphocytes / chemistry. B-Lymphocytes / pathology. Clone Cells / chemistry. Clone Cells / pathology. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Lymphocytes / chemistry. Lymphocytes / pathology. Lymphoma, B-Cell, Marginal Zone / metabolism. Lymphoma, B-Cell, Marginal Zone / pathology. T-Lymphocytes / chemistry. T-Lymphocytes / pathology

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Hepatol. 1997 Jan;26(1):209-14 [9148014.001]
  • [Cites] Arch Pathol Lab Med. 1999 Aug;123(8):716-9 [10420230.001]
  • [Cites] J Clin Gastroenterol. 1993 Apr;16(3):240-4 [8505499.001]
  • [Cites] Blood. 2003 Apr 1;101(7):2489-95 [12456507.001]
  • [Cites] Hepatology. 2003 Apr;37(4):781-7 [12668970.001]
  • [Cites] Pathol Int. 1994 Sep;44(9):704-11 [7804433.001]
  • [Cites] Intern Med. 1994 Jan;33(1):18-22 [7514058.001]
  • [Cites] J Hepatol. 1997 Nov;27(5):922-7 [9382982.001]
  • [Cites] Z Gastroenterol. 2001 Mar;39(3):219-24 [11324139.001]
  • [Cites] Leukemia. 2003 Dec;17(12):2257-317 [14671650.001]
  • [Cites] Pathol Int. 1996 Oct;46(10):782-6 [8916149.001]
  • [Cites] Am J Surg Pathol. 1995 May;19(5):571-5 [7726367.001]
  • [Cites] J Gastroenterol Hepatol. 1999 Feb;14 (2):163-7 [10029298.001]
  • [Cites] Arch Pathol Lab Med. 2000 Apr;124(4):604-8 [10747320.001]
  • [Cites] Am J Surg Pathol. 1999 Mar;23(3):302-8 [10078921.001]
  • [Cites] Mod Pathol. 1998 Apr;11(4):404-10 [9578094.001]
  • [Cites] Cancer. 1984 Jun 1;53(11):2515-24 [6424928.001]
  • [Cites] Scand J Rheumatol. 2001;30(2):117-9 [11324789.001]
  • (PMID = 16331470.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antigens, CD20; 0 / Antigens, CD3
  •  go-up   go-down


34. Tian QH, Yun JP, Miao J, Chen G, Fu J, Zhang CQ, Su SG, Zhang MF, Wu QL: [High expression of nucleophosmin/B23 in hepatocellular carcinoma]. Zhonghua Bing Li Xue Za Zhi; 2006 Jul;35(7):407-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Immunohistochemical study for B23 was performed on 103 cases of HCC, 12 cases of focal nodular hyperplasia and 17 cases of native liver tissue adjacent to hepatic hemangioma.
  • Fresh specimens from 10 cases of HCC and the adjacent liver tissue were also collected for reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blot analysis.
  • RESULTS: RT-PCR and Western blot analysis showed that B23 expression in HCC was higher than that in adjacent liver tissue.
  • CONCLUSIONS: B23 expression in HCC was significantly higher than that in liver tissues with non-malignant diseases.
  • B23 may be used as a marker for neoplastic changes in liver cells and thus has potential clinicopathologic application.
  • [MeSH-major] Biomarkers, Tumor / biosynthesis. Carcinoma, Hepatocellular / pathology. Liver Neoplasms / pathology. Nuclear Proteins / biosynthesis
  • [MeSH-minor] Focal Nodular Hyperplasia / genetics. Focal Nodular Hyperplasia / metabolism. Focal Nodular Hyperplasia / pathology. Gene Expression Regulation, Neoplastic. Humans. Immunohistochemistry. Liver / metabolism. Liver / pathology. Neoplasm Staging. RNA, Messenger / biosynthesis. RNA, Messenger / genetics. Reverse Transcriptase Polymerase Chain Reaction

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17069676.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Nuclear Proteins; 0 / RNA, Messenger; 117896-08-9 / nucleophosmin
  •  go-up   go-down


35. Paradis V: Benign liver tumors: an update. Clin Liver Dis; 2010 Nov;14(4):719-29
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign liver tumors: an update.
  • One of the consequences of extensive use of abdominal imaging, and especially liver ultrasonography, is the detection of asymptomatic liver tumors.
  • In the absence of underlying chronic liver disease, the vast majority of these lesions correspond to benign liver tumors including solid and cystic lesions.
  • This article is dedicated to hepatocellular tumors and also addresses hemangiomas as the most common benign liver tumors, and angiomyolipomas as a rare tumor often misdiagnosed.
  • [MeSH-major] Adenoma, Liver Cell / pathology. Angiomyolipoma / pathology. Carcinoma, Hepatocellular / pathology. Hemangioma / pathology. Liver Neoplasms / pathology
  • [MeSH-minor] Diagnosis, Differential. Humans

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 21055692.001).
  • [ISSN] 1557-8224
  • [Journal-full-title] Clinics in liver disease
  • [ISO-abbreviation] Clin Liver Dis
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


36. van Gorcum M, van Buuren HR, Hussain SM, Zondervan PE, IJzermans JN, de Man RA: [Fever as a sign of inflammatory syndrome in a female patient with hepatic haemangioma]. Ned Tijdschr Geneeskd; 2005 May 28;149(22):1227-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Fever as a sign of inflammatory syndrome in a female patient with hepatic haemangioma].
  • [Transliterated title] Koorts als uiting van inflammatoir syndroom bij een patiënte met een leverhemangioom.
  • Diagnostic imaging revealed a hepatic haemangioma with a diameter of 20 cm.
  • Because such giant haemangiomas of the liver can lead to inflammatory syndrome, the tumour was surgically removed.
  • Pathological analysis confirmed the clinical diagnosis and evidence of extensive thrombosis and other vascular defects was found.
  • In patients with a giant haemangioma in the liver who present with an inflammatory syndrome, the haemangioma should be considered as the causal factor.
  • [MeSH-major] Hemangioma / diagnosis. Liver Neoplasms / diagnosis. Systemic Inflammatory Response Syndrome / diagnosis
  • [MeSH-minor] Abdominal Pain / etiology. Adult. Diagnosis, Differential. Female. Fever / etiology. Humans. Treatment Outcome. Weight Loss

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15952499.001).
  • [ISSN] 0028-2162
  • [Journal-full-title] Nederlands tijdschrift voor geneeskunde
  • [ISO-abbreviation] Ned Tijdschr Geneeskd
  • [Language] dut
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


37. Bernatik T, Seitz K, Blank W, Schuler A, Dietrich CF, Strobel D: Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors. Ultraschall Med; 2010 Dec;31(6):577-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
  • MATERIALS AND METHODS: CEUS was performed on 1349 liver lesions with an unclear diagnosis after native ultrasound using a standardized protocol (phase inversion; low MI < 0.4; Sonovue Bolus 1.2 - 4.8 ml).
  • The diagnosis based on CEUS results was compared to the final diagnosis (histology: n = 1006; MRI: n = 269; CT: n = 269 - multiple examinations possible).
  • RESULTS: Of the 1349 enclosed liver lesions, 20 could not be definitively diagnosed even using all diagnostic steps including histology (the others were proven to be benign n = 573 or malignant n = 756).
  • Of the 1349 unclear liver lesions, 1257 could be differentiated with an accuracy of 90.3% using CEUS.
  • The sensitivity, specificity, and positive and negative predictive value for malignant liver lesions was 95.8%, 83.1%, 88.2% and 93.7% respectively.
  • 92 liver lesions (6.8%) could not be definitively diagnosed using CEUS.
  • Most of them were benign (n = 67) on final diagnosis.
  • The CEUS diagnosis was wrong for 39 lesions.
  • However, only 8 lesions classified as benign by CEUS turned out to be malignant.
  • Two lesions diagnosed by CEUS as hemangiomas turned out to be an HCC and a metastasis.
  • One lesion classified as benign by CEUS was ultimately diagnosed as a lymphoma.
  • CONCLUSION: Even in this multi-center trial, CEUS proved to be an excellent method for clarifying liver lesions remaining unclear after native ultrasound.
  • The CEUS diagnosis of benign was only incorrect in a few cases.
  • [MeSH-major] Carcinoma, Hepatocellular / ultrasonography. Image Enhancement / methods. Liver Neoplasms / ultrasonography. Ultrasonography / methods
  • [MeSH-minor] Biopsy. Biopsy, Fine-Needle. Contrast Media / administration & dosage. Diagnosis, Differential. Focal Nodular Hyperplasia / pathology. Focal Nodular Hyperplasia / ultrasonography. Hemangioma / pathology. Hemangioma / ultrasonography. Humans. Liver / pathology. Liver / ultrasonography. Liver Diseases / pathology. Liver Diseases / ultrasonography. Phospholipids. Regional Blood Flow / physiology. Sensitivity and Specificity. Sulfur Hexafluoride

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Ultrasound.
  • Hazardous Substances Data Bank. SULFUR HEXAFLUORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © Georg Thieme Verlag KG Stuttgart · New York.
  • (PMID = 20740399.001).
  • [ISSN] 1438-8782
  • [Journal-full-title] Ultraschall in der Medizin (Stuttgart, Germany : 1980)
  • [ISO-abbreviation] Ultraschall Med
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Phospholipids; 0 / contrast agent BR1; WS7LR3I1D6 / Sulfur Hexafluoride
  •  go-up   go-down


38. Gönül M, Gul U, Gunduz H, Artantas S, Demiriz M: Disseminated lobular capillary hemangioma: two case reports. J Dermatol; 2005 Dec;32(12):996-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Disseminated lobular capillary hemangioma: two case reports.
  • Lobular capillary hemangioma, also known as pyogenic granuloma, is a common, solitary, benign neoplasm of the skin and mucous membranes.
  • Lobular capillary hemangioma can present rarely in a disseminated form, usually associated with other disorders.
  • Two patients, aged 17 and 33, were admitted to the dermatology clinic with disseminated lobular capillary hemangiomas which appeared suddenly.
  • The histopathology of the lesions was consistent with lobular capillary hemangioma.
  • No associated disorders were found in physical and laboratory examinations other than mental retardation in one patient and a small hemangioma in the liver in the other.
  • We report two cases of disseminated lobular capillary hemangioma without an associated disorder.


39. Assy N, Nasser G, Djibre A, Beniashvili Z, Elias S, Zidan J: Characteristics of common solid liver lesions and recommendations for diagnostic workup. World J Gastroenterol; 2009 Jul 14;15(26):3217-27
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characteristics of common solid liver lesions and recommendations for diagnostic workup.
  • Due to the widespread clinical use of imaging modalities such as ultrasonography, computed tomography and magnetic resonance imaging (MRI), previously unsuspected liver masses are increasingly being found in asymptomatic patients.
  • This review discusses the various characteristics of the most common solid liver lesions and recommends a practical approach for diagnostic workup.
  • Likely diagnoses include hepatocellular carcinoma (the most likely; a solid liver lesion in a cirrhotic liver) and hemangioma (generally presenting as a mass in a non-cirrhotic liver).
  • Focal nodular hyperplasia and hepatic adenoma should be ruled out in young women.
  • If the patient is known to have a primary malignancy and the lesion was found at tumor staging or follow up, histology is required only when the nature of the liver lesion is doubtful.
  • [MeSH-major] Diagnostic Imaging / methods. Liver Neoplasms
  • [MeSH-minor] Algorithms. Biomarkers, Tumor / metabolism. Biopsy. Biopsy, Fine-Needle. Humans. Incidental Findings. Liver Cirrhosis / pathology

  • MedlinePlus Health Information. consumer health - Diagnostic Imaging.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] World J Gastroenterol. 2006 Jul 7;12(25):4089-92 [16810767.001]
  • [Cites] World J Surg. 2006 Aug;30(8):1560-6 [16865321.001]
  • [Cites] Liver Int. 2006 Sep;26(7):781-8 [16911459.001]
  • [Cites] Leuk Res. 2006 Oct;30(10):1315-7 [16516291.001]
  • [Cites] World J Surg. 2006 Oct;30(10):1892-9; discussion 1900-1 [16855806.001]
  • [Cites] Ann Ist Super Sanita. 2006;42(2):163-9 [17033136.001]
  • [Cites] Ann Hepatol. 2006 Jul-Sep;5(3):206-11 [17060885.001]
  • [Cites] Radiographics. 2006 Nov-Dec;26(6):1621-36 [17102040.001]
  • [Cites] J Surg Oncol. 2006 Dec 1;94(7):587-91 [17066420.001]
  • [Cites] Eur J Cancer Care (Engl). 2006 Dec;15(5):463-6 [17177904.001]
  • [Cites] APMIS. 2006 Dec;114(12):908-11 [17207092.001]
  • [Cites] Eur J Radiol. 2007 Jan;61(1):33-43 [17118603.001]
  • [Cites] Cochrane Database Syst Rev. 2007;(1):CD005164 [17253542.001]
  • [Cites] Ann N Y Acad Sci. 2006 Nov;1089:228-36 [17261770.001]
  • [Cites] J Nucl Med. 2007 Apr;48(4):498-500 [17401084.001]
  • [Cites] Prog Transplant. 2007 Mar;17(1):70-2 [17484250.001]
  • [Cites] Nat Clin Pract Endocrinol Metab. 2007 Jun;3(6):458-69 [17515890.001]
  • [Cites] Am J Surg Pathol. 2007 Jun;31(6):817-26 [17527068.001]
  • [Cites] Hematol Oncol Clin North Am. 2007 Jun;21(3):545-60; ix-x [17548039.001]
  • [Cites] J Coll Physicians Surg Pak. 2007 May;17(5):280-2 [17553327.001]
  • [Cites] J Endocrinol Invest. 2007 Apr;30(4):327-33 [17556871.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2007;14(6):595-9 [18040628.001]
  • [Cites] J Hepatol. 2008 Jul;49(1):34-42 [18456366.001]
  • [Cites] J Gastroenterol Hepatol. 2008 Oct;23(10):1520-7 [18713303.001]
  • [Cites] Blood. 2003 Dec 15;102(13):4261-9 [12907441.001]
  • [Cites] Radiographics. 2004 Jan-Feb;24(1):3-17; discussion 18-9 [14730031.001]
  • [Cites] Am J Hematol. 2004 Apr;75(4):225-30 [15054815.001]
  • [Cites] Leuk Lymphoma. 2004 Jan;45(1):193-8 [15061221.001]
  • [Cites] Semin Liver Dis. 2004 May;24(2):115-25 [15192785.001]
  • [Cites] Dig Dis Sci. 2004 May;49(5):866-71 [15259511.001]
  • [Cites] Gut. 2004 Sep;53(9):1356-62 [15306600.001]
  • [Cites] Medicine (Baltimore). 1979 Jan;58(1):48-64 [368508.001]
  • [Cites] Abdom Imaging. 1999 Jan-Feb;24(1):47-55 [9933673.001]
  • [Cites] N Engl J Med. 1999 Mar 11;340(10):745-50 [10072408.001]
  • [Cites] J Gastroenterol Hepatol. 1999 May;14 Suppl:S32-6 [10382636.001]
  • [Cites] Hepatology. 1999 Oct;30(4):889-93 [10498639.001]
  • [Cites] Arch Surg. 1961 Nov;83:729-33 [13911012.001]
  • [Cites] Clin Nucl Med. 2004 Dec;29(12):844-5 [15545902.001]
  • [Cites] Scand J Gastroenterol Suppl. 2004;(241):85-92 [15696855.001]
  • [Cites] Magn Reson Imaging Clin N Am. 2005 May;13(2):255-75 [15935311.001]
  • [Cites] Hepatogastroenterology. 1999 Nov-Dec;46(30):3208-11 [10626187.001]
  • [Cites] Pediatr Radiol. 2000 Jan;30(1):64-8 [10663513.001]
  • [Cites] Liver Transpl. 2000 Jan;6(1):67-72 [10648580.001]
  • [Cites] Liver Transpl. 2000 Jan;6(1):73-5 [10648581.001]
  • [Cites] Dig Dis Sci. 1991 Jul;36(7):962-72 [1649041.001]
  • [Cites] J Gastroenterol Hepatol. 1990 Jan-Feb;5(1):94-5 [2103386.001]
  • [Cites] Hepatology. 1992 Jul;16(1):132-7 [1352268.001]
  • [Cites] AJR Am J Roentgenol. 1992 Dec;159(6):1191-4 [1442380.001]
  • [Cites] J Surg Oncol Suppl. 1993;3:131-3 [8389160.001]
  • [Cites] Gastroenterol Clin Biol. 1993;17(3):218-22 [8330697.001]
  • [Cites] AJR Am J Roentgenol. 1993 Aug;161(2):319-22 [8333369.001]
  • [Cites] Mayo Clin Proc. 1993 Sep;68(9):874-9 [8396700.001]
  • [Cites] Semin Liver Dis. 1993 Nov;13(4):423-35 [8303323.001]
  • [Cites] J Hepatol. 1994 Jan;20(1):117-21 [8201212.001]
  • [Cites] Lancet. 1994 Dec 3;344(8936):1568-9 [7983964.001]
  • [Cites] Gastroenterology. 1995 Mar;108(3):865-9 [7875490.001]
  • [Cites] Am J Surg Pathol. 1995 Aug;19(8):859-72 [7611533.001]
  • [Cites] Hepatology. 1995 Sep;22(3):983-93 [7657307.001]
  • [Cites] Hepatology. 1995 Dec;22(6):1674-81 [7489973.001]
  • [Cites] Semin Roentgenol. 1995 Oct;30(4):375-95 [8539646.001]
  • [Cites] Surg Clin North Am. 2000 Apr;80(2):603-32 [10836009.001]
  • [Cites] Hepatogastroenterology. 2000 Nov-Dec;47(36):1654-8 [11149026.001]
  • [Cites] Gut. 2001 Feb;48(2):251-9 [11156649.001]
  • [Cites] J Hepatol. 2001 Apr;34(4):603-5 [11394662.001]
  • [Cites] Radiographics. 2001 Jul-Aug;21(4):877-92; discussion 892-4 [11452062.001]
  • [Cites] J Hepatol. 2001 Aug;35(2):254-8 [11580148.001]
  • [Cites] J Hepatol. 2001 Sep;35(3):421-30 [11592607.001]
  • [Cites] Semin Oncol. 2001 Oct;28(5):460-73 [11685739.001]
  • [Cites] Eur Radiol. 2001;11 Suppl 3:E15-26 [11793049.001]
  • [Cites] Hepatogastroenterology. 2002 May-Jun;49(45):740-5 [12063982.001]
  • [Cites] Radiographics. 2002 Sep-Oct;22(5):1023-36; discussion 1037-9 [12235331.001]
  • [Cites] Cardiovasc Intervent Radiol. 2002 Jul-Aug;25(4):295-9 [12324817.001]
  • [Cites] Best Pract Res Clin Haematol. 2003 Mar;16(1):33-40 [12670463.001]
  • [Cites] Gut. 2003 May;52 Suppl 3:iii1-8 [12692148.001]
  • [Cites] Acta Cytol. 2003 May-Jun;47(3):332-6 [12789910.001]
  • [Cites] Acta Gastroenterol Belg. 2003 Apr-Jun;66(2):160-5 [12891926.001]
  • [Cites] J Gastroenterol. 2003;38(8):759-64 [14505130.001]
  • [Cites] Cancer. 1980 Jul 15;46(2):372-9 [6248194.001]
  • [Cites] Radiology. 1981 Feb;138(2):405-10 [7455122.001]
  • [Cites] AJR Am J Roentgenol. 1981 Nov;137(5):983-90 [6975026.001]
  • [Cites] Am J Surg. 1983 Jan;145(1):49-53 [6849494.001]
  • [Cites] Gastroenterology. 1983 May;84(5 Pt 1):994-1002 [6299876.001]
  • [Cites] Semin Liver Dis. 1983 Aug;3(3):193-202 [6623102.001]
  • [Cites] Semin Surg Oncol. 1985;1(1):12-22 [3887538.001]
  • [Cites] AJR Am J Roentgenol. 1985 Aug;145(2):213-22 [2992250.001]
  • [Cites] Cancer. 1985 Sep 15;56(6):1434-45 [4027877.001]
  • [Cites] J Nucl Med. 1985 Oct;26(10):1117-22 [3900307.001]
  • [Cites] Am J Surg Pathol. 1985 Oct;9(10):695-704 [3904492.001]
  • [Cites] Am J Surg. 1986 Apr;151(4):518-23 [2421594.001]
  • [Cites] Radiology. 1986 Jul;160(1):53-8 [3520655.001]
  • [Cites] Acta Pathol Microbiol Immunol Scand A. 1986 Mar;94(2):141-7 [3716801.001]
  • [Cites] Hepatology. 1986 Jul-Aug;6(4):729-38 [2426173.001]
  • [Cites] Semin Liver Dis. 1986 Aug;6(3):259-66 [3022387.001]
  • [Cites] Int J Cancer. 1988 Jan 15;41(1):17-23 [2826343.001]
  • [Cites] AJR Am J Roentgenol. 1988 Aug;151(2):295-9 [2839968.001]
  • [Cites] AJR Am J Roentgenol. 1988 Nov;151(5):933-8 [2845763.001]
  • [Cites] Cancer. 1989 Jul 15;64(2):455-9 [2736492.001]
  • [Cites] Cancer. 1989 Aug 1;64(3):658-66 [2545324.001]
  • [Cites] Ultraschall Med. 1989 Jun;10(3):123-6 [2672314.001]
  • [Cites] Scand J Gastroenterol. 1989 Oct;24(8):949-55 [2688068.001]
  • [Cites] Dig Dis Sci. 1990 Apr;35(4):422-7 [1690630.001]
  • [Cites] Radiology. 1991 Jan;178(1):253-8 [1984314.001]
  • [Cites] Am J Clin Pathol. 1991 Feb;95(2):125-30 [1704175.001]
  • [Cites] J Hepatol. 1990 Nov;11(3):344-8 [2290025.001]
  • [Cites] Br J Surg. 1996 Aug;83(8):1062-64 [8869303.001]
  • [Cites] Int J Epidemiol. 1996 Oct;25(5):933-40 [8921477.001]
  • [Cites] Br J Surg. 1996 Dec;83(12):1715-6 [9038549.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1997 Mar;24(3):276-9 [9138172.001]
  • [Cites] AJR Am J Roentgenol. 1997 Jul;169(1):131-5 [9207512.001]
  • [Cites] Clin Imaging. 1997 Sep-Oct;21(5):359-65 [9316757.001]
  • [Cites] J Hepatol. 1997 Nov;27(5):796-802 [9382965.001]
  • [Cites] Clin Nucl Med. 1997 Dec;22(12):825-31 [9408643.001]
  • [Cites] CA Cancer J Clin. 1998 Jan-Feb;48(1):6-29 [9449931.001]
  • [Cites] Hepatology. 1998 Feb;27(2):488-96 [9462648.001]
  • [Cites] AJR Am J Roentgenol. 1998 Sep;171(3):651-8 [9725291.001]
  • [Cites] Ann Intern Med. 1998 Oct 15;129(8):643-53 [9786813.001]
  • [Cites] J Comput Assist Tomogr. 1998 Nov-Dec;22(6):861-7 [9843222.001]
  • [Cites] Curr Treat Options Oncol. 2005 Sep;6(5):397-409 [16107243.001]
  • [Cites] Ann Surg. 2006 Feb;243(2):236-40 [16432357.001]
  • [Cites] N Engl J Med. 2006 Feb 2;354(5):509-14 [16452563.001]
  • [Cites] Eur J Med Res. 2006 Feb 21;11(2):58-65 [16504962.001]
  • [Cites] Gastroenterol Clin Biol. 2006 Feb;30(2):304-6 [16565667.001]
  • [Cites] Liver Int. 2006 May;26(4):433-8 [16629646.001]
  • [Cites] Am Surg. 2006 Jun;72(6):555-9 [16808214.001]
  • (PMID = 19598296.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 131
  • [Other-IDs] NLM/ PMC2710776
  •  go-up   go-down


40. Chung JJ, Kim MJ, Kim KW: Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful? J Magn Reson Imaging; 2006 May;23(5):706-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
  • PURPOSE: To investigate the usefulness of early and delayed hepatic MRI after mangafodipir trisodium (Mn-DPDP) administration for the detection and characterization of focal hepatic lesions.
  • MATERIALS AND METHODS: Forty-five patients (31 males and 14 females, mean age = 61 years) with a total of 113 hepatic lesions (mean size = 3.5 cm) were included in this study (15 with hepatocellular carcinoma (HCC, N = 35), 20 with hepatic metastasis (N = 63), five with hemangioma (N = 10), three with cholangiocarcinoma (CC, N = 3), and two with liver abscess (N = 2)).
  • A qualitative analysis (including the size and signal intensity (SI)) and quantitative analysis (including enhancement and lesion-liver contrast-to-noise ratio (CNR)) were performed on pre- and postcontrast early and delayed MR images.
  • All 63 metastases, 10 hemangiomas, three CCs, and two abscesses showed no SI change.
  • On delayed imaging, ring enhancement was noted in 53 metastases (84.1%), three hemangiomas (30.0%), and one abscess (50.0%), but was not seen in HCCs or CCs.
  • No newly detected hepatic lesions were revealed on postcontrast delayed MR images compared to postcontrast early images.
  • However, none of the metastases, hemangiomas, CCs, and abscesses showed a significant increase of CNR from postcontrast early to delayed images.
  • CONCLUSION: Postcontrast delayed MR images after Mn-DPDP administration were helpful in distinguishing hepatocellular from nonhepatocellular lesions, but were not useful for lesion detection and had limited utility for lesion characterization, since benign and malignant hepatic lesions looked the same.
  • [MeSH-major] Bile Duct Neoplasms / diagnosis. Carcinoma, Hepatocellular / diagnosis. Cholangiocarcinoma / diagnosis. Edetic Acid / analogs & derivatives. Hemangioma / diagnosis. Liver Neoplasms / diagnosis. Magnetic Resonance Imaging / methods. Pyridoxal Phosphate / analogs & derivatives
  • [MeSH-minor] Adult. Aged. Bile Ducts, Intrahepatic / pathology. Contrast Media / administration & dosage. Diagnosis, Differential. Female. Humans. Image Enhancement / methods. Liver Abscess / diagnosis. Male. Middle Aged. Observer Variation. Time Factors

  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • Hazardous Substances Data Bank. Disodium EDTA .
  • Hazardous Substances Data Bank. ETHYLENEDIAMINE TETRAACETIC ACID .
  • Hazardous Substances Data Bank. DISODIUM CALCIUM EDTA .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2006 Wiley-Liss, Inc.
  • (PMID = 16565954.001).
  • [ISSN] 1053-1807
  • [Journal-full-title] Journal of magnetic resonance imaging : JMRI
  • [ISO-abbreviation] J Magn Reson Imaging
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; 5V5IOJ8338 / Pyridoxal Phosphate; 9G34HU7RV0 / Edetic Acid; P28BIW0UTB / N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
  •  go-up   go-down


41. Scialpi M, Piscioli I, Brunese L, Lupattelli L: Cavernous malformation or cavernous hemangioma: an appropriate term to define liver hemangioma. Eur Radiol; 2008 Dec;18(12):2854; author reply 2854
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cavernous malformation or cavernous hemangioma: an appropriate term to define liver hemangioma.
  • [MeSH-major] Hemangioma / diagnosis. Liver / abnormalities. Liver / diagnostic imaging. Liver Neoplasms / diagnosis
  • [MeSH-minor] Contrast Media. Diagnosis, Differential. Diagnostic Imaging. Humans. Radiography

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Eur Radiol. 2007 Jun;17(6):1544-54 [17260159.001]
  • [Cites] Surg Today. 2005;35(9):796-9 [16133680.001]
  • [Cites] Eur Radiol. 2007 Jun;17(6):1544-54 [17260159.001]
  • [Cites] Semin Diagn Pathol. 2008 Feb;25(1):1-16 [18350917.001]
  • [Cites] Radiology. 1997 Apr;203(1):121-5 [9122378.001]
  • (PMID = 18618123.001).
  • [ISSN] 1432-1084
  • [Journal-full-title] European radiology
  • [ISO-abbreviation] Eur Radiol
  • [Language] eng
  • [Publication-type] Letter; Comment
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


42. Aksenov IV, Fedorchenko AN: [Hepatic hemangioma: the choice of treatment]. Khirurgiia (Mosk); 2010;(6):40-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Hepatic hemangioma: the choice of treatment].
  • 117 patients with hepatic hemangioma were treated.
  • The possibility and technical features of liver resections by hepatic hemangiomas are discussed.
  • Authors state the necessity of reduction of surgical treatment of hepatic hemangiomas and substantiate the need of dynamic observation of such lesions of the liver.
  • [MeSH-major] Hemangioma / surgery. Liver Neoplasms / surgery

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20559223.001).
  • [ISSN] 0023-1207
  • [Journal-full-title] Khirurgiia
  • [ISO-abbreviation] Khirurgiia (Mosk)
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


43. Artiko MV, Sobić-Saranović PD, Perisić-Savić SM, Stojković VM, Radoman BI, Knezević SJ, Petrović SN, Obradović BV, Milović V: 99mTc-red blood cells SPECT and planar scintigraphy in the diagnosis of hepatic hemangiomas. Acta Chir Iugosl; 2008;55(4):23-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] 99mTc-red blood cells SPECT and planar scintigraphy in the diagnosis of hepatic hemangiomas.
  • The aim of the study is the assessment of the value of SPECT (single photon emission computerized tomography) using 99mTc-labeled red blood cells in the detection of liver hemangioma, in comparison to planar imaging.
  • [MeSH-major] Hemangioma / radionuclide imaging. Liver Neoplasms / radionuclide imaging. Sodium Pertechnetate Tc 99m. Tomography, Emission-Computed, Single-Photon
  • [MeSH-minor] Adult. Erythrocytes. Female. Humans. Liver / radionuclide imaging. Male. Middle Aged. Predictive Value of Tests. Sensitivity and Specificity. Young Adult

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19245136.001).
  • [ISSN] 0354-950X
  • [Journal-full-title] Acta chirurgica Iugoslavica
  • [ISO-abbreviation] Acta Chir Iugosl
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Serbia
  • [Chemical-registry-number] A0730CX801 / Sodium Pertechnetate Tc 99m
  •  go-up   go-down


44. Akamatsu N, Sugawara Y, Komagome M, Ishida T, Shin N, Cho N, Ozawa F, Hashimoto D: Giant liver hemangioma resected by trisectorectomy after efficient volume reduction by transcatheter arterial embolization: a case report. J Med Case Rep; 2010;4:283
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant liver hemangioma resected by trisectorectomy after efficient volume reduction by transcatheter arterial embolization: a case report.
  • INTRODUCTION: Liver hemangiomas are the most common benign liver tumors, usually small in size and requiring no treatment.
  • Giant hemangiomas complicated with consumptive coagulopathy (Kasabach-Merritt syndrome) or causing severe incapacitating symptoms, however, are generally considered an absolute indication for surgical resection.
  • Here, we present the case of a giant hemangioma, which was, to the best of our knowledge, one of the largest ever reported.
  • Examinations at the first visit revealed a right liver hemangioma occupying the abdominal cavity, protruding into the right diaphragm up to the right thoracic cavity and extending down to the pelvic cavity, with a maximum diameter of 43 cm, complicated with "asymptomatic" Kasabach-Merritt syndrome.
  • Based on the tumor size and the anatomic relationship between the tumor and hepatic vena cava, primary resection seemed difficult and dangerous, leading us to first perform transcatheter arterial embolization to reduce the tumor volume and to ensure the safety of future resection.
  • CONCLUSIONS: To date, there have been several reports of aggressive surgical treatments, including extra-corporeal hepatic resection and liver transplantation, for huge hemangiomas like the present case, but because of its benign nature, every effort should be made to avoid life-threatening surgical stress for patients.
  • Our experience demonstrates that a pre-operative arterial embolization may effectively enable the resection of large hemangiomas.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20731839.001).
  • [ISSN] 1752-1947
  • [Journal-full-title] Journal of medical case reports
  • [ISO-abbreviation] J Med Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2936318
  •  go-up   go-down


45. Berloco P, Bruzzone P, Mennini G, Della Pietra F, Iappelli M, Novelli G, Rossi M: Giant hemangiomas of the liver: surgical strategies and technical aspects. HPB (Oxford); 2006;8(3):200-1
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant hemangiomas of the liver: surgical strategies and technical aspects.
  • The incidence of hemangiomas is 2-7% in the general population.
  • We evaluated more than 300 patients with hepatic hemangiomas.
  • Surgical removal of hepatic hemangiomas was performed in 48 cases due to uncertain diagnosis (2 cases), intractable symptoms (26 cases), size increase (18 cases), and liver failure in 2 cases that were treated by hepatic transplantation.
  • In all, 26 patients underwent enucleation of hemangiomas or segmentectomies, while the remaining 20 patients underwent right lobectomies or left lateral segmentectomies.
  • Blood transfusions were required in four cases (including two liver transplants); mean post-resection hospital stay was 6.3 days.
  • Our experience confirms that, after adequate patient selection, surgical treatment of hepatic hemangiomas is a very effective therapeutic choice with no mortality and low morbidity.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Surg. 1996 Jul;83(7):915-8 [8813773.001]
  • [Cites] World J Surg. 1995 Jan-Feb;19(1):19-24 [7740805.001]
  • [Cites] Liver Transpl. 2004 Nov;10(11):1436-7 [15497149.001]
  • [Cites] Br J Surg. 2001 Jun;88(6):808-13 [11412249.001]
  • [Cites] J Gastrointest Surg. 2004 Nov;8(7):785-93 [15531231.001]
  • (PMID = 18333276.001).
  • [ISSN] 1365-182X
  • [Journal-full-title] HPB : the official journal of the International Hepato Pancreato Biliary Association
  • [ISO-abbreviation] HPB (Oxford)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2131674
  •  go-up   go-down


46. Kim KW, Kim AY, Kim TK, Kim SY, Kim MJ, Park MS, Park SH, Lee KH, Kim JK, Kim PN, Ha HK, Lee MG: Hepatic hemangiomas with arterioportal shunt: sonographic appearances with CT and MRI correlation. AJR Am J Roentgenol; 2006 Oct;187(4):W406-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hepatic hemangiomas with arterioportal shunt: sonographic appearances with CT and MRI correlation.
  • OBJECTIVE: The purpose of this study was to summarize and illustrate the sonographic appearance of hepatic hemangiomas with arterioportal shunt and to correlate them with CT and MRI findings.
  • CONCLUSION: High-flow hepatic hemangiomas tend to be seen as hypoechoic lesions at sonography.
  • In the presence of fatty infiltration in the liver, they may accompany peritumoral low-echoic areas presumably caused by peritumoral sparing of fatty infiltration similar to a hyperattenuating or hyperintense peritumoral rim on unenhanced CT or MR chemical shift imaging.
  • Knowledge of such sonographic findings may ensure an accurate sonographic diagnosis of these tumors.
  • [MeSH-major] Hemangioma / ultrasonography. Liver Neoplasms / ultrasonography. Magnetic Resonance Imaging. Tomography, X-Ray Computed
  • [MeSH-minor] Adult. Fatty Liver / complications. Fatty Liver / radiography. Fatty Liver / ultrasonography. Female. Hepatic Artery / radiography. Hepatic Artery / ultrasonography. Humans. Male. Middle Aged. Portal Vein / radiography. Portal Vein / ultrasonography

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16985113.001).
  • [ISSN] 1546-3141
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


47. Blondet A, Ridereau-Zins C, Michalak S, Pessaux P, Aubertin A, Aubé C: [Multiple pedunculated liver hemangiomas presenting with volvulus]. J Radiol; 2007 Jun;88(6):891-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Multiple pedunculated liver hemangiomas presenting with volvulus].
  • [MeSH-major] Hemangioma / complications. Intestinal Volvulus / etiology. Liver Neoplasms / complications

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17652983.001).
  • [ISSN] 0221-0363
  • [Journal-full-title] Journal de radiologie
  • [ISO-abbreviation] J Radiol
  • [Language] fre
  • [Publication-type] Case Reports; Letter
  • [Publication-country] France
  •  go-up   go-down


48. Bernini GP, Moretti A, Mannelli M, Ercolino T, Bardini M, Caramella D, Taurino C, Salvetti A: Unique association of non-functioning pheochromocytoma, ganglioneuroma, adrenal cortical adenoma, hepatic and vertebral hemangiomas in a patient with a new intronic variant in the VHL gene. J Endocrinol Invest; 2005 Dec;28(11):1032-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unique association of non-functioning pheochromocytoma, ganglioneuroma, adrenal cortical adenoma, hepatic and vertebral hemangiomas in a patient with a new intronic variant in the VHL gene.
  • In addition, CT and MR revealed a vertebral and two hepatic hemangiomas.
  • [MeSH-major] Adrenal Gland Neoplasms / genetics. Adrenocortical Adenoma / genetics. Ganglioneuroma / genetics. Hemangioma / genetics. Liver Neoplasms / genetics. Neoplasms, Multiple Primary. Pheochromocytoma / genetics. Spinal Neoplasms / genetics. Von Hippel-Lindau Tumor Suppressor Protein / genetics

  • Genetic Alliance. consumer health - Pheochromocytoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Clin Pathol. 1994 Aug;102(2):163-70 [8042583.001]
  • [Cites] Lancet. 2003 Jun 14;361(9374):2059-67 [12814730.001]
  • [Cites] Am J Surg Pathol. 1988 Jul;12(7):559-66 [3389453.001]
  • [Cites] Nat Genet. 2002 Dec;32(4):614-21 [12415268.001]
  • [Cites] Am J Surg Pathol. 1991 Jan;15(1):81-6 [1898683.001]
  • [Cites] Pathology. 2003 Jun;35(3):263-5 [14506975.001]
  • [Cites] J Endocrinol Invest. 1998 Jun;21(6):365-71 [9699128.001]
  • [Cites] Histopathology. 1993 Dec;23(6):567-9 [8314241.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Feb 13;98 (4):1583-8 [11171994.001]
  • [Cites] Endocrinol Jpn. 1986 Feb;33(1):67-74 [3720679.001]
  • [Cites] Cancer. 1977 Oct;40(4):1526-32 [907969.001]
  • [Cites] Mod Pathol. 2002 Mar;15(3):183-8 [11904334.001]
  • [Cites] Histopathology. 1998 Mar;32(3):281-2 [9568520.001]
  • [Cites] Am J Hypertens. 1998 Jan;11(1 Pt 1):117-21 [9504459.001]
  • [Cites] J Clin Endocrinol Metab. 2000 Feb;85(2):637-44 [10690869.001]
  • [Cites] Endocr Rev. 1995 Aug;16(4):460-84 [8521790.001]
  • [Cites] J Comput Assist Tomogr. 1999 Jul-Aug;23 (4):565-6 [10433288.001]
  • [Cites] Endocr Pathol. 2001 Fall;12(3):343-50 [11740055.001]
  • [Cites] Hum Pathol. 1990 Nov;21(11):1168-80 [2172151.001]
  • [Cites] Ultrastruct Pathol. 1988 Sep-Oct;12(5):513-27 [3194994.001]
  • [Cites] Cancer Res. 2003 Sep 1;63(17):5320-8 [14500363.001]
  • [Cites] Cancer. 1985 Jun 15;55(12):2794-8 [3922614.001]
  • [Cites] Endocr Pathol. 1999 Winter;10 (4):343-352 [12114771.001]
  • [Cites] Am J Surg Pathol. 1997 Jan;21(1):102-8 [8990146.001]
  • [Cites] J Urol. 2001 Apr;165(4):1199-200 [11257670.001]
  • [Cites] West J Med. 1991 Mar;154(3):334-7 [2028605.001]
  • [Cites] Arch Pathol Lab Med. 1999 Dec;123(12):1274-9 [10583935.001]
  • (PMID = 16483185.001).
  • [ISSN] 0391-4097
  • [Journal-full-title] Journal of endocrinological investigation
  • [ISO-abbreviation] J. Endocrinol. Invest.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / DNA, Neoplasm; EC 2.3.2.27 / Von Hippel-Lindau Tumor Suppressor Protein; EC 6.3.2.- / VHL protein, human
  •  go-up   go-down


49. Aseni P, Lauterio A, Slim AO, Giacomoni A, Lamperti L, De Carlis L: Life-saving super-urgent liver transplantation with replacement of retrohepatic vena cava by dacron graft. HPB Surg; 2010;2010
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Life-saving super-urgent liver transplantation with replacement of retrohepatic vena cava by dacron graft.
  • We describe a modified technique of side-to-side cavo-cavostomy by Dacron interposition prosthesis during a super urgent liver transplantation.
  • A liver graft from a deceased donor was immediately requested on a top priority basis as a consequence of massive bleeding during extended left hepatectomy for a huge hepatic haemangioma arising from the caudate lobe.
  • A liver graft from a deceased donor was available 16 hours later.
  • Due to the shortness of the vena cava of the donor liver graft, the removal of the Dacron graft was impossible and a modified side-to-side cavo-cavostomy between the Dacron interposition graft and the vena cava of the donor liver was than performed.
  • Liver transplantation was uneventful and the patient is doing well 25 months after the surgical procedure.
  • Although the use of synthetic vascular prosthesis should usually be discouraged during organ transplantation, its exceptional use during liver transplantation is possible with long-term good results.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20811479.001).
  • [ISSN] 1607-8462
  • [Journal-full-title] HPB surgery : a world journal of hepatic, pancreatic and biliary surgery
  • [ISO-abbreviation] HPB Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2926580
  •  go-up   go-down


50. Park SM, Shin SM, Seo HE, Kim SH, Kim HS, Park JH, Kim JH, Sohn KR: [A case of sclerosed hemangioma mimicking intrahepatic cholangiocarcinoma]. Korean J Gastroenterol; 2009 Dec;54(6):399-403
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of sclerosed hemangioma mimicking intrahepatic cholangiocarcinoma].
  • Hemangioma is one of the most frequently encountered benign hepatic neoplasm which can develop secondary degeneration.
  • Sclerosed hemangioma is a rare disease histologically characterized by large amount of collagen and elastic fibril between sclerosed small vessels.
  • Its differential diagnosis is very difficult.
  • It should be included in the differential diagnosis of other hepatic lesions such as hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and metastatic hepatic tumor.
  • Abdominal ultrasonography revealed GB stone, dilated common bile duct with bile duct stone, and a 4.6 cm sized hyperechoic mass at segment 5 and 6 of the liver.
  • We removed common bile duct stone with endoscopic retrograde cholangiopancreatography then decided to undergo right lower segmentectomy of liver due to possibility of cholangiocarcinoma.
  • Histopathological examination of hepatic mass showed large amount of fibrous tissue with occasional residual vascular channels.
  • We describe one case of sclerosed hemangioma mimicking cholangiocarcinoma.
  • [MeSH-major] Hemangioma / diagnosis. Liver Neoplasms / diagnosis
  • [MeSH-minor] Aged. Bile Duct Neoplasms / diagnosis. Bile Ducts, Intrahepatic. Cholangiocarcinoma / diagnosis. Diagnosis, Differential. Humans. Magnetic Resonance Imaging. Male. Tomography, X-Ray Computed. Ultrasonography


51. Ng WW, Cheung YS, Lee KF, Wong J, Yu SC, Lee PS, Lai PB: Is regular follow-up scan for giant liver haemangioma necessary? Hong Kong Med J; 2007 Oct;13(5):353-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Is regular follow-up scan for giant liver haemangioma necessary?
  • OBJECTIVES: To review the reliability of radiological diagnosis and need of regular scans for giant liver haemangioma, in terms of long-term outcome and management options.
  • PATIENTS: Patients with giant liver haemangioma noted on initial imaging from February 1996 to July 2006.
  • RESULTS: There were 42 female and 22 male patients with a median age of 49 (range, 27-84) years with a suspected haemangioma.
  • Besides regular follow-up scans, 22 patients were investigated further to confirm the diagnosis/exclude malignancy.
  • Finally, 63 patients had a haemangioma and one had a hepatocellular carcinoma.
  • Most (54%) of the patients were asymptomatic, but in 17% the haemangioma enlarged to exceed its original size by more than 20%.
  • There were no haemangioma-associated complications.
  • CONCLUSIONS: Majority of patients having giant liver haemangioma are asymptomatic and do not suffer complications.
  • If the diagnosis is uncertain, selective further investigations may be necessary.
  • Lesions with a confirmed diagnosis tend to remain static in size; performing regular scans for asymptomatic giant liver haemangiomas may not be necessary.

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17914140.001).
  • [ISSN] 1024-2708
  • [Journal-full-title] Hong Kong medical journal = Xianggang yi xue za zhi
  • [ISO-abbreviation] Hong Kong Med J
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] China
  •  go-up   go-down


52. Malagari K, Alexopoulou E, Dourakis S, Kelekis A, Hatzimichail K, Sissopoulos A, Delis S, Letsou D, Kelekis D: Transarterial embolization of giant liver hemangiomas associated with Kasabach-Merritt syndrome: a case report. Acta Radiol; 2007 Jul;48(6):608-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transarterial embolization of giant liver hemangiomas associated with Kasabach-Merritt syndrome: a case report.
  • Of 22 patients with symptomatic giant liver hemangiomas referred for embolization, two females (52 and 74 years) had Kasabach-Merritt syndrome (KMS).
  • Hepatic angiography revealed excessive vascular lakes typical of cavernous hemangiomas.
  • Coil packing of the feeding hepatic artery was additionally used in one patient.
  • [MeSH-major] Blood Coagulation Disorders / therapy. Embolization, Therapeutic / methods. Hemangioma / complications. Hemangioma / therapy. Liver Neoplasms / complications. Liver Neoplasms / therapy
  • [MeSH-minor] Aged. Female. Fibrinogen. Follow-Up Studies. Hematocrit / methods. Hepatic Artery / radiography. Humans. Microspheres. Middle Aged. Platelet Count. Rare Diseases. Syndrome. Tomography, X-Ray Computed. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Bleeding Disorders.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17611866.001).
  • [ISSN] 0284-1851
  • [Journal-full-title] Acta radiologica (Stockholm, Sweden : 1987)
  • [ISO-abbreviation] Acta Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Sweden
  • [Chemical-registry-number] 9001-32-5 / Fibrinogen
  •  go-up   go-down


53. Lanka B, Jang HJ, Kim TK, Burns PN, Wilson SR: Impact of contrast-enhanced ultrasonography in a tertiary clinical practice. J Ultrasound Med; 2007 Dec;26(12):1703-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: The purpose of this study was to assess the impact of contrast-enhanced ultrasonography (CEUS) of the liver in a tertiary clinical practice.
  • Clinical impact included reduced referrals for other imaging in 226 (21.7%) of 1040 patients, decreased time to diagnosis in 390 (37.5%), and successful guidance for ablation therapy in 26 (2.5%).
  • A positive change in management occurred in 182 (17.5%) of 1040, including alteration of a previous diagnosis, a diagnosis made by CEUS after indeterminate prior imaging, and a diagnosis upstaged by CEUS.
  • Negative impacts included delayed management in 8 (0.8%) small hepatocellular carcinomas misdiagnosed as benign lesions and wrong management of a solitary sclerotic hemangioma, in a high-risk patient for hepatoma, misdiagnosed as a malignant tumor on CEUS, computed tomography, and magnetic resonance imaging, leading to its surgical removal.
  • CONCLUSIONS: Contrast-enhanced ultrasonography has a positive impact on clinical management, providing rapid, accurate diagnosis of incidentally detected masses and resolving nodules on surveillance scans and indeterminate masses on other imaging.
  • [MeSH-major] Critical Pathways / statistics & numerical data. Fluorocarbons. Liver Neoplasms / epidemiology. Liver Neoplasms / ultrasonography. Practice Patterns, Physicians' / statistics & numerical data. Ultrasonography / statistics & numerical data

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Ultrasound.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Ultrasound Med. 2008 Jun;27(6):991-2 [18499863.001]
  • (PMID = 18029922.001).
  • [ISSN] 0278-4297
  • [Journal-full-title] Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
  • [ISO-abbreviation] J Ultrasound Med
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Definity; 0 / Fluorocarbons
  •  go-up   go-down


54. Miliaras D, Conroy J, Pervana S, Meditskou S, McQuaid D, Nowak N: Karyotypic changes detected by comparative genomic hybridization in a stillborn infant with chorioangioma and liver hemangioma. Birth Defects Res A Clin Mol Teratol; 2007 Mar;79(3):236-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Karyotypic changes detected by comparative genomic hybridization in a stillborn infant with chorioangioma and liver hemangioma.
  • BACKGROUND: Placental hemangioma (chorioangioma) and congenital hemangioma are relatively common tumors, which on rare occasions may occur together.
  • CASE: Herein we describe a rare case of a stillborn infant with chorioangioma, placental mesenchymal dysplasia, and liver cavernous hemangioma.
  • The chromosomal abnormalities that we found were deletions at 2q13 and 7p21.1 and were common to both placental and liver lesions.
  • CONCLUSIONS: None of the identified chromosomal aberrations have been previously associated with chorioangiomas or hemangiomas.
  • Important genes that lie in these DNA regions may be implicated in the pathogenesis of congenital hemangiomas and mesenchymal dysplasia.
  • [MeSH-major] Chromosome Aberrations. Hemangioma / genetics. Hemangioma, Cavernous / genetics. Liver Neoplasms / genetics. Placenta Diseases / genetics. Stillbirth / genetics

  • Genetic Alliance. consumer health - Hemangioma.
  • Genetic Alliance. consumer health - Stillborn.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Stillbirth.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17203486.001).
  • [ISSN] 1542-0752
  • [Journal-full-title] Birth defects research. Part A, Clinical and molecular teratology
  • [ISO-abbreviation] Birth Defects Res. Part A Clin. Mol. Teratol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA016056-30
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  •  go-up   go-down


55. Farruggia P, Alaggio R, Cardella F, Tropia S, Trizzino A, Ferrara F, D'Angelo P: Focal nodular hyperplasia of the liver: an unusual association with diabetes mellitus in a child and review of literature. Ital J Pediatr; 2010;36:41
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Focal nodular hyperplasia of the liver: an unusual association with diabetes mellitus in a child and review of literature.
  • Hepatic hemangioma, adenoma and focal nodular hyperplasia are the most frequent benign lesions of the liver, but they are all infrequent among pediatric population.
  • [MeSH-minor] Biopsy. Child. Diagnosis, Differential. Follow-Up Studies. Hepatectomy / methods. Humans. Male. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Diabetes.
  • MedlinePlus Health Information. consumer health - Diabetes Type 1.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1999 Dec;23(12):1441-54 [10584697.001]
  • [Cites] J Hepatol. 2008 Jul;49(1):61-71 [18466996.001]
  • [Cites] Am J Gastroenterol. 2002 Sep;97(9):2371-3 [12358258.001]
  • [Cites] J Hepatol. 2008 Jan;48(1):163-70 [17997499.001]
  • [Cites] Hepatology. 2006 Jul;44(1):7-14 [16799965.001]
  • [Cites] Pediatr Radiol. 2005 Dec;35(12):1234-9 [16052333.001]
  • [Cites] Arch Pathol Lab Med. 1999 Sep;123(9):846-9 [10458838.001]
  • [Cites] HPB Surg. 1992 Apr;5(3):171-6; discussion 176-80 [1324705.001]
  • [Cites] J Surg Oncol. 1986 Oct;33(2):129-35 [3762186.001]
  • [Cites] Gastroenterol Jpn. 1984 Oct;19(5):419-23 [6083895.001]
  • [Cites] Zentralbl Allg Pathol. 1983;127(1-2):135-43 [6858421.001]
  • [Cites] Am J Med. 1976 Dec;61(6):871-7 [188336.001]
  • [Cites] Acta Pathol Microbiol Scand A. 1975 Nov;83(6):615-22 [171910.001]
  • [Cites] J Hepatol. 2004 Apr;40(4):660-8 [15030983.001]
  • [Cites] Gastroenterology. 2003 Mar;124(3):651-9 [12612904.001]
  • [Cites] Gut. 2002 Jun;50(6):877-80 [12010893.001]
  • (PMID = 20504362.001).
  • [ISSN] 1824-7288
  • [Journal-full-title] Italian journal of pediatrics
  • [ISO-abbreviation] Ital J Pediatr
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2883986
  •  go-up   go-down


56. Yamamoto K, Shiraki K, Nakanishi S, Fuke H, Hashimoto A, Shimizu A, Nakano T: The usefulness of 1.5 harmonic imaging ultrasonography with Levovist in the diagnosis of focal hepatic tumors. Int J Oncol; 2005 Oct;27(4):989-95
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The usefulness of 1.5 harmonic imaging ultrasonography with Levovist in the diagnosis of focal hepatic tumors.
  • In the present study, we investigated the usefulness of 1.5 harmonic imaging sonography with the use of the contrast agent Levovist for the diagnosis of hepatocellular carcinoma (HCC), metastatic hepatic tumor, and hepatic hemangioma.
  • The subjects in this study were 64 patients with 70 nodules of hepatic tumors (42 nodules in 36 cases of hepatocellular carcinoma, 20 nodules in 20 cases of metastatic hepatic tumor, and 8 nodules in 8 cases of hepatic hemangioma).
  • 1.5 harmonic imaging sonography of metastatic hepatic tumor showed hypervascular enhancement of the margin of 20 nodules (100%) in the early and portal phases, which changed to images with no contrast enhancement in the late phase.
  • 1.5 harmonic imaging sonography of hepatic hemangiomas maintained hypervascular enhancement on the tumor margin of 5 nodules (62.5%) in the early and portal phases.
  • 1.5 harmonic imaging sonography of hepatic tumors (hepatocellular carcinoma, metastatic hepatic tumor and hepatic hemangioma) provided characteristic findings of contrast enhancement in the early, portal, and late phases, and will contribute to differential diagnosis.
  • [MeSH-major] Carcinoma, Hepatocellular / diagnosis. Contrast Media / pharmacology. Hemangioma / diagnosis. Liver Neoplasms / diagnosis. Polysaccharides. Ultrasonography / methods
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Angiography. Carbon Dioxide / metabolism. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Neoplasm Metastasis

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Ultrasound.
  • Hazardous Substances Data Bank. Carbon dioxide .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16142315.001).
  • [ISSN] 1019-6439
  • [Journal-full-title] International journal of oncology
  • [ISO-abbreviation] Int. J. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Polysaccharides; 127279-08-7 / SHU 508; 142M471B3J / Carbon Dioxide
  •  go-up   go-down


57. Chou CT, Chen RC, Chen WT, Lii JM: Percentage of signal intensity loss for characterisation of focal liver lesions in patients with chronic liver disease using ferucarbotran-enhanced MRI. Br J Radiol; 2010 Dec;83(996):1023-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Percentage of signal intensity loss for characterisation of focal liver lesions in patients with chronic liver disease using ferucarbotran-enhanced MRI.
  • The purpose of this study was to determine the percentage of signal intensity loss (PSIL) threshold for the characterisation of focal liver lesions among patients with chronic liver disease.
  • 55 nodules in 49 patients with chronic liver disease who underwent ferucarbotran-enhanced MR studies were included.
  • Among the 49 patients, 40 had liver cirrhosis and 9 had chronic hepatitis.
  • The diagnostic performance of PSIL on ferucarbotran-enhanced T(2) weighted images (PSIL(T2WI)) and T(2) weighted fat-suppression images (PSIL(FS-T2WI)) that characterised hepatic tumours was compared with receiver operating characteristic (ROC) analysis.
  • The mean PSIL(FS-T2WI) of the benign lesions was significantly higher than that of HCC (p<0.001), and the mean PSIL(FS-T2WI) of well-differentiated HCC was significantly higher than that of moderately/poorly differentiated HCCs (p = 0.001).
  • In conclusion, with ferucarbotran-enhanced FS-T2WI, a PSIL(FS-T2WI) threshold of 40% for characterising focal liver nodules among patients with chronic liver disease is recommended.
  • It is useful for distinguishing HCC from benign nodules.
  • [MeSH-major] Carcinoma, Hepatocellular / diagnosis. Contrast Media. Dextrans. Liver Neoplasms / diagnosis. Magnetic Resonance Imaging / methods. Magnetite Nanoparticles
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Focal Nodular Hyperplasia / diagnosis. Hemangioma / diagnosis. Hepatitis, Chronic / diagnosis. Humans. Liver Cirrhosis / diagnosis. Male. Middle Aged. ROC Curve

  • Genetic Alliance. consumer health - Liver Disease.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • Hazardous Substances Data Bank. Ferumoxides .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Magn Reson Imaging. 2000 Jun;11(6):665-72 [10862066.001]
  • [Cites] Am J Med. 2007 Mar;120(3):194-202 [17349437.001]
  • [Cites] Hepatology. 2000 Aug;32(2):205-12 [10915725.001]
  • [Cites] J Magn Reson Imaging. 2001 Feb;13(2):249-57 [11169831.001]
  • [Cites] Radiology. 2001 Sep;220(3):669-76 [11526265.001]
  • [Cites] J Magn Reson Imaging. 2004 Jul;20(1):75-82 [15221811.001]
  • [Cites] Hum Pathol. 1991 Feb;22(2):172-8 [1848205.001]
  • [Cites] Cancer. 1994 Oct 15;74(8):2234-8 [7922974.001]
  • [Cites] Invest Radiol. 1994 Jun;29 Suppl 2:S87-9 [7928280.001]
  • [Cites] Radiology. 1994 Dec;193(3):665-9 [7972805.001]
  • [Cites] Radiology. 1995 May;195(2):489-96 [7724772.001]
  • [Cites] Radiology. 1996 Mar;198(3):881-7 [8628887.001]
  • [Cites] AJR Am J Roentgenol. 1999 Jun;172(6):1547-54 [10350287.001]
  • [Cites] AJR Am J Roentgenol. 2005 Jan;184(1):63-9 [15615952.001]
  • [Cites] J Magn Reson Imaging. 2007 Apr;25(4):755-65 [17335040.001]
  • [Cites] Eur J Med Res. 2007 Oct 30;12(10):527-34 [18024261.001]
  • [Cites] Hepatology. 2008 Jan;47(1):97-104 [18069697.001]
  • [Cites] Radiology. 2008 May;247(2):311-30 [18430871.001]
  • [Cites] J Formos Med Assoc. 2008 Oct;107(10):798-805 [18926947.001]
  • [Cites] AJR Am J Roentgenol. 2000 Jul;175(1):159-63 [10882267.001]
  • (PMID = 20413445.001).
  • [ISSN] 1748-880X
  • [Journal-full-title] The British journal of radiology
  • [ISO-abbreviation] Br J Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Magnetite Nanoparticles; G6N3J05W84 / ferumoxides; K3R6ZDH4DU / Dextrans
  • [Other-IDs] NLM/ PMC3473610
  •  go-up   go-down


58. Meguro M, Soejima Y, Taketomi A, Ikegami T, Yamashita Y, Harada N, Itoh S, Hirata K, Maehara Y: Living donor liver transplantation in a patient with giant hepatic hemangioma complicated by Kasabach-Merritt syndrome: report of a case. Surg Today; 2008;38(5):463-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Living donor liver transplantation in a patient with giant hepatic hemangioma complicated by Kasabach-Merritt syndrome: report of a case.
  • We herein present a case of unresectable giant hepatic hemangiomas with Kasabach-Merritt syndrome which was successfully treated by living donor liver transplantation using a left lobe graft.
  • The hepatic tumors were thus judged untreatable and the only option for a cure was to offer living donor liver transplantation, because of the tumor size, its location, and the association with Kasabach-Merritt syndrome.
  • A left lobe graft with the middle hepatic vein donated by her 47-year-old brother was transplanted under venovenous bypass.
  • In conclusion, living donor liver transplantation was found to be an effective option for the treatment of a patient with unresectable giant hepatic hemangiomas complicated by Kasabach-Merritt syndrome.
  • [MeSH-major] Disseminated Intravascular Coagulation / etiology. Hemangioma / surgery. Liver Neoplasms / surgery. Liver Transplantation. Living Donors


59. Terkivatan T, Hussain SM, De Man RA, Ijzermans JN: Diagnosis and treatment of benign focal liver lesions. Scand J Gastroenterol Suppl; 2006;(243):102-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis and treatment of benign focal liver lesions.
  • BACKGROUND: With the routine use of improved imaging modalities, more benign liver lesions are detected nowadays.
  • METHODS: A Medline search of studies relevant to imaging diagnosis and management of the most common, benign, solid and non-solid liver lesions was undertaken.
  • The authors' own experiences with benign liver lesions were also taken into account.
  • RESULTS: Although atypical imaging features are the exception rather than the rule, it is sometimes difficult to differentiate between benign and malignant lesions, and knowledge of their imaging features is essential if unnecessary work-up is to be avoided.
  • The use of tissue-specific contrast media, which has clearly improved the accuracy of highly advanced radiological techniques, may be helpful during differential diagnosis.
  • Once having established an accurate diagnosis, surgery is rarely indicated for a benign liver lesion because of its asymptomatic nature.
  • [MeSH-major] Focal Nodular Hyperplasia / diagnosis. Focal Nodular Hyperplasia / therapy. Liver Neoplasms / diagnosis. Liver Neoplasms / therapy
  • [MeSH-minor] Adenoma, Liver Cell / diagnosis. Adenoma, Liver Cell / therapy. Angiomyolipoma / diagnosis. Angiomyolipoma / therapy. Carcinoma, Hepatocellular / diagnosis. Carcinoma, Hepatocellular / therapy. Echinococcosis, Hepatic / diagnosis. Echinococcosis, Hepatic / therapy. Embolization, Therapeutic. Hamartoma / diagnosis. Hamartoma / therapy. Hemangioma, Cavernous / diagnosis. Hemangioma, Cavernous / therapy. Hepatectomy. Humans

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16782629.001).
  • [ISSN] 0085-5928
  • [Journal-full-title] Scandinavian journal of gastroenterology. Supplement
  • [ISO-abbreviation] Scand. J. Gastroenterol. Suppl.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Norway
  • [Number-of-references] 144
  •  go-up   go-down


60. Xu HX, Liu GJ, Lu MD, Xie XY, Xu ZF, Zheng YL, Liang JY: Characterization of small focal liver lesions using real-time contrast-enhanced sonography: diagnostic performance analysis in 200 patients. J Ultrasound Med; 2006 Mar;25(3):349-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characterization of small focal liver lesions using real-time contrast-enhanced sonography: diagnostic performance analysis in 200 patients.
  • OBJECTIVE: The purpose of this study was to assess the diagnostic performance of real-time contrast-enhanced sonography in characterization of small focal liver lesions (FLLs; < or = 3.0 cm in diameter).
  • A 5-point confidence level was used to discriminate malignant from benign FLLs, and specific diagnoses were recorded.
  • RESULTS: After review of contrast-enhanced sonography, ROC analysis revealed significant improvement in differentiating between malignant and benign small FLLs that the areas under the ROC curve were 0.856 at baseline sonography versus 0.954 at contrast-enhanced sonography for reader 1 (P < .001) and 0.857 versus 0.954 for reader 2 (P = .003).
  • A better result of specific diagnosis was obtained (38.5% [77/200] at baseline sonography versus 80.5% [161/200] at contrast-enhanced sonography for reader 1 and 34.5% [69/200] versus 80.5% [161/200] for reader 2; both P < .001) after contrast agent administration, and a better interobserver agreement was achieved (kappa = 0.425 at baseline sonography versus 0.716 at contrast-enhanced sonography).
  • [MeSH-major] Carcinoma, Hepatocellular / diagnosis. Contrast Media / administration & dosage. Hemangioma / diagnosis. Image Enhancement / methods. Liver / ultrasonography. Liver Diseases / diagnosis. Liver Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Echocardiography, Doppler, Color / methods. Female. Granuloma, Plasma Cell / diagnosis. Humans. Male. Microbubbles. Middle Aged. Observer Variation. Prospective Studies. ROC Curve. Reproducibility of Results. Sensitivity and Specificity. Sulfur Hexafluoride / administration & dosage

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Liver Diseases.
  • Hazardous Substances Data Bank. SULFUR HEXAFLUORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16495496.001).
  • [ISSN] 0278-4297
  • [Journal-full-title] Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
  • [ISO-abbreviation] J Ultrasound Med
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; WS7LR3I1D6 / Sulfur Hexafluoride
  •  go-up   go-down


61. Limawararut V, Davis G, Crompton J, Leibovitch I, Selva D: Recurrent multiple cavernous hemangiomas of the orbit in association with systemic tumors. Am J Ophthalmol; 2006 May;141(5):943-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent multiple cavernous hemangiomas of the orbit in association with systemic tumors.
  • PURPOSE: To report the clinical findings and management of multiple, recurrent cavernous hemangiomas of the orbit in a patient with concurrent liver involvement.
  • RESULTS: A 35-year-old woman with blurry vision and proptosis was found to have multiple cavernous hemangiomas of the orbit.
  • Fifteen years later, the patient had recurrent, multiple cavernous hemangiomas in the same orbit.
  • Further investigations for vague back pain revealed a presumed cavernous hemangioma in the liver and a presumed schwannoma arising from the neural foramen of the spine at the level of T2 through T4.
  • CONCLUSION: Multiple cavernous hemangiomas may recur after complete excision and may exist with concurrent systemic tumors.
  • [MeSH-major] Hemangioma, Cavernous / pathology. Liver Neoplasms / pathology. Neoplasm Recurrence, Local / pathology. Neoplasms, Multiple Primary / pathology. Neurilemmoma / pathology. Orbital Neoplasms / pathology. Pleural Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16678512.001).
  • [ISSN] 0002-9394
  • [Journal-full-title] American journal of ophthalmology
  • [ISO-abbreviation] Am. J. Ophthalmol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


62. Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, Boix L, Sala M, Varela M, Llovet JM, Brú C, Bruix J: Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology; 2008 Jan;47(1):97-104
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
  • This study prospectively evaluates the accuracy of contrast-enhanced ultrasound (CEUS) and dynamic magnetic resonance imaging (MRI) for the diagnosis of nodules 20 mm or smaller detected during ultrasound (US) surveillance.
  • Hepatic MRI, CEUS, and fine-needle biopsy (gold standard) (FNB) were performed at baseline.
  • Final diagnoses were: HCC (n = 60), cholangiocarcinoma (n = 1), and benign lesions (regenerative/dysplastic nodule, hemangioma, focal nodular hyperplasia) (n = 28).
  • Sex, cirrhosis cause, liver function, and alpha-fetoprotein (AFP) levels were similar between HCC and non-HCC groups.
  • Thus, diagnosis of HCC 20 mm or smaller can be established without a positive biopsy if both CEUS and MRI are conclusive.
  • These results validate the American Association for the Study of Liver Disease (AASLD) guidelines.
  • [MeSH-major] Carcinoma, Hepatocellular / ultrasonography. Liver / pathology. Liver Cirrhosis / complications. Liver Neoplasms / ultrasonography. Magnetic Resonance Imaging

  • MedlinePlus Health Information. consumer health - Cirrhosis.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Hepatology. 2008 Jun;47(6):2145-6; author reply 2146-7 [18508292.001]
  • [CommentIn] Hepatology. 2008 Jun;47(6):2145; author reply 2146-7 [18508306.001]
  • [ErratumIn] Hepatology. 2008 Feb;47(2):769
  • (PMID = 18069697.001).
  • [ISSN] 1527-3350
  • [Journal-full-title] Hepatology (Baltimore, Md.)
  • [ISO-abbreviation] Hepatology
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / 1R01DK076986-0
  • [Publication-type] Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Studies
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


63. Rademaker J, Kim YJ, Leibecke T, Raman SS, Voit C: Cowden disease: CT findings in three patients. Abdom Imaging; 2005 Mar-Apr;30(2):204-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cowden disease, also known as multiple hamartoma syndromes, is an autosomal dominant disease characterized by numerous benign mucocutaneous tumors, hamartomas of multiple organs, and malignancies of the breast and thyroid.
  • In addition to the classic findings, the patients were diagnosed with spinal neurinoma (n=1), meningioma (n=1), and hepatic hemangioma (n=3).
  • [MeSH-minor] Adult. Diagnosis, Differential. Duodenum / radiography. Female. Follow-Up Studies. Humans. Liver / radiography. Lung / radiography. Retrospective Studies. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15812679.001).
  • [ISSN] 0942-8925
  • [Journal-full-title] Abdominal imaging
  • [ISO-abbreviation] Abdom Imaging
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


64. Vasconcelos L, Silva S, Garcia A, Medeiros D, Albuquerque E Castro J, Capitão LM: [Visceral artery aneurysms: alternative therapeutic approach]. Rev Port Cir Cardiotorac Vasc; 2006 Jul-Sep;13(3):155-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Case number 2 was a 72 year-old woman with a past medical history significant for hepatic angioma and hypothyroidism.

  • MedlinePlus Health Information. consumer health - Aneurysms.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17057828.001).
  • [ISSN] 0873-7215
  • [Journal-full-title] Revista portuguesa de cirurgia cardio-torácica e vascular : órgão oficial da Sociedade Portuguesa de Cirurgia Cardio-Torácica e Vascular
  • [ISO-abbreviation] Rev Port Cir Cardiotorac Vasc
  • [Language] por
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Portugal
  •  go-up   go-down


65. Muthamilselvan S, Vinoth PN, Vilvanathan V, Ninan B, Amboiram P, Sai V, Anand V, Scott JX: Hepatic haemangioma of infancy: role of propranolol. Ann Trop Paediatr; 2010;30(4):335-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hepatic haemangioma of infancy: role of propranolol.
  • A newborn girl with a haemangioma of the liver failed to respond to cortico-steroid therapy.
  • Ultrasonic evidence of the haemangioma disappeared after 2 months of treatment with propranolol.
  • [MeSH-major] Adrenergic beta-Antagonists / therapeutic use. Hemangioma / drug therapy. Infant, Premature, Diseases / drug therapy. Liver Neoplasms / drug therapy. Propranolol / therapeutic use

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Premature Babies.
  • Hazardous Substances Data Bank. PROPRANOLOL HYDROCHLORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21118629.001).
  • [ISSN] 1465-3281
  • [Journal-full-title] Annals of tropical paediatrics
  • [ISO-abbreviation] Ann Trop Paediatr
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Adrenergic beta-Antagonists; 9Y8NXQ24VQ / Propranolol
  •  go-up   go-down


66. Han SL, Wu XL, Jia ZR, Wang PF: Adult hepatic cavernous haemangioma with highly elevated alpha-fetoprotein. Hong Kong Med J; 2010 Oct;16(5):400-2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adult hepatic cavernous haemangioma with highly elevated alpha-fetoprotein.
  • Laboratory examination revealed that his serum alpha-fetoprotein level was 1890 microg/L (reference range, 0-20 microg/L), and computed tomographic scan showed a hypodense lesion in the left liver lobe.
  • At laparotomy, a dark reddish soft tumour (3.0 x 3.5 cm in diameter) was found in the medial segment of the liver (segment III).
  • Intra-operative pathology and postoperative histopathology examinations revealed that the tumour was a cavernous haemangioma of the liver.
  • Clinicians should be aware that some rare tumours besides hepatocellular carcinoma and endodermal sinus tumours (yolk sac tumour), for example, hepatic haemangioma, can produce alpha-fetoprotein.

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20890007.001).
  • [ISSN] 1024-2708
  • [Journal-full-title] Hong Kong medical journal = Xianggang yi xue za zhi
  • [ISO-abbreviation] Hong Kong Med J
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / alpha-Fetoproteins
  •  go-up   go-down


67. Zenzen W, Perez-Atayde AR, Elisofon SA, Kim HB, Alomari AI: Hepatic failure in a rapidly involuting congenital hemangioma of the liver: failure of embolotherapy. Pediatr Radiol; 2009 Oct;39(10):1118-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hepatic failure in a rapidly involuting congenital hemangioma of the liver: failure of embolotherapy.
  • We report the clinical course, imaging findings, and management of a rare case of rapidly involuting congenital hemangioma of the liver in a newborn girl.
  • The baby presented with severe progressive hepatic dysfunction and cardiomegaly.
  • Multimodality imaging demonstrated a large hypervascular solitary hepatic mass with marked transhepatic shunting, consistent with rapidly involuting congenital hemangioma.
  • Because medical therapy failed, transarterial and transvenous embolization was performed with the main intention to improve the hepatic perfusion and function.
  • Unfortunately, despite improvement in the cardiac overload, liver function continued to deteriorate.
  • The baby eventually underwent successful liver transplantation.
  • [MeSH-major] Embolization, Therapeutic / methods. Hemangioma / therapy. Liver Neoplasms / therapy
  • [MeSH-minor] Female. Humans. Infant, Newborn. Liver Failure / diagnosis. Liver Failure / etiology. Liver Failure / surgery. Liver Transplantation. Treatment Failure. Treatment Outcome

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Paediatr Taiwan. 2003 Jan-Feb;44(1):8-13 [12800377.001]
  • [Cites] Turk J Gastroenterol. 2007 Sep;18(3):182-7 [17891692.001]
  • [Cites] J Pediatr Surg. 2008 Jan;43(1):120-5; discussion 126 [18206468.001]
  • [Cites] J Pediatr Surg. 2007 Jan;42(1):62-7; discussion 67-8 [17208542.001]
  • [Cites] Radiology. 1985 Jul;156(1):85-8 [4001425.001]
  • [Cites] J Pediatr. 1996 Sep;129(3):346-54 [8804322.001]
  • [Cites] Pediatr Radiol. 2003 Jan;33(1):15-9 [12497230.001]
  • [Cites] J Pediatr Surg. 1999 Jan;34(1):98-105; discussion 105-6 [10022152.001]
  • (PMID = 19588131.001).
  • [ISSN] 1432-1998
  • [Journal-full-title] Pediatric radiology
  • [ISO-abbreviation] Pediatr Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


68. Xu J, Wu Y, Dong F: Clinical value of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions. J Huazhong Univ Sci Technolog Med Sci; 2007 Dec;27(6):703-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical value of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions.
  • To explore the clinical value of contrast-enhanced ultrasound (CEUS) in differentiating benign and malignant focal liver lesions (FLLs) with SonoVue, CEUS was used to examine 113 patients with focal liver lesions (FLLs) in our hospital during July 2005 to December 2006.
  • Except for patients with focal fatty sparings (n=18) and with hemangiomas (n=8), all the patients were confirmed by operation or ultrasonic-guided liver puncture biopsy.
  • Seventy-eight cases of benign FLLs, including 33 hemangiomas, 9 focal nodular hyperplasias (FNHs), 19 focal fatty sparings, 5 abscesses, 7 regenerative nodules and 2 inflammatory pseudo-tumor, were involved.
  • The contrast pattern of benign and malignant FLLs was quite different.
  • CEUS has higher specificity and sensitivity than conventional ultrasound in differentiating benign and malignant FLLs.
  • [MeSH-major] Carcinoma, Hepatocellular / diagnostic imaging. Contrast Media. Image Enhancement / methods. Liver Diseases / diagnostic imaging. Liver Neoplasms / ultrastructure
  • [MeSH-minor] Adult. Aged. Diagnosis, Differential. Female. Hemangioma / ultrastructure. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Sensitivity and Specificity. Ultrasonography. Young Adult

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Liver Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Ultrasound Med. 2004 Dec;23 (12 ):1557-68 [15557299.001]
  • [Cites] Rofo. 2003 Jun;175(6):835-43 [12811698.001]
  • [Cites] Eur Radiol. 1999;9 Suppl 3:S347-8 [10602926.001]
  • [Cites] Eur J Radiol. 2002 Mar;41(3):200-6 [11861094.001]
  • [Cites] Invest Radiol. 1995 Aug;30(8):451-7 [8557510.001]
  • (PMID = 18231748.001).
  • [ISSN] 1672-0733
  • [Journal-full-title] Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban
  • [ISO-abbreviation] J. Huazhong Univ. Sci. Technol. Med. Sci.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


69. Rodríguez-Peláez M, Menéndez De Llano R, Varela M: [Benign liver tumors]. Gastroenterol Hepatol; 2010 May;33(5):391-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Benign liver tumors].
  • [Transliterated title] Tumores benignos del hígado.
  • There is a wide range of benign liver tumors that behave in very different ways and require a management strategy specifically tailored to each.
  • The most common benign solid liver tumor is hemangioma followed by focal nodular hyperplasia; the most common cystic tumor is the simple cyst.
  • The differential diagnosis with malignant liver tumors is sometimes difficult.
  • [MeSH-major] Adenoma / pathology. Cysts / pathology. Focal Nodular Hyperplasia / pathology. Hemangioma / pathology. Liver Diseases / pathology. Liver Neoplasms / pathology
  • [MeSH-minor] Adult. Biomarkers, Tumor. Carcinoma, Hepatocellular / diagnosis. Child. Diagnosis, Differential. Diagnostic Imaging. Female. Hepatectomy. Humans. Incidental Findings. Male. Mutation

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Liver Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Gastroenterol Hepatol. 2010 Jun-Jul;33(6):473-4; author reply 474-5 [20537429.001]
  • (PMID = 20096966.001).
  • [ISSN] 0210-5705
  • [Journal-full-title] Gastroenterología y hepatología
  • [ISO-abbreviation] Gastroenterol Hepatol
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 31
  •  go-up   go-down


71. Wan P, Susman J, Kandel J, Jan D, Jerome EH, Parravicini E: Neonatal hepatic mesenchymal hamartoma causing cardiac failure and disseminated intravascular coagulopathy. Am J Perinatol; 2009 Sep;26(8):601-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neonatal hepatic mesenchymal hamartoma causing cardiac failure and disseminated intravascular coagulopathy.
  • Even with advance prenatal diagnostic tools, differentiating among specific types of hepatic masses continues to challenge many physicians.
  • Here, we report a neonate with life-threatening hepatic mass, cardiac failure, and disseminated intravascular coagulopathy, which clinically resembled hepatic hemangioma.
  • A hepatic mesenchymal hamartoma was detected by postmortem pathology.
  • [MeSH-major] Disseminated Intravascular Coagulation / etiology. Hamartoma / complications. Hamartoma / congenital. Heart Failure / etiology. Liver Diseases / complications. Liver Diseases / congenital

  • MedlinePlus Health Information. consumer health - Heart Failure.
  • MedlinePlus Health Information. consumer health - Liver Diseases.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Thieme Medical Publishers.
  • (PMID = 19370509.001).
  • [ISSN] 1098-8785
  • [Journal-full-title] American journal of perinatology
  • [ISO-abbreviation] Am J Perinatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


72. Maizlin ZV, Vos PM, Cooperberg PL: Is it a fibroid? Are you sure? Sonography with MRI assistance. Ultrasound Q; 2007 Mar;23(1):55-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Uterine fibroids are common benign lesions.
  • Other common benign masses include renal cysts, renal angiomyolipomas, hepatic cysts, hepatic hemangiomas, thyroid cysts, adrenal incidentalomas, pulmonary granulomas and hamartomas, ovarian cysts, and dermoids.
  • [MeSH-minor] Diagnosis, Differential. Female. Humans

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17558230.001).
  • [ISSN] 0894-8771
  • [Journal-full-title] Ultrasound quarterly
  • [ISO-abbreviation] Ultrasound Q
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 28
  •  go-up   go-down


73. Abdullaev AG, Milonova VB, Tsarenko IA: [Computed tomography diagnosis of hepatic space-occupying lesion of different nature]. Khirurgiia (Mosk); 2005;(6):61-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Computed tomography diagnosis of hepatic space-occupying lesion of different nature].
  • Specific CT-symptoms are reliable criteria for differential diagnosis of benign lesions of the liver.
  • The method permits to diagnose exactly cystic lesions of the liver in 95.3% cases, and tumor lesions -- in 83%.
  • Diagnostic value of CT is higher in solitary non-parasitic cysts, polycystic disease and echinococcosis than in hemangioma, alveococcosis and malignant tumors of the liver (p<0,05).
  • [MeSH-major] Echinococcosis, Hepatic / radiography. Hemangioma / radiography. Liver Neoplasms / radiography. Tomography, X-Ray Computed
  • [MeSH-minor] Diagnosis, Differential. Humans. Severity of Illness Index

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16044130.001).
  • [ISSN] 0023-1207
  • [Journal-full-title] Khirurgiia
  • [ISO-abbreviation] Khirurgiia (Mosk)
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


74. Pudil J, Martínek J, Belsan T, Ryska M: [Atypically localised hepatic haemangioma as a cause of dyspeptic syndrome]. Rozhl Chir; 2006 Jul;85(7):354-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Atypically localised hepatic haemangioma as a cause of dyspeptic syndrome].
  • [Transliterated title] Atypicky lokalizovaný hemangiom jater jako prícina dyspeptického syndromu.
  • INTRODUCTION: Haemangioma is a benign mesenchymal tumor growing from the endothehum of blood vessels.
  • Most hepatic haemangiomas are asymptomatic while symptomatic haemangioma are usually manifested by non-specific pain dyspeptic syndrome, quite rarely also by hemorrhage, or icterus Symptomatic haemangiomas or large haemangiomas with fast growth, are indicated for surgical treatment.
  • USG, CT, MR, CT angiography and EUS have all shown two lesiones (haemangioma of the left hepatic lobe, a tumor in the left subphrenic area of uncertain origin).
  • We proposed an operational solution, and, surprisingly, the finding was a single haemangioma (2 parts-- intra- and extraparenchymatous--connected by a vascular bridge).
  • DISCUSSION: In the diagnosis of haemangioma, MR is a method of choice with high specificity and sensitivity.
  • Why did not it yield the correct diagnosis?
  • The structure, the signal and the type of postcontrast enhancement of the second lesion corresponded to a haemangioma, but the extraparenchymatous location and also the considerable remoteness from the liver invalidated this possibility before operation.
  • Regarding to the differential diagnostics of the lesiones in the subphrenic area, which according to the imaging techniques are not related to the hepatic parenchyma, it is advisable to consider the possibility of the incidence of pedunculated hepatic haemangioma.
  • [MeSH-major] Dyspepsia / etiology. Hemangioma, Cavernous / complications. Liver Neoplasms / complications

  • MedlinePlus Health Information. consumer health - Indigestion.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17044281.001).
  • [ISSN] 0035-9351
  • [Journal-full-title] Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti
  • [ISO-abbreviation] Rozhl Chir
  • [Language] cze
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Czech Republic
  •  go-up   go-down


75. Noda T, Sasaki Y, Yamada T, Eguchi H, Takachi K, Noura S, Miyashiro I, Murata K, Doki Y, Ohigashi H, Ishikawa O, Imaoka S, Mitani H, Ishiguro S: Adult capillary hemangioma of the liver: report of a case. Surg Today; 2005;35(9):796-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adult capillary hemangioma of the liver: report of a case.
  • We report a rare case of capillary hemangioma of the liver in an adult.
  • The patient was a 55-year-old man, admitted for investigation of a hepatic tumor.
  • Computed tomography (CT) showed an enhancement pattern different from that of hepatocellular carcinoma (HCC) or cavernous hemangioma.
  • We could not establish whether the tumor was HCC or cavernous hemangioma by the imaging findings, so we performed a hepatic resection.
  • Histopathological examination confirmed a diagnosis of capillary hemangioma.
  • Ultrasonography, CT, and magnetic resonance imaging showed an intermediate pattern between cavernous hemangioma and HCC.
  • Thus, we must be aware of the possibility of capillary hemangioma when finding an atypical liver tumor inconsistent with HCC or cavernous hemangioma.
  • [MeSH-major] Hemangioma, Capillary / diagnosis. Hemangioma, Capillary / surgery. Liver Neoplasms / diagnosis. Liver Neoplasms / surgery
  • [MeSH-minor] Diagnosis, Differential. Diagnostic Imaging. Humans. Male. Middle Aged

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiology. 1980 Oct;137(1 Pt 1):149-55 [7422836.001]
  • [Cites] Radiology. 1981 Jan;138(1):115-21 [7455071.001]
  • [Cites] Surg Today. 2000;30(1):86-8 [10648092.001]
  • [Cites] AJR Am J Roentgenol. 1992 Nov;159(5):1005-9 [1329454.001]
  • [Cites] Gastroenterology. 1984 Mar;86(3):495-502 [6198238.001]
  • [Cites] Med Clin North Am. 1975 Jul;59(4):995-1013 [167242.001]
  • [Cites] Radiology. 1986 Sep;160(3):613-8 [3016794.001]
  • [Cites] Surg Gynecol Obstet. 1949 Apr;88(4):281-323 [18113323.001]
  • [Cites] Surv Ophthalmol. 1994 Mar-Apr;38(5):399-426 [8009426.001]
  • (PMID = 16133680.001).
  • [ISSN] 0941-1291
  • [Journal-full-title] Surgery today
  • [ISO-abbreviation] Surg. Today
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


76. Horii KA, Drolet BA, Baselga E, Frieden IJ, Metry DW, Morel KD, Newell BD, Nopper AJ, Garzon MC, Hemangioma Investigator Group: Risk of hepatic hemangiomas in infants with large hemangiomas. Arch Dermatol; 2010 Feb;146(2):201-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Risk of hepatic hemangiomas in infants with large hemangiomas.
  • [MeSH-major] Hemangioma / epidemiology. Hemangioma / pathology. Liver Neoplasms / epidemiology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20157038.001).
  • [ISSN] 1538-3652
  • [Journal-full-title] Archives of dermatology
  • [ISO-abbreviation] Arch Dermatol
  • [Language] eng
  • [Databank-accession-numbers] ClinicalTrials.gov/ NCT00374335
  • [Publication-type] Letter; Multicenter Study
  • [Publication-country] United States
  • [Investigator] Horii KA; Drolet BA; Baselga E; Frieden IJ; Metry DW; Morel KD; Newell BD; Nopper AJ; Garzon MC; Chamlin SL; Haggstrom AN; Lucky AW; Mancini AJ; Siegel D; Holland K; Powell J; McCuaig CM; Adams D
  •  go-up   go-down


77. Toldo I, Drigo P, Mammi I, Marini V, Carollo C: Vertebral and spinal cavernous angiomas associated with familial cerebral cavernous malformation. Surg Neurol; 2009 Feb;71(2):167-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vertebral and spinal cavernous angiomas associated with familial cerebral cavernous malformation.
  • BACKGROUND: Cerebral cavernous malformations are vascular malformations that affect the CNS and have been associated with cutaneous, retinal, and hepatic lesions.
  • Until now, vertebral hemangiomas associated with CCM have been described only in one case.
  • The coexistence of intracranial and spinal cavernous angiomas in familial CCM is extremely rare.
  • In addition to previous studies, the occurrence of spinal, vertebral, and cutaneous cavernous angiomas is now described in different members of a large family with CCM.
  • CASE DESCRIPTION: Our study reports a previously described family (IFCAS-07) with 12 members affected by autosomal dominant cavernous angiomas: 11 had CCM either alone or associated with hepatic or retinal angiomas, and one had only hepatic angioma.
  • Spinal MRI showed in 5 subjects spinal cavernous angiomas either alone or associated with vertebral hemangiomas.
  • CONCLUSIONS: To our knowledge, this is the largest family reported with different subjects affected by CCM associated with multiple cavernous angiomas throughout (brain and spinal cord) and besides (retina, skin, liver, and vertebral column) the CNS.
  • We emphasize the importance of spinal MRI in the diagnosis of spinal and vertebral cavernous angiomas in all patients affected by familial CCM.
  • [MeSH-major] Central Nervous System Neoplasms / etiology. Central Nervous System Vascular Malformations / complications. Hemangioma, Cavernous / etiology. Spinal Neoplasms / etiology
  • [MeSH-minor] Adult. Cohort Studies. Female. Humans. Male. Microtubule-Associated Proteins / genetics. Middle Aged. Pedigree. Proto-Oncogene Proteins / genetics. Skin Neoplasms / diagnosis. Skin Neoplasms / etiology. Skin Neoplasms / therapy. Young Adult

  • Genetic Alliance. consumer health - Cerebral Cavernous Malformation.
  • SciCrunch. Clinical Genomic Database: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18207546.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / KRIT1 protein, human; 0 / Microtubule-Associated Proteins; 0 / Proto-Oncogene Proteins
  •  go-up   go-down


78. Lanthaler M, Freund M, Nehoda H: Laparoscopic resection of a giant liver hemangioma. J Laparoendosc Adv Surg Tech A; 2005 Dec;15(6):624-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic resection of a giant liver hemangioma.
  • We present a case report of hepatic resection performed laparoscopically for a giant symptomatic hemangioma.
  • The patient was a 50-year-old woman who was diagnosed with a giant hemangioma 20 cm in diameter.
  • As in the case of our patient, laparoscopic resection of hepatic hemangiomas can be performed successfully, even when dealing with giant hemangiomas.
  • [MeSH-major] Hemangioma / surgery. Laparoscopy / methods. Liver Neoplasms / surgery

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16366871.001).
  • [ISSN] 1092-6429
  • [Journal-full-title] Journal of laparoendoscopic & advanced surgical techniques. Part A
  • [ISO-abbreviation] J Laparoendosc Adv Surg Tech A
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


79. Dong KR, Zheng S, Xiao X: Conservative management of neonatal hepatic hemangioma: a report from one institute. Pediatr Surg Int; 2009 Jun;25(6):493-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Conservative management of neonatal hepatic hemangioma: a report from one institute.
  • PURPOSE: To summarize the conservative treatment of neonatal hepatic hemangioma at one institute.
  • PATIENTS AND MATERIALS: Fifteen cases of neonatal hepatic hemangioma were managed in our hospital during the previous 5 years.
  • Initial symptoms, combination symptoms, diagnosis, and treatment were analyzed.
  • Combination symptoms were multiple skin hemangiomas, pneumonia, and cardiac insufficiency.
  • Ultrasound and CT showed the typical characteristics of the liver hemangioma.
  • There were three types of hepatic hemangioma: nine cases had a single focus, four cases were multiple foci, and two had diffuse changes in the liver.
  • One patient having multi-focus in the liver gave up the treatment after biopsy.
  • In those who received conservative therapy, all hemangiomas disappeared within 1 year.
  • CONCLUSION: The diagnosis of hepatic hemangioma can be made from symptomology, ultrasound, and CT; pathologic samples are not necessary.
  • Proactive therapy for congestive heart failure is helpful for those endangering liver hemangioma.
  • Surgery can increase the risk of complications and is not advised for treatment of neonatal hepatic hemangioma.
  • [MeSH-major] Hemangioma / diagnosis. Hemangioma / therapy. Liver Neoplasms / diagnosis. Liver Neoplasms / therapy

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Pediatr Endocrinol Metab. 2005 May;18(5):511-4 [15921182.001]
  • [Cites] Semin Liver Dis. 2001 May;21(2):251-69 [11436576.001]
  • [Cites] J Pediatr Surg. 2008 Jan;43(1):120-5; discussion 126 [18206468.001]
  • [Cites] Radiat Med. 2005 Aug;23 (5):371-5 [16342910.001]
  • [Cites] J R Soc Med. 2005 Aug;98(8):364-5 [16055903.001]
  • [Cites] J Pediatr Surg. 2007 Jan;42(1):62-7; discussion 67-8 [17208542.001]
  • [Cites] AJR Am J Roentgenol. 1983 Jun;140(6):1091-6 [6602472.001]
  • [Cites] Pediatrics. 2003 Dec;112(6 Pt 1):1424-6 [14654623.001]
  • [Cites] Radiographics. 2004 Nov-Dec;24(6):1719-24 [15537980.001]
  • [Cites] Pediatr Dermatol. 2005 Sep-Oct;22(5):383-406 [16190987.001]
  • [Cites] Pediatr Surg Int. 2006 Mar;22(3):228-32 [16395609.001]
  • [Cites] J Pediatr Hematol Oncol. 2004 Feb;26(2):121-3 [14767204.001]
  • [Cites] J Pediatr. 1996 Sep;129(3):346-54 [8804322.001]
  • [Cites] Cardiovasc Intervent Radiol. 2008 Mar-Apr;31(2):411-4 [17031730.001]
  • [Cites] Hum Pathol. 2004 Feb;35(2):200-9 [14991538.001]
  • [Cites] N Engl J Med. 2000 Jul 20;343(3):185-9 [10900278.001]
  • [Cites] Dig Dis Sci. 2003 May;48(5):916-20 [12772790.001]
  • [Cites] J Pediatr Hematol Oncol. 2008 Jun;30(6):447-50 [18525461.001]
  • (PMID = 19415303.001).
  • [ISSN] 1437-9813
  • [Journal-full-title] Pediatric surgery international
  • [ISO-abbreviation] Pediatr. Surg. Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Glucocorticoids
  •  go-up   go-down


80. Losanoff JE, Millis JM: Liver hemangioma complicated by obstructive jaundice. Am J Surg; 2008 Sep;196(3):e3-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Liver hemangioma complicated by obstructive jaundice.
  • This report describes a liver hemangioma causing obstructive jaundice, an extremely rare condition that has been reported on 3 previous occasions.
  • A hemangioma can compress the major bile ducts and require partial hepatectomy for a successful outcome.
  • [MeSH-major] Hemangioma, Cavernous / complications. Jaundice, Obstructive / etiology. Liver Neoplasms / complications

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18519125.001).
  • [ISSN] 1879-1883
  • [Journal-full-title] American journal of surgery
  • [ISO-abbreviation] Am. J. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


81. Wang ZL, Tang J, Weskott HP, Li JL, Wang W, Luo YK, An LC, Xu JH: Undetermined focal liver lesions on gray-scale ultrasound in patients with fatty liver: characterization with contrast-enhanced ultrasound. J Gastroenterol Hepatol; 2008 Oct;23(10):1511-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Undetermined focal liver lesions on gray-scale ultrasound in patients with fatty liver: characterization with contrast-enhanced ultrasound.
  • BACKGROUND AND AIM: The purpose of this study was to assess the clinical value and potential impact of contrast-enhanced ultrasound (CEUS) in the characterization of undetermined focal liver lesions (FLLs) in patients with fatty liver.
  • METHODS: Fifty-two patients (34 men, 18 women) with fatty liver with 67 FLLs (size range, 1-8.6 cm; mean, 4.1 +/- 3.1 cm) undetermined at baseline ultrasound (US) underwent contrast-enhanced US.
  • CEUS examinations were analyzed by two experienced sonologists blinded to the final diagnosis.
  • Readers evaluated by consensus the baseline echogenicity, the dynamic enhancement pattern in comparison with peripheral liver parenchyma.
  • The final diagnosis was based on consensus interpreting of all examinations by another two expert observers with access to histological data.
  • The characterization accuracy, sensitivity, and specificity of CEUS in characterizing the lesion as benign or malignant, and as the correct pathologic type, were analyzed.
  • RESULTS: After CEUS, two hemangiomas, three inflammatory pseudotumors, and one hepatocellular carcinoma were misdiagnosed.
  • Forty-three benign lesions were diagnosed as the correct pathologic type.
  • CONCLUSION: CEUS can improve the characterization of undetermined FLLs arising from fatty liver.
  • [MeSH-major] Bile Duct Neoplasms / ultrasonography. Contrast Media. Diagnostic Errors. Fatty Liver / ultrasonography. Liver Neoplasms / ultrasonography. Phospholipids. Sulfur Hexafluoride. Ultrasonography, Doppler, Color
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Bile Ducts, Intrahepatic / ultrasonography. Carcinoma, Hepatocellular / ultrasonography. Cholangiocarcinoma / ultrasonography. Female. Granuloma, Plasma Cell / ultrasonography. Hemangioma / ultrasonography. Humans. Image Interpretation, Computer-Assisted. Lymphoma / ultrasonography. Male. Microbubbles. Middle Aged. Predictive Value of Tests. Sensitivity and Specificity. Young Adult

  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. SULFUR HEXAFLUORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Gastroenterol Hepatol. 2008 Oct;23(10):1465-6 [19120843.001]
  • (PMID = 18713302.001).
  • [ISSN] 1440-1746
  • [Journal-full-title] Journal of gastroenterology and hepatology
  • [ISO-abbreviation] J. Gastroenterol. Hepatol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Phospholipids; 0 / contrast agent BR1; WS7LR3I1D6 / Sulfur Hexafluoride
  •  go-up   go-down


82. Cho SH, Lee JY, Han JK, Choi BI: Acoustic radiation force impulse elastography for the evaluation of focal solid hepatic lesions: preliminary findings. Ultrasound Med Biol; 2010 Feb;36(2):202-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acoustic radiation force impulse elastography for the evaluation of focal solid hepatic lesions: preliminary findings.
  • This study was designed to investigate the potential usefulness of acoustic radiation force impulse (ARFI) elastography to evaluate focal solid hepatic lesions.
  • In total, 51 patients with 60 focal hepatic lesions, which included 17 hemangiomas, 25 hepatocellular carcinomas (HCCs), 15 metastases and three cholangiocarcinomas, underwent ARFI elastography.
  • The lesions were classified into three groups: Group I consisted of metastatic liver tumors and cholangiocarcinomas, group II consisted of HCCs and group III consisted of hemangiomas.
  • Shear wave velocity was obtained to quantify stiffness for 36 focal hepatic lesions: 11 hemangiomas, 17 HCCs and eight other malignant lesions.
  • On ARFI elastography images, group I tumors (n=18) appeared stiffer than the background liver for 13 lesions (72%), softer for two lesions and had identical stiffness in three lesions compared with the background liver.
  • For group II tumors (n=25), 13 lesions (52%) appeared stiffer than the liver, six lesions appeared softer than the liver and the remaining six lesions showed the same stiffness as the liver.
  • For group III tumors (n=17), six lesions (35%) appeared stiffer than the liver, seven lesions appeared softer and the remaining four lesions showed the same stiffness as the liver.
  • Images obtained with ARFI elastography provided additional qualitative information regarding the stiffness and tumor margin of liver tumors.
  • By measuring shear wave velocity, quantification of stiffness was made possible and showed the potential to differentiate malignant hepatic tumors from hepatic hemangiomas.
  • [MeSH-major] Elasticity Imaging Techniques. Liver Neoplasms / ultrasonography

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2010 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20018432.001).
  • [ISSN] 1879-291X
  • [Journal-full-title] Ultrasound in medicine & biology
  • [ISO-abbreviation] Ultrasound Med Biol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


83. Faccioli N, D'Onofrio M, Comai A, Cugini C: Contrast-enhanced ultrasonography in the characterization of benign focal liver lesions: activity-based cost analysis. Radiol Med; 2007 Sep;112(6):810-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Contrast-enhanced ultrasonography in the characterization of benign focal liver lesions: activity-based cost analysis.
  • PURPOSE: The aim of this study was to perform a cost analysis of contrast-enhanced ultrasonography (CEUS) in the study of benign focal liver lesions (BFLL) with indeterminate appearance on ultrasonography (US).
  • We analysed the cost effectiveness of CEUS, considering whether or not computed tomography (CT) was necessary for the diagnosis.
  • There were 398 patients with 213 angiomas, 41 focal nodular hyperplasias (FNH) and 154 pseudolesions (focal fatty sparing, focal fatty areas).
  • For diagnosis of haemangiomas, we saved 1,406.97 euros in 2002, 5,315.22 euros in 2003, 10,317.78 euros in 2004 and 9,536.13 euros in 2005.
  • For diagnosis of focal nodular hyperplasias, we saved 781.65 euros in 2003, 781.65 euros in 2004 and 1,406.97 euros in 2005.
  • For diagnosis of pseudolesions, we saved 2,813.94 euros in 2002, 5,158.89 euros in 2003, 5,158.89 euros in 2004 and 4,220.91 euros in 2005.
  • In the period 2002-2005, the introduction of CEUS allowed us to save a total of 47,055.33 euros in the diagnosis of benign focal hepatic liver lesions.
  • CONCLUSIONS: This cost analysis shows that CEUS is the least expensive second-line modality after baseline US for the diagnosis of BFLL.
  • [MeSH-major] Contrast Media. Liver Diseases / diagnostic imaging. Liver Diseases / economics. Phospholipids. Sulfur Hexafluoride. Ultrasonography / economics
  • [MeSH-minor] Costs and Cost Analysis. Focal Nodular Hyperplasia / diagnostic imaging. Focal Nodular Hyperplasia / economics. Hemangioma / diagnostic imaging. Hemangioma / economics. Humans. Italy. Tomography, X-Ray Computed / economics

  • MedlinePlus Health Information. consumer health - Liver Diseases.
  • MedlinePlus Health Information. consumer health - Ultrasound.
  • Hazardous Substances Data Bank. SULFUR HEXAFLUORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiology. 2000 Jun;215(3):708-16 [10831689.001]
  • [Cites] Radiology. 2004 Aug;232(2):420-30 [15286314.001]
  • [Cites] Radiol Med. 2003 Mar;105(3):215-29 [12835645.001]
  • [Cites] Eur J Radiol. 1998 May;27(2):123-30 [9639137.001]
  • [Cites] Abdom Imaging. 2004 May-Jun;29(3):348-59 [15354344.001]
  • [Cites] Radiol Med. 2006 Feb;111(1):73-84 [16623307.001]
  • [Cites] Acad Radiol. 2004 Feb;11(2):141-8 [14974588.001]
  • [Cites] Radiology. 2001 Jun;219(3):611-20 [11376244.001]
  • [Cites] Am J Gastroenterol. 2004 Nov;99(11):2223-34 [15555006.001]
  • [Cites] J Clin Ultrasound. 2005 May;33(4):164-72 [15856516.001]
  • [Cites] Pharmacoeconomics. 1996 Nov;10(5):460-6 [10172868.001]
  • [Cites] Abdom Imaging. 2006 Sep-Oct;31(5):529-36 [16802201.001]
  • [Cites] Eur Radiol. 2005 Dec;15 Suppl 5:E98-103 [18637236.001]
  • [Cites] Radiology. 1997 Apr;203(1):87-91 [9122421.001]
  • (PMID = 17891342.001).
  • [ISSN] 0033-8362
  • [Journal-full-title] La Radiologia medica
  • [ISO-abbreviation] Radiol Med
  • [Language] eng; ita
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Phospholipids; 0 / contrast agent BR1; WS7LR3I1D6 / Sulfur Hexafluoride
  •  go-up   go-down


84. Colakoğlu O, Taşkiran B, Yazici N, Buyraç Z, Unsal B: Safety of biopsy in liver hemangiomas. Turk J Gastroenterol; 2005 Dec;16(4):220-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Safety of biopsy in liver hemangiomas.
  • Hemangiomas are the most common tumors of the liver.
  • In case of inconclusive radiologic features and a history of malignancy or underlying liver disease, liver biopsy is indicated.
  • Bleeding is the most feared complication of biopsy of hemangiomas due to its highly vascular structure.
  • In our clinic, we biopsied seven patients with suspected masses and they were diagnosed histopathologically afterwards as having hemangiomas.
  • Although the case number is too small to reach a definite conclusion, we think that our report deserves attention in showing that concerns about bleeding during biopsy of hemangiomas may be overstated.
  • [MeSH-major] Hemangioma / pathology. Liver Neoplasms / pathology
  • [MeSH-minor] Biopsy, Needle / methods. Diagnosis, Differential. Humans. Middle Aged

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16547852.001).
  • [ISSN] 1300-4948
  • [Journal-full-title] The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
  • [ISO-abbreviation] Turk J Gastroenterol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


85. Zincirkeser S, Celen ZY, Yilmaz M, Topalhan F, Sahin E: A false negative by planar scintigraphy liver hemangioma, diagnosed by technetium-99m-red blood cells and technetium-99m-sulfur colloid single photon emission tomography scan. Hell J Nucl Med; 2006 May-Aug;9(2):109-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A false negative by planar scintigraphy liver hemangioma, diagnosed by technetium-99m-red blood cells and technetium-99m-sulfur colloid single photon emission tomography scan.
  • Ultrasonography showed a 4.7 cm solid hepatic mass on the right lateral side of the right lobe of the liver.
  • The patient was then sent to the Nuclear Medicine Department of Gaziantep University for liver scan.
  • After injecting autologous red blood cells labeled with 740 MBq of technetium-99m ((99m)Tc-RBC), early and delayed anterior planar images of the liver showed no significant findings because of the right kidney shine through the liver.
  • Two days later, after injecting again 740 MBq of (99m)Tc-RBC, we performed a single photon emission tomography (SPET) scan but still this scan was nondiagnostic even in the delayed images of the liver.
  • Three days later, after the iv injection of 185 MBq of technetium-99m-sulphur colloid ((99m)Tc-SC), we observed in the delayed SPET images of the liver, a mismatch defect with decreased focal uptake of (99m)Tc-SC at 60 min while the uptake of (99m)Tc-RBC at the same area was normal or slightly increased.
  • A cavernous hemangioma was found, confirmed by histology.
  • In conclusion, the mismatch of the SPET delayed images between the (99m)Tc-RBC and the (99m)Tc-SC scans indicated that this procedure was effective for the diagnosis of liver cavernous hemangioma located in this unusual position.
  • [MeSH-major] Erythrocytes / radionuclide imaging. Hemangioma / radionuclide imaging. Liver Neoplasms / radionuclide imaging. Technetium. Technetium Tc 99m Sulfur Colloid. Tomography, Emission-Computed, Single-Photon / methods

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. TECHNETIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Hell J Nucl Med. 2009 May-Aug;12(2):177-8 [19675879.001]
  • [CommentIn] Hell J Nucl Med. 2006 Sep-Dec;9(3):187 [17160164.001]
  • (PMID = 16894416.001).
  • [ISSN] 1790-5427
  • [Journal-full-title] Hellenic journal of nuclear medicine
  • [ISO-abbreviation] Hell J Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 556Q0P6PB1 / Technetium Tc 99m Sulfur Colloid; 7440-26-8 / Technetium
  •  go-up   go-down


86. Choi BY, Nguyen MH: The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol; 2005 May-Jun;39(5):401-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The diagnosis and management of benign hepatic tumors.
  • Benign hepatic tumors include a broad spectrum of regenerative and true neoplastic processes.
  • Because of advances in imaging studies such as computed tomography (CT) and magnetic resonance imaging (MRI) as well as progress in immunohistochemistry, accurate diagnosis can now be made in a large percentage of patients without surgical laparotomy or resection.
  • This article will focus on the pathogenesis, diagnosis, and management of focal benign lesions of the liver.
  • The most common benign hepatic tumors include cavernous hemangioma, focal nodular hyperplasia, hepatic adenoma, and nodular regenerative hyperplasia.
  • In the majority of cases of benign hepatic tumors, patients are asymptomatic, and no treatment is indicated.
  • [MeSH-major] Liver Neoplasms / diagnosis. Liver Neoplasms / therapy
  • [MeSH-minor] Adenoma, Liver Cell / diagnosis. Adenoma, Liver Cell / therapy. Combined Modality Therapy / methods. Cysts / diagnosis. Cysts / therapy. Diagnosis, Differential. Focal Nodular Hyperplasia / diagnosis. Focal Nodular Hyperplasia / therapy. Hemangioma / diagnosis. Hemangioma / therapy. Humans. Magnetic Resonance Imaging. Tomography, Emission-Computed, Single-Photon. Tomography, X-Ray Computed. Ultrasonography, Doppler, Color

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15815209.001).
  • [ISSN] 0192-0790
  • [Journal-full-title] Journal of clinical gastroenterology
  • [ISO-abbreviation] J. Clin. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 89
  •  go-up   go-down


87. Bozgeyik Z, Kocakoc E, Gul Y, Dagli AF: Evaluation of liver hemangiomas using three different b values on diffusion MR. Eur J Radiol; 2010 Sep;75(3):360-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluation of liver hemangiomas using three different b values on diffusion MR.
  • PURPOSE: To determine which diffusion-weighted MR technique (i.e., b-100, b-600, b-1000 s/mm(2)) is most useful in depicting liver hemangiomas.
  • MATERIALS AND METHODS: Diffusion-weighed MR (DWMR) was performed for 61 hemangiomas in 32 patients.
  • ADCs were measured for each lesions and compared with normal liver parenchymal ADCs on different b values.
  • Hemangiomas were subdivided according to lesion size (less than 3 cm and 3 cm or greater).
  • Lower ADC values were obtained for higher b values in normal liver tissue and hemangiomas.
  • Although there is significant difference between normal liver tissue and hemangiomas; this is more apparent on b-1000 images (p=0.022 on b-100, p=0.003 on b-600, and p=0.000 on b-1000 images).
  • Variance analysis revealed hemangiomas had higher ADC values than normal liver tissue on b-1000 images.
  • CONCLUSION: Mean values for ADCs of hemangiomas were lower than ADCs of the normal liver except for b-1000 value.
  • Higher b values are useful for the differentiation between normal liver tissue and hemangiomas.
  • [MeSH-major] Diffusion Magnetic Resonance Imaging / methods. Hemangioma / diagnosis. Image Enhancement / methods. Liver Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 19481893.001).
  • [ISSN] 1872-7727
  • [Journal-full-title] European journal of radiology
  • [ISO-abbreviation] Eur J Radiol
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


88. R Aglyamov S, R Skovoroda A, Xie H, Kim K, M Rubin J, O'Donnell M, W Wakefield T, Myers D, Y Emelianov S: Model-based reconstructive elasticity imaging using ultrasound. Int J Biomed Imaging; 2007;2007:35830
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The model-based approach is illustrated using two potential clinical applications: differentiation of liver hemangioma and staging of deep venous thrombosis.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Thromb Haemost. 2005 Feb;93(2):368-74 [15711756.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 1995 Feb;15(2):258-68 [7749835.001]
  • [Cites] J Biomech. 1995 Oct;28(10 ):1145-54 [8550633.001]
  • [Cites] IEEE Trans Ultrason Ferroelectr Freq Control. 2004 May;51(5):540-50 [15217232.001]
  • [Cites] Phys Med Biol. 2000 Jun;45(6):1591-610 [10870713.001]
  • [Cites] J Ultrasound Med. 2006 Sep;25(9):1179-86 [16929019.001]
  • [Cites] J Med Ultrason (2001). 2002 Dec;29(4):155 [27277961.001]
  • [Cites] Radiology. 1990 Feb;174(2):425-31 [2404315.001]
  • [Cites] IEEE Trans Ultrason Ferroelectr Freq Control. 1999;46(3):523-35 [18238453.001]
  • [Cites] Ultrasound Med Biol. 2002 Jun;28(6):757-67 [12113788.001]
  • [Cites] Ultrasound Med Biol. 2004 Oct;30(10 ):1385-96 [15582239.001]
  • [Cites] Cornea. 2002 Jan;21(1):68-73 [11805511.001]
  • [Cites] IEEE Trans Ultrason Ferroelectr Freq Control. 1999;46(1):82-96 [18238401.001]
  • [Cites] Eur J Echocardiogr. 2000 Sep;1(3):154-70 [11916589.001]
  • [Cites] IEEE Trans Ultrason Ferroelectr Freq Control. 2004 May;51(5):521-31 [15217230.001]
  • [Cites] IEEE Trans Med Imaging. 1998 Jun;17(3):419-28 [9735905.001]
  • [Cites] Ultrasound Med Biol. 2005 Jun;31(6):787-802 [15936495.001]
  • [Cites] Eur J Ultrasound. 1998 Aug;7(3):219-24 [9700219.001]
  • [Cites] Ultrasound Med Biol. 2005 Oct;31(10 ):1351-9 [16223638.001]
  • [Cites] IEEE Trans Biomed Eng. 1995 Feb;42(2):193-202 [7868147.001]
  • [Cites] IEEE Trans Med Imaging. 1996;15(3):299-313 [18215911.001]
  • [Cites] N Engl J Med. 1990 May 3;322(18):1260-4 [2183055.001]
  • [Cites] Ultrasound Med Biol. 1996;22(8):959-77 [9004420.001]
  • [Cites] Chest. 1998 Nov;114(5 Suppl):561S-578S [9822063.001]
  • [Cites] Phys Med Biol. 2006 Jan 7;51(1):95-112 [16357433.001]
  • [Cites] Circulation. 1996 Jun 15;93(12):2212-45 [8925592.001]
  • [Cites] Phys Med Biol. 2002 Jun 21;47(12):2147-64 [12118606.001]
  • [Cites] J Ultrasound Med. 2003 May;22(5):443-8 [12751855.001]
  • (PMID = 18256732.001).
  • [ISSN] 1687-4188
  • [Journal-full-title] International journal of biomedical imaging
  • [ISO-abbreviation] Int J Biomed Imaging
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / R01 HL068658
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC1986825
  •  go-up   go-down


89. Lai HJ, Yu JC, Liu YC, Shih ML, Hsieh CB: Anterior approach for a symptomatic giant hepatic haemangioma (&gt;30 centimetre). ANZ J Surg; 2006 Sep;76(9):863-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anterior approach for a symptomatic giant hepatic haemangioma (>30 centimetre).
  • [MeSH-major] Hemangioma / surgery. Hepatectomy / methods. Liver Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16922914.001).
  • [ISSN] 1445-1433
  • [Journal-full-title] ANZ journal of surgery
  • [ISO-abbreviation] ANZ J Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


90. Yun JP, Miao J, Chen GG, Tian QH, Zhang CQ, Xiang J, Fu J, Lai PB: Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters. Br J Cancer; 2007 Feb 12;96(3):477-84
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, we examined NPM expression in 103 paired cases of hepatocellular carcinoma (HCC), 12 cases of hepatic focal nodular hyperplasia, 17 cases of liver tissue adjacent to a hepatic haemangioma, and series of array tissues from normal human organs and malignancies using a monoclonal antibody against NPM and reverse transcription-PCR techniques, Western blot analysis, immunohistochemistry, and immunocytofluorescence.
  • Moreover, enhanced expression of NPM in HCC correlated with the level of PCNA (R(2)=0.5639) and with the clinical prognostic parameters such as serum alpha fetal protein level, tumour pathological grading, and liver cirrhosis (P<0.05).
  • [MeSH-major] Carcinoma, Hepatocellular / chemistry. Liver Neoplasms / chemistry. Nuclear Proteins / analysis

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Zhonghua Yi Xue Za Zhi. 2002 Jul 25;82(14):974-8 [12181092.001]
  • [Cites] Nat Rev Cancer. 2006 Jul;6(7):493-505 [16794633.001]
  • [Cites] J Biol Chem. 2003 Mar 14;278(11):9107-15 [12511551.001]
  • [Cites] J Cell Biochem. 2003 Dec 15;90(6):1140-8 [14635188.001]
  • [Cites] Mol Cell. 2003 Nov;12(5):1151-64 [14636574.001]
  • [Cites] Mol Cell Biol. 2004 Feb;24(3):985-96 [14729947.001]
  • [Cites] Mol Cell Biol. 2004 May;24(9):3703-11 [15082766.001]
  • [Cites] J Biol Chem. 2004 Oct 1;279(40):41275-9 [15310764.001]
  • [Cites] Cell Cycle. 2004 Mar;3(3):259-62 [14726681.001]
  • [Cites] Mol Cell Biol. 2004 Nov;24(21):9327-38 [15485902.001]
  • [Cites] Urology. 2004 Oct;64(4):839-44 [15491744.001]
  • [Cites] Chromosoma. 1984;90(2):139-48 [6206987.001]
  • [Cites] Biochim Biophys Acta. 1985 Dec 18;826(4):167-73 [3907710.001]
  • [Cites] J Cell Biol. 2000 Apr 17;149(2):293-306 [10769023.001]
  • [Cites] J Biol Chem. 2000 Aug 11;275(32):24451-7 [10829026.001]
  • [Cites] Cell. 2000 Sep 29;103(1):127-40 [11051553.001]
  • [Cites] Cancer Res. 2001 Jul 15;61(14):5389-95 [11454681.001]
  • [Cites] J Biochem. 2001 Aug;130(2):199-205 [11481036.001]
  • [Cites] Curr Opin Hematol. 2001 Jul;8(4):231-6 [11561161.001]
  • [Cites] J Biol Chem. 2001 Dec 21;276(51):48285-91 [11604407.001]
  • [Cites] Carcinogenesis. 2002 Jan;23(1):93-100 [11756229.001]
  • [Cites] Nat Cell Biol. 2002 Jul;4(7):529-33 [12080348.001]
  • [Cites] J Biol Chem. 1987 Aug 15;262(23):11389-97 [3301855.001]
  • [Cites] J Cell Biol. 1988 Nov;107(5):1629-42 [3141428.001]
  • [Cites] Cell. 1989 Feb 10;56(3):379-90 [2914325.001]
  • [Cites] J Biol Chem. 1990 Oct 25;265(30):18227-33 [2211699.001]
  • [Cites] Cancer Res. 1992 Jun 15;52(12):3372-7 [1596895.001]
  • [Cites] Cell Mol Biol Res. 1993;39(1):33-42 [8287070.001]
  • [Cites] Biochem Biophys Res Commun. 1994 Feb 28;199(1):46-51 [8123045.001]
  • [Cites] J Pathol. 1996 Jan;178(1):48-52 [8778315.001]
  • [Cites] Oncogene. 1997 Sep;15(11):1275-81 [9315094.001]
  • [Cites] Blood. 1999 Jan 15;93(2):632-42 [9885226.001]
  • [Cites] J Biochem. 1999 May;125(5):904-9 [10220582.001]
  • [Cites] Prostate. 1999 Jun 1;39(4):298-304 [10344220.001]
  • [Cites] Endocr Relat Cancer. 2004 Dec;11(4):843-54 [15613457.001]
  • [Cites] N Engl J Med. 2005 Jan 20;352(3):254-66 [15659725.001]
  • [Cites] J Biol Chem. 2005 Feb 18;280(7):5496-502 [15596447.001]
  • [Cites] J Biol Chem. 2005 Mar 25;280(12):10988-96 [15644315.001]
  • [Cites] Hepatology. 2005 Apr;41(4):707-16 [15795889.001]
  • [Cites] Biochem Biophys Res Commun. 2005 Sep 30;335(3):826-31 [16099430.001]
  • [Cites] Nature. 2005 Sep 1;437(7055):147-53 [16007073.001]
  • [Cites] Blood. 2005 Dec 1;106(12):3733-9 [16076867.001]
  • [Cites] Oncogene. 2006 Feb 23;25(8):1125-42 [16314846.001]
  • [Cites] Carcinogenesis. 2006 Apr;27(4):748-57 [16339184.001]
  • [Cites] Cancer Lett. 2006 May 8;236(1):115-24 [15990224.001]
  • [Cites] Oncogene. 2002 Sep 9;21(40):6170-4 [12214246.001]
  • (PMID = 17245342.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Nuclear Proteins; 0 / Proliferating Cell Nuclear Antigen; 117896-08-9 / nucleophosmin
  • [Other-IDs] NLM/ PMC2360035
  •  go-up   go-down


91. Inoue A, Okura Y, Kawashita I, Ito K, Matsunaga N, Sanada T, Akiyama M, Ishida T: [Development of comprehensive image processing technique for differential diagnosis of liver disease by using multi-modality images-pixel-based cross-correlation method using a profile-]. Nihon Hoshasen Gijutsu Gakkai Zasshi; 2009 Apr 20;65(4):438-50
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Development of comprehensive image processing technique for differential diagnosis of liver disease by using multi-modality images-pixel-based cross-correlation method using a profile-].
  • In this scheme, the criteria of an attending radiologist for the differential diagnosis of liver cyst, hemangioma of liver, hepatocellular carcinoma, and metastatic liver cancer on magnetic resonance images with various sequences and CT images with and without contrast enhancement employ a cross-correlation coefficient.
  • This comprehensive image-processing technique could assist radiologists in the differential diagnosis of liver diseases.
  • [MeSH-major] Image Processing, Computer-Assisted / methods. Liver Diseases / diagnosis. Magnetic Resonance Imaging / methods. Tomography, Spiral Computed / methods
  • [MeSH-minor] Diagnosis, Differential. Humans

  • Genetic Alliance. consumer health - Liver Disease.
  • MedlinePlus Health Information. consumer health - Liver Diseases.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19420828.001).
  • [ISSN] 0369-4305
  • [Journal-full-title] Nihon Hōshasen Gijutsu Gakkai zasshi
  • [ISO-abbreviation] Nihon Hoshasen Gijutsu Gakkai Zasshi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


92. Madhusudhan KS, Srivastava DN, Gamanagatti S: Giant hemangioma of liver presenting as deep vein thrombosis of the lower limbs. J Postgrad Med; 2009 Oct-Dec;55(4):290-1
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant hemangioma of liver presenting as deep vein thrombosis of the lower limbs.
  • [MeSH-major] Hemangioma / complications. Liver Neoplasms / complications. Venous Thrombosis / etiology


93. Marinis A, Kairi E, Theodosopoulos T, Kondi-Pafiti A, Smyrniotis V: Right colon and liver hemangiomatosis: a case report and a review of the literature. World J Gastroenterol; 2006 Oct 21;12(39):6405-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Right colon and liver hemangiomatosis: a case report and a review of the literature.
  • Cavernous hemangiomatosis of the colon and liver in a 38-year-old woman presenting with a history of cramp like abdominal pain and a mass in the right iliac fossa are presented.
  • Abdominal ultrasonography and computed tomography demonstrated multiple liver hemangiomas as well as a noncystic lesion in the right iliac fossa.
  • [MeSH-major] Colonic Neoplasms / diagnosis. Hemangioma, Cavernous / diagnosis. Liver Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Indian J Pathol Microbiol. 1999 Oct;42(4):487-9 [11127383.001]
  • [Cites] AJR Am J Roentgenol. 2002 Oct;179(4):1042-4 [12239062.001]
  • [Cites] Dtsch Med Wochenschr. 2004 Sep 17;129(38):1970-2 [15375738.001]
  • [Cites] Pediatr Radiol. 1998 Jul;28(7):512-4 [9662569.001]
  • [Cites] Lille Med. 1967 May;12(5):592-4 [5304577.001]
  • [Cites] Dis Colon Rectum. 1976 May-Jun;19(4):363-5 [1084262.001]
  • [Cites] Acta Chir Belg. 1993 Jul-Aug;93(4):173-6 [8237232.001]
  • [Cites] Dis Colon Rectum. 1984 Jun;27(6):404-14 [6734365.001]
  • [Cites] J Clin Gastroenterol. 1985 Oct;7(5):416-21 [4067229.001]
  • [Cites] Gastrointest Radiol. 1987;12(4):347-9 [3623006.001]
  • [Cites] Clin Pediatr (Phila). 1988 Sep;27(9):425-30 [3046807.001]
  • [Cites] Ital J Surg Sci. 1989;19(1):89-92 [2745046.001]
  • [Cites] Can Assoc Radiol J. 1991 Dec;42(6):431-4 [1751906.001]
  • [Cites] Gastroenterology. 1976 Dec;71(6):1079-82 [1086811.001]
  • (PMID = 17072971.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] China
  • [Number-of-references] 16
  • [Other-IDs] NLM/ PMC4088156
  •  go-up   go-down


94. Fan RF, Chai FL, He GX, Wan WX, Bai MD, Cao ML, Li HM, Yan SZ: [Radiofrequency ablation therapy combined with suture and ligation surgery for patients with giant cavernous hemangiomas of the liver]. Zhonghua Yi Xue Za Zhi; 2006 Aug 15;86(30):2134-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Radiofrequency ablation therapy combined with suture and ligation surgery for patients with giant cavernous hemangiomas of the liver].
  • OBJECTIVE: To evaluate the feasibility and efficacy of radiofrequency ablation (RFA) therapy combined with suture and ligation surgery for patients with giant hepatic cavernous hemangioma (HCH).
  • METHODS: Between June 2004 and June 2005, a total of 30 patients were treated by RFA therapy after suture and ligation surgery (SL group, n = 15, with 18 liver lesions) or RFA therapy without suture and ligation surgery (non-SL group, n = 15, with 17 liver lesions) under general anesthesia.
  • Preoperative diagnosis of HCH was established by means of ultrasonography, helical computed tomography (CT) scans, and magnetic resonance imaging (MRI).
  • All of the 35 lesions were located on the liver surface, in the caudate lobe of the liver, or adjacent to the gallbladder.
  • Cholecystectomy was performed simultaneously for gallstones in 7 patients and for abutting of gallbladder from hemangioma in 2 patients.
  • [MeSH-major] Catheter Ablation. Hemangioma, Cavernous / surgery. Liver Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17064621.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Randomized Controlled Trial
  • [Publication-country] China
  •  go-up   go-down


95. Skalický T, Treska V, Sutnar A, Liska V, Molácek J, Mírka H, Ferda J, Ohlídalová K, Slauf F, Novák M: [Surgical treatment of benign liver tumours--indications and results]. Zentralbl Chir; 2009 Apr;134(2):141-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Surgical treatment of benign liver tumours--indications and results].
  • The authors present their results on the treatment of benign liver tumors.
  • Benign liver lesions were rather rare compared to malignant tumours, for which 273 patients were treated within the same period.
  • The most often found benign -lesions were hepatocellular adenoma, focal nodular hyperplasia (FNH) and hemangioma.
  • Sometimes, it was not possible to make a correct diagnosis preoperatively.
  • The surgical procedures used for benign tumours were mostly enucleation and non-anatomic parenchyma-saving resection (55.4 %).
  • [MeSH-major] Adenoma, Liver Cell / surgery. Focal Nodular Hyperplasia / surgery. Hemangioma / surgery. Hepatectomy / methods. Liver Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Cystadenoma / diagnosis. Cystadenoma / surgery. Diagnosis, Differential. Diagnostic Imaging. Female. Hamartoma / diagnosis. Hamartoma / surgery. Humans. Lymphangioma / diagnosis. Lymphangioma / surgery. Male. Middle Aged. Young Adult

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19382044.001).
  • [ISSN] 0044-409X
  • [Journal-full-title] Zentralblatt für Chirurgie
  • [ISO-abbreviation] Zentralbl Chir
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


96. Feuerlein S, Pauls S, Juchems MS, Stuber T, Hoffmann MH, Brambs HJ, Ernst AS: Pitfalls in abdominal diffusion-weighted imaging: how predictive is restricted water diffusion for malignancy. AJR Am J Roentgenol; 2009 Oct;193(4):1070-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of our retrospective study was to investigate the specificity of restricted diffusion in differentiation of benign from malignant abdominal disease.
  • The 12 benign lesions were liver hemangioma, liver adenoma, autoimmune pancreatitis, pancreatic teratoma, two abscesses, three cases of inflammatory bowel wall thickening due to Crohn's disease, Bartholin cyst, hemorrhagic ovarian cyst, and renal Rosai-Dorfman disease.
  • However, in interpretation of diffusion-weighted images, it should be kept in mind that a number of benign lesions, as many as 22% in our cohort, can exhibit restricted diffusion on images with high b values, thus mimicking malignant lesions.
  • [MeSH-major] Abdominal Neoplasms / diagnosis. Artifacts. Diffusion Magnetic Resonance Imaging / methods

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19770331.001).
  • [ISSN] 1546-3141
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. Cao J, Luo S, Liang L, Lai J, Chen S: Effects of parenteral nutrition with and without GH on the GH/IGF-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis. Front Med China; 2007 Jul;1(3):287-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effects of parenteral nutrition with and without GH on the GH/IGF-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis.
  • Postoperative hepatic insulin-like growth factor-1 (IGF-1) production may be severely disturbed in patients with liver cirrhosis.
  • Liver function, serum GH, IGF-1 and IGFBP-3 were measured before the operation and at post-operative days (POD) 1 and 6.
  • Insulin-like growth factor-1 and IGFBP-3 mRNA in the liver tissue was detected by RT-PCR.
  • The liver Ki67 immunohistochemistry staining was studied.
  • At the same time, 12 patients with cholelithiasis or liver hemangioma who underwent operation served as normal control group.
  • On POD 6, serum prealbumin, GH, IGF-1, IGFBP-3, hepatic IGF-1 mRNA, IGFBP-3 mRNA and liver Ki67 LI were higher in the rhGH + PN group than in the PN group.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Hepatol. 1999 Aug;31(2):271-6 [10453940.001]
  • [Cites] Lancet Oncol. 2002 May;3(5):298-302 [12067807.001]
  • [Cites] Endocr Rev. 1994 Feb;15(1):80-101 [8156941.001]
  • [Cites] J Clin Endocrinol Metab. 1995 Feb;80(2):374-8 [7852493.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2004 Jan;286(1):E151-7 [12759221.001]
  • [Cites] Physiol Res. 2002;51(6):587-90 [12511182.001]
  • [Cites] Zhonghua Wai Ke Za Zhi. 2005 Jun 1;43(11):697-701 [16008955.001]
  • [Cites] Endocrinology. 1994 Mar;134(3):1570-6 [7509741.001]
  • [Cites] Fed Proc. 1982 Nov;41(13):3008-11 [6292004.001]
  • [Cites] Gastroenterology. 1992 Jan;102(1):200-5 [1727754.001]
  • [Cites] World J Surg. 2003 Apr;27(4):412-5 [12658483.001]
  • [Cites] Cancer Res. 2006 Mar 15;66(6):3024-33 [16540651.001]
  • [Cites] Nutrition. 1997 Mar;13(3):185-90 [9131676.001]
  • [Cites] Lancet. 1997 May 3;349(9061):1269-76 [9142060.001]
  • [Cites] Novartis Found Symp. 2004;262:247-60; discussion 260-68 [15562834.001]
  • [Cites] Hepatogastroenterology. 2003 May-Jun;50(51):814-6 [12828091.001]
  • [Cites] World J Gastroenterol. 2001 Aug;7(4):445-54 [11819809.001]
  • [Cites] J Cell Physiol. 2000 Mar;182(3):311-22 [10653597.001]
  • [Cites] Mutat Res. 1996 Jan 2;362(1):97-103 [8538654.001]
  • [Cites] JPEN J Parenter Enteral Nutr. 2000 May-Jun;24(3):140-4 [10850937.001]
  • [Cites] J Clin Invest. 1995 May;95(5):2258-65 [7537760.001]
  • [Cites] J Hepatol. 2005 Oct;43(4):630-6 [16024131.001]
  • [Cites] Surgery. 1995 Mar;117(3):260-7 [7878530.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E916-26 [14749210.001]
  • [Cites] J Ren Nutr. 2000 Oct;10(4):184-90 [11070145.001]
  • [Cites] World J Gastroenterol. 2000 Aug;6(4):565-568 [11819648.001]
  • [Cites] J Gastroenterol Hepatol. 2000 Jul;15(7):706-17 [10937674.001]
  • [Cites] Gastroenterology. 1996 Sep;111(3):720-6 [8780578.001]
  • [Cites] J Biol Chem. 1997 May 2;272(18):12181-8 [9115291.001]
  • [Cites] Hepatology. 1991 Dec;14(6):1090-6 [1959859.001]
  • [Cites] Clin Endocrinol (Oxf). 2003 Dec;59(6):699-706 [14974910.001]
  • [Cites] Hepatology. 1993 Apr;17(4):564-76 [8477961.001]
  • [Cites] Biochem Pharmacol. 2004 Sep 15;68(6):1003-15 [15313394.001]
  • [Cites] J Hepatol. 2000 Mar;32(3):505-7 [10735622.001]
  • [Cites] J Clin Endocrinol Metab. 1995 Feb;80(2):443-9 [7531712.001]
  • (PMID = 24573868.001).
  • [ISSN] 1673-7342
  • [Journal-full-title] Frontiers of medicine in China
  • [ISO-abbreviation] Front Med China
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  •  go-up   go-down


98. Zuber-Jerger I, Schacherer D, Woenckhaus M, Jung EM, Schölmerich J, Klebl F: Contrast-enhanced ultrasound in diagnosing liver malignancy. Clin Hemorheol Microcirc; 2009;43(1-2):109-18
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Contrast-enhanced ultrasound in diagnosing liver malignancy.
  • PURPOSE: The use of contrast enhancers has widened the possibilities of sonographic imaging, and allows the differentiation of characteristic enhancement patterns leading to diagnosis in focal liver lesions.
  • The aim of our study was to evaluate contrast ultrasound signs in diagnosing malignant liver lesions.
  • METHODS: 86 patients with 100 solid liver lesions were enrolled.
  • Final diagnosis was confirmed by histology or in case of haemangioma by CT/NMR and quantitative contrast harmonic imaging (CHI) with perfusion analysis (contrast).
  • RESULTS: 55 malignant (6 HCC, 46 secondary malignant lesions - 3 of them lymphoma, 3 cholangiocarcinoma), and 45 benign lesions (8 FNH, 1 von Meyenburg complex, 1 granuloma, 3 adenoma, 21 hemangioma, 2 focal fat storage imbalances, 7 abscesses, one scar, and in one case normal liver) were found.
  • 51/55 malignant (all but one filia and three HCC), but also 17/45 benign lesions showed hypoperfusion in the late phase.
  • In all but one malignant lesion a diminishing of contrast agent in the late phase compared to the arterial phase with respect to the surrounding liver tissue was observed.
  • Only three benign lesions with this later sign were falsely diagnosed as malignant: one adenoma, one epitheloid granuloma, and a scar.
  • Diminishing of contrast agent in the late phase compared to the arterial phase with respect to the surrounding liver tissue as a sign for malignancy had a positive predictive value of 95%, a sensitivity of 98%, a negative predictive value of 98%, and a specificity of 93%.
  • CONCLUSIONS: Diminishing of contrast agent in the late phase compared to the arterial phase with respect to the surrounding liver tissue is a helpful sign in contrast enhanced ultrasound to diagnose malignancies.
  • [MeSH-major] Contrast Media. Liver Neoplasms / ultrasonography

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19713605.001).
  • [ISSN] 1875-8622
  • [Journal-full-title] Clinical hemorheology and microcirculation
  • [ISO-abbreviation] Clin. Hemorheol. Microcirc.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


99. Blonski W, Reddy KR: Evaluation of nonmalignant liver masses. Curr Gastroenterol Rep; 2006 Feb;8(1):38-45
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluation of nonmalignant liver masses.
  • Nonmalignant liver masses are increasingly being recognized with the widespread use of imaging modalities such as ultrasonography, computed tomography, and magnetic resonance imaging.
  • Based on the radiologic appearance, benign lesions can be categorized as solid or cystic, single or multiple, hypervascular or hypovascular.
  • In the majority of patients, a proper diagnosis can be made based on these characteristics on imaging modalities alone.
  • This review discusses the various characteristics of the most common benign liver lesions and recommends a practical approach.
  • [MeSH-major] Adenoma, Liver Cell / diagnosis. Focal Nodular Hyperplasia / diagnosis. Hemangioma, Cavernous / diagnosis. Liver / pathology. Liver Neoplasms / diagnosis
  • [MeSH-minor] Cysts / diagnosis. Humans. Hyperplasia. Liver Diseases / diagnosis

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur Radiol. 2001;11(9):1578-93 [11511877.001]
  • [Cites] Gut. 2002 Jun;50(6):877-80 [12010893.001]
  • [Cites] Radiology. 1991 Jul;180(1):25-30 [2052704.001]
  • [Cites] Radiographics. 2001 Jul-Aug;21(4):895-910 [11452064.001]
  • [Cites] Radiology. 2004 Aug;232(2):420-30 [15286314.001]
  • [Cites] Gut. 2005 Jul;54(7):1021-3 [15951553.001]
  • [Cites] Scand J Gastroenterol Suppl. 2002;(236):81-6 [12408510.001]
  • [Cites] Ultrasound Q. 2004 Dec;20(4):155-69 [15602218.001]
  • [Cites] Abdom Imaging. 1996 Mar-Apr;21(2):117-9 [8661756.001]
  • [Cites] AJR Am J Roentgenol. 1987 Apr;148(4):711-5 [3030082.001]
  • [Cites] Scand J Gastroenterol. 2004 Jan;39(1):67-73 [14992564.001]
  • [Cites] Eur Radiol. 2002 Mar;12 (3):537-44 [11870467.001]
  • [Cites] J Am Coll Surg. 2001 Jul;193(1):36-45 [11442252.001]
  • [Cites] AJR Am J Roentgenol. 1995 Dec;165(6):1403-6 [7484574.001]
  • [Cites] AJR Am J Roentgenol. 2000 Mar;174(3):705-12 [10701613.001]
  • [Cites] Eur Radiol. 1999;9(3):428-35 [10087111.001]
  • [Cites] Hepatology. 1992 Oct;16(4):1069-83 [1398487.001]
  • [Cites] J Clin Gastroenterol. 2002 Apr;34(4):463-71 [11907365.001]
  • [Cites] Abdom Imaging. 1999 May-Jun;24(3):262-6 [10227890.001]
  • [Cites] Radiology. 2001 Jun;219(3):699-706 [11376257.001]
  • [Cites] Br J Radiol. 1989 Apr;62(736):335-7 [2653548.001]
  • [Cites] Radiology. 2001 Apr;219(1):61-8 [11274535.001]
  • [Cites] Eur Radiol. 2001;11(2):202-12 [11218015.001]
  • [Cites] Gastroenterology. 2000 Mar;118(3):560-4 [10702207.001]
  • [Cites] J Hepatol. 1985;1(6):573-8 [2997324.001]
  • [Cites] Radiology. 1994 Feb;190(2):387-92 [8284385.001]
  • [Cites] Radiographics. 2004 Jan-Feb;24(1):3-17; discussion 18-9 [14730031.001]
  • [Cites] Ultrasound Med Biol. 2004 Sep;30(9):1089-97 [15550313.001]
  • [Cites] Radiographics. 2000 Mar-Apr;20(2):379-97 [10715338.001]
  • [Cites] Radiology. 1990 Jan;174(1):161-3 [2294544.001]
  • [Cites] Hepatology. 1999 Oct;30(4):889-93 [10498639.001]
  • [Cites] Radiographics. 2001 Jul-Aug;21(4):877-92; discussion 892-4 [11452062.001]
  • [Cites] Am J Surg Pathol. 1999 Dec;23(12):1441-54 [10584697.001]
  • [Cites] Clin Liver Dis. 2001 Feb;5(1):17-42, v [11218914.001]
  • [Cites] Clin Liver Dis. 2001 Feb;5(1):1-15, v [11218909.001]
  • [Cites] J Ultrasound Med. 1999 Jul;18(7):445-51; quiz 453-4 [10400046.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1997 Mar;24(3):276-9 [9138172.001]
  • [Cites] Eur J Radiol. 1999 Oct;32(1):52-60 [10580322.001]
  • [Cites] Curr Probl Diagn Radiol. 2004 Nov-Dec;33(6):239-53 [15549050.001]
  • [Cites] J Clin Gastroenterol. 2005 May-Jun;39(5):401-12 [15815209.001]
  • [Cites] Radiol Clin North Am. 1998 Mar;36(2):319-31 [9520985.001]
  • [Cites] Radiology. 2000 Aug;216(2):395-402 [10924560.001]
  • [Cites] J Hepatol. 1991 Jan;12(1):94-9 [2007779.001]
  • [Cites] Eur Radiol. 2005 Aug;15(8):1643-9 [15712000.001]
  • [Cites] Br J Surg. 2001 Jun;88(6):808-13 [11412249.001]
  • [Cites] Lancet. 1973 Oct 27;2(7835):926-9 [4126557.001]
  • [Cites] Gastroenterology. 1983 May;84(5 Pt 1):994-1002 [6299876.001]
  • [Cites] J Comput Assist Tomogr. 2000 Jan-Feb;24(1):61-6 [10667661.001]
  • [Cites] Med Clin North Am. 1975 Jul;59(4):995-1013 [167242.001]
  • [Cites] Radiology. 2000 Jun;215(3):746-51 [10831693.001]
  • [Cites] Radiographics. 1999 Mar-Apr;19(2):431-51 [10194789.001]
  • [Cites] Ann Surg. 1970 Aug;172(2):239-45 [5433290.001]
  • [Cites] AJR Am J Roentgenol. 1998 Feb;170(2):391-5 [9456952.001]
  • [Cites] Gastroenterology. 1985 Nov;89(5):1132-8 [2412930.001]
  • [Cites] J Am Coll Surg. 2000 Sep;191(3):311-21 [10989905.001]
  • [Cites] AJR Am J Roentgenol. 1995 Mar;164(3):625-9 [7863883.001]
  • [Cites] J Clin Gastroenterol. 1990 Aug;12(4):460-5 [1975817.001]
  • [Cites] AJR Am J Roentgenol. 2002 Oct;179(4):1053-7 [12239064.001]
  • [Cites] J Am Coll Surg. 2003 Sep;197(3):392-402 [12946794.001]
  • [Cites] Abdom Imaging. 2000 May-Jun;25(3):255-8 [10823445.001]
  • [Cites] JAMA. 1979 Aug 17;242(7):644-8 [221698.001]
  • [Cites] Am J Obstet Gynecol. 2002 Feb;186(2):195-7 [11854634.001]
  • [Cites] J Clin Ultrasound. 1993 Feb;21(2):115-8 [8381130.001]
  • [Cites] Hepatology. 1995 Sep;22(3):983-93 [7657307.001]
  • [Cites] Semin Liver Dis. 2001 May;21(2):237-49 [11436575.001]
  • [Cites] Radiology. 2000 Mar;214(3):861-8 [10715059.001]
  • [Cites] Arch Surg. 1994 Jul;129(7):712-7 [7517661.001]
  • [Cites] Semin Roentgenol. 1995 Oct;30(4):324-46 [8539643.001]
  • [Cites] Magn Reson Imaging Clin N Am. 1997 May;5(2):241-53 [9113674.001]
  • [Cites] Abdom Imaging. 2001 Sep-Oct;26(5):500-6 [11503088.001]
  • [Cites] Eur Radiol. 1997;7(5):654-8 [9166561.001]
  • [Cites] Clin Liver Dis. 2002 Feb;6(1):119-45 [11933585.001]
  • [Cites] N Engl J Med. 1976 Feb 26;294(9):470-2 [173996.001]
  • [Cites] Adv Surg. 1997;31:127-48 [9408491.001]
  • [Cites] Am Surg. 2001 Feb;67(2):173-8 [11243545.001]
  • [Cites] Radiology. 1995 Aug;196 (2):465-9 [7617862.001]
  • [Cites] Arch Surg. 2001 Sep;136(9):1033-8 [11529826.001]
  • [Cites] Hepatology. 1985 Nov-Dec;5(6):1194-200 [4065824.001]
  • [Cites] Liver Transpl Surg. 1997 Mar;3(2):160-5 [9346730.001]
  • (PMID = 16510033.001).
  • [ISSN] 1522-8037
  • [Journal-full-title] Current gastroenterology reports
  • [ISO-abbreviation] Curr Gastroenterol Rep
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 81
  •  go-up   go-down


100. Dardenne S, Hubert C, Sempoux C, Annet L, Jouret-Mourin A, Horsmans Y, Van Beers BE, Zech F, Gigot JF: Conservative and operative management of benign solid hepatic tumours: a successful stratified algorithm. Eur J Gastroenterol Hepatol; 2010 Nov;22(11):1337-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Conservative and operative management of benign solid hepatic tumours: a successful stratified algorithm.
  • BACKGROUND: The progress of modern imaging studies has improved the diagnostic approach of benign liver tumours, leading to a tailored approach with increased conservative management.
  • METHODS: One hundred and thirty-two patients suffering from benign hepatic tumours were enrolled in this study, including an operative (group I, 49 patients) and a conservative (group II, 83 patients) management.
  • Indication for resection based on diagnosis of tumour nature (hepatic cell adenoma or uncertain diagnosis) and significant tumour-related abdominal pain was 15% out of 33 patients with hepatic haemangioma, 21.7% out of 60 patients with focal nodular hyperplasia and 78.4% out of 37 patients with hepatocellular adenoma.
  • Interestingly, 87.9% of all observed benign liver tumours remained stable, decreased in size or disappeared.
  • CONCLUSION: A restrictive policy of surgical management of benign liver tumours based on clinical symptoms, tumour size and nature on imaging studies (including dubious lesions) and tumour biopsies in selected cases is safe and reliable with a low-operative mortality in resected patients and satisfactory disease-control in the vast majority of observed benign liver tumours.
  • [MeSH-major] Adenoma, Liver Cell / therapy. Algorithms. Critical Pathways. Focal Nodular Hyperplasia / therapy. Hemangioma / therapy. Hepatectomy. Laparoscopy. Liver Neoplasms / therapy

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20683192.001).
  • [ISSN] 1473-5687
  • [Journal-full-title] European journal of gastroenterology & hepatology
  • [ISO-abbreviation] Eur J Gastroenterol Hepatol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down






Advertisement